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SUMMARY.
I have isolated a full length cDNA clone encoding a 
thyroid hormone receptor from a Xenopus laevis mature 
oocyte cDNA library. This receptor binds thyroid hormone 
with high affinity when expressed in COS cells. Expression 
from the thymidine kinase promoter containing an 
artificial thyroid hormone response element could be 
induced by thyroid hormone in the presence (but not in the 
absence) of this receptor. Thyroid hormone receptors 
isolated from other organisms are known to act directly 
upon gene expression at the level of transcription by 
binding to regulatory sequences within thyroid hormone 
responsive genes. My results with the Xenopus thyroid 
hormone receptor are consistent with this mode of action.
There appear to be several rare transcripts in X.laevis 
ovary which hybridised to the thyroid hormone receptor 
cDNA clone. These transcripts could not be detected in 
eggs, suggesting that they are located in the follicle 
cells rather than the oocyte itself.
Several rare transcripts which hybridised to the cDNA 
clone are also present in early embryonic stages. These 
differently sized but clearly related transcripts are 
suggestive of differential splicing. Synthetic RNA 
prepared from the entire cDNA translates very poorly in 
vitro and this is almost certainly due to the presence oF 
several AUG codons upstream of the long open reading 
frame.
Thyroid hormone is known to play a vital role in 
inducing the many biochemical and physiological changes 
that occur during amphibian metamorphosis. It is almost 
certain that some of these changes are the result of the 
activation and repression of specific genes at a 
transcriptional level. I have demonstrated that 
transcription of the Xenopus albumin genes is activated at 
the onset of metamorphosis. The albumin genes are 
therefore candidates for genes whose expression is 
activated by thyroid hormone. I have tested the response 
of a cloned X.laevis 68Kda albumin gene to thyroid hormone 
in a transient transfection assay. From this experiment I 
tentatively conclude that thyroid hormone does increase 
expression of the 68Kda albumin gene, at the level of the 
messenger RNA, and that this increase requires the 
presence of the co-transfected (Xenopus) thyroid hormone 
receptor.
The liver-specific expression of albumin genes from 
Xenopus and other organisms is known to be controlled at 
the level of transcription by liver-specific trans-acting 
factors which interact with regulatory sequences upstream 
of these genes. Iti vivo, in the developing liver, 
transcription of the Xenopus albumin genes might require 
the presence of both tissue-specific trans-acting factors 
and the thyroid hormone receptor complex.
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C H A P T E R  1 
INTRODUCTION
Determining the mechanisms by which the expression of 
eukaryotic genes are controlled is of prime importance if 
we are to understand how a single cellt the fertilised egg 
develops into a complex multicellular organism. The 
identity and function of a differentiated cell ultimately 
depends upon the pattern of gene expression within that 
cell. From a simplified point of view, the process of 
development and differentiation is the result of a 
specific temporal and spatial pattern of differential gene 
expression. Thus, a lot of work has been focused upon 
determining the mechanisms by which particular genes are 
expressed in one cell type but not in others.
The transmission of information from gene to protein is 
extremely complex, involving many steps, the precise 
details of which are only now being elucidated. Therefore 
there are many steps at which gene expression may be 
regulated. It is now becoming clear that the expression of 
significant numbers of genes is at least partially 
controlled post-transcriptionally. There are many examples 
in the literature where differential gene expression is 
controlled by stabilisation of the mRNA. The discovery 
that the primary transcripts of seme genes are subject to 
alternative splicing provides an additional point for the 
control of gene expression. There is at least one example
1
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of the developmental regulation of alternative splicing 
(Troponin T in the chicken embryo; Cooper and Ordahl, 
1985). There are also examples of translational control 
(for a recent example see Miller and Hinnebusch, 1989).
However, it is now becoming clear that for the majority 
of genes the primary control point is at the level of 
transcription. As yet very little is known about the 
nature of the signals and biochemical pathways which bring 
about transcriptional changes. However, significant 
progress has been made towards understanding the 
mechanisms of transcription initiation. It has become 
clear that the frequency of transcription initiation 
depends upon protein factors that interact with DNA 
sequence elements within genes. An increasing number of 
these trans-acting factors are being identified and the 
genes for some of them have been cloned. The next step 
will be to try and understand how the expression and/or 
activity of the transcription factors themselves is 
regulated.
1.1 The control of eukaryotic mRNA synthesis.
A variety of methods have led to the identification of 
DNA sequences required for the transcription of genes by 
RNA polymerase II (for more details see the reviews by 
Dynan and Tjian, 1985, Maniatis et ¿1, 1987). It is now 
clear that these sequence elements can be broadly divided 
into two groups; promoter elements and enhancers.
2
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Promoters are located immediately upstream of the start of 
transcription and are typically no more than 150bp in 
length. The promoter is required for accurate and 
efficient initiation of transcription and contains a 
binding site for RNA polymerase. Promoters have a modular 
structure, being composed of a variable number of clearly 
defined sequence elements (see the review by Dynan, 1989). 
The majority of RNA polymerase II promoters contain an AT 
rich motif known as a TATA box located about 30 base pairs 
upstream of the transcription initiation site. The primary 
function of the TATA box appears to be to ensure that 
transcripts are initiated at the correct start site. In 
addition to a TATA box, promoters may also contain one or 
more sequence elements that are required for the maximal 
activity of the promoter. Some of these such as the CAAT 
box and SP1 box are found in the promoters of many genes 
and confer a basal level of transcription (see the review 
by Dynan and Tjian, 1985). Other sequence elements are 
required for correct tissue-specific transcription (for 
example the octamer motif found in the promoter of 
immunoglobulin heavy chain genes (Schaffner, 1989), and 
the HP1 element found in the promoters of several liver- 
specific genes (Courtois e_t a_l, 1987; Kugler ejt a_l, 1988; 
Hardon eji al, 1988; Courtois et a_l, 1988). Some promoter 
elements are responsible for conferring inducible 
transcription (for example the API site confers 
inducibility by phorbol esters (see the review by Lenardo
3
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and Baltimore, 1989)).
Enhancers are distinct from promoters in that they can 
affect transcription at great distances from the 
transcription start site. They are also characterised by 
the ability to function in both orientations and when 
placed upstream or downstream of the transcription start 
site. Enhancers often play crucial roles in tissue- 
specific transcription whilst others are responsible for 
inducible transcription, for example by steroid hormones 
(see Maniatis et «1, 1987 for a review).
In almost all cases both enhancers and the conserved 
sequence elements within promoters have been shown to 
specifically interact with proteins called transcription 
factors. This interaction leads to the enhancement or 
repression of the rate of transcription initiation. Based 
upon work with the prokaryotic transcription factors 
lambda and cro, it is thought that eukaryotic 
transcription factors activate transcription via protein- 
protein interactions (see the review by Ptashne, 1988). 
However, the exact details of how protein factors, 
especially those bound to sites distant from the promoter 
(enhancers), activate transcription remain to be 
elucidated. Only a small number of negatively acting 
transcription factors have been identified but there is 
some evidence that they may function by blocking the 
binding sites on DNA for other positive transcription 
factors (for example; Barberis et a_l, 1987).
4
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An increasing number of transcription factors are being 
purified and a number have been cloned. Structural and 
functional analysis has shown that the different 
transcription factors are usually composed of a variety of 
separable DNA binding and trans-activation domains.
Several distinct types of DNA binding domain have now 
been identified in eukaryotic transcription factors (for a 
review see Mitchell and Tjian, 1989). Zinc finger motifs 
were first identified as being important for the DNA 
binding activity of the RNA polymerase III transcription 
factor TFIIIA (Miller et al, 1985). Since then at least 
two distinct classes of zinc finger motif have been 
identified in RNA polymerase II transcription factors (see 
Evans and Hollenberg, 1988). In the first class, typified 
by SP1, two cysteine and two histidine residues stabilise 
the domain by tetrahedrally coordinating a zinc ion. A 
second class is typified by the DNA binding domains of the 
steroid hormone receptors. Here a zinc ion is 
tetrahedrally coordinated by two pairs of cysteine 
residues rather than the histidine-cysteine arrangement 
found in SP1. Both SP1 and the glucocorticoid receptor 
have been shown to require zinc for DNA binding activity 
(Kadonga e_t a_l, 1987; Freedman e_t a_l, 1988), and 
mutational analysis has confirmed the importance of the 
conserved cysteine residues in the DNA binding domain of 
the glucocorticoid receptor (Giguere e£ a_l, 1986; 
Hollenberg and Evans, 1988). The steroid hormone type DNA
>
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binding domain will be discussed in more detail in section 
1.4.4.
A second type of DNA binding domain is the so called 
homeodomain (for a review see Levine and Hoey, 1988). This 
domain was initially identified as a conserved region in a 
number of Drosophila proteins that have crucial roles in 
embryogenesis. Since then the homeodomain has also been 
found in vertebrate genes. The homeodomain is distantly 
related to the helix turn helix motif of prokaryotic 
transcriptional activators.
The cloning of three mammalian transcription factors 
oct-1, oct-2 and pit-1 and unc-86, a regulatory protein 
from Caenorhabditis elegans lead to the discovery of a new 
class of transcription factors related to the homeodomain 
containing proteins (for a review see Levine and Hoey, 
1988). These four proteins all contain a bi-partite domain 
termed the POU domain which consists of the homeodomain 
and a second region the POU box. More recertly, several 
other POU domain containing genes have been isolated. The 
distinct tissue distributions of their mRNAs suggest that 
they may play a role in brain development and 
differentiation (He £t al^ , 1989).
A third type of DNA binding domain has been identified 
in the mammalian transcription factors jun, fos, C/EBP and 
CREB (for a review see Mitchell and Tjian, 1989). This 
consists of a conserved stretch of 30 amino acids which 
have a net negative charge, followed by four leucine
6
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residues at intervals of seven amino acids. The leucine 
region (known as the leucine zipper) mediates dimerisation 
(between identical or different monomers) and this is 
essential for DNA binding. It is thought that the DNA 
binding domain is created by dimerisation and that both 
the basic region and the leucine region contribute to the 
DNA binding domain.
The number and types of DNA binding domain is certainly 
not limited to these four because several transcription 
factors do not fit in to any of these categories.
The regions of transcription factors responsible for 
activation of transcription have been less well defined 
than those responsible for DNA binding. Activation domains 
have been identified in only a small number of 
transcription factors and so far several types have been 
identified. One of these consists of a short stretch of 
amino acids the only significant features of which are an 
overall negative charge and the ability to form an 
amphipathic helix (see Ptashne, 1988). This so called 
acidic domain has been functionally identified only in 
GCN4 and GAL4. However, one of the activation domains of 
the glucocorticoid receptor resembles this type of 
structure (Hollenberg and Evans, 1988). It has been 
proposed that acidic activation domains could make 
contacts with other components of the transcriptional 
machinery, such as TFIID, and thereby activate 
transcription ( Ptashne, 1988).
- 7 -
Introduction
Another type of activation domain was identified in the 
transcription factor SP1. The most notable feature of this 
domain is that it is rich in glutamine residues. A third 
type of activating domain consisting of a stretch of amino 
acids rich in proline has been identified in the CAAT box 
transcription factor, CTF (see the review by fjitchell and 
Tjian, 1989).
A big question which remains to be answered is how 
transcription factors themselves are regulated. Many 
transcription factors are phosphoproteins so their 
activity could be regulated by phosphorylation/de- 
phosphorylation. This provides a possible link between 
transcription factors and the second messenger system 
present in many cells. The activity of one transcription 
factor, NFKB, is known to be regulated by a second 
protein; IKB. IKB binds to NFKB in the cytoplasm and 
prevents it from activating transcription (for a review 
see Lenardo and Baltimore, 1987). Treatment with phorbol 
esters results in the dissociation of IKB and the 
subsequent transcriptional activation of various lymphoid- 
specific genes. For steroid and thyroid hormone receptors, 
transcriptional activation can only occur when the 
receptor has formed a complex with its cognate hormone. 
There is now at least one example of the transcriptional 
control of the expression of a transcription factor 
(Xanthopoulos et al, 1989). The transcription factor C/EBP
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is an enhancer binding protein thought to be involved in 
the liver-specific transcription of a number of genes. The 
mRNA encoding this protein is found at higher 
concentrations in liver cells than in most other cell 
types. Nuclear run-on experiments indicated that the 
restricted distribution of the mRNA was due to 
transcriptional regulation of the gene.
1.2 The involvement of chromatin structure in gene 
regulation.
Any model for the control of eukaryotic gene expression 
must take into account the fact that inside cells the DNA 
is complexed with a variety of proteins in the form of 
chromatin. Most genes that are being expressed (as well as 
the non-expressed ones) are organized into nucleosomes. 
However, the chromatin structure of expressed genes has 
often been found to be significantly different from those 
which are transcriptionally inactive (for a review see 
Gross and Garrard, 1987). Transcriptionally active genes 
often contain nuclease hypersensitive sites. These sites 
are now known to be caused by the binding of trans-acting 
factors to cis-acting regulatory elements (for example; 
Emerson et a_l, 1985). Histone HI is responsible for the 
compaction of nucleosomes into the 300A° fibre, and active 
genes may also be organised into a decondensed chromatin
9
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structure via the depletion of histone HI. There is some 
evidence that some active genes may be under torsional 
stress and that this maybe necessary for transcriptional 
activation. Active genes may also be undermethylated. 
Since the state of methylation is maintained through semi­
conservative DNA replication it has been proposed that 
this might provide a mechanism for the stable maintainance 
of patterns of gene expression (for example; Groudine and 
Conkin, 1985).
The establishment of this active chromatin state is 
believed to be initiated by the binding of transcription 
factors to cis-acting regulatory sequences (see Gross and 
Garrard, 1987). This may require DNA replication since 
nucleosomes have been shown to prevent binding of some 
transcription factors (Emerson e£ al^ 1985). Several lines 
of evidence suggest that the interactions between 
transcription factors and cis-acting DNA elements may only 
be required to establish transcriptionaly active chromatin 
and not to maintain or propagate it (for example: Wang and 
Calame, 1986). This provides a possible mechanism for the 
maintainance of patterns of gene expression through cell 
division.
The DNA in both mitotic and interphase nuclei is 
organised into loops of 5 to 100Kb that are anchored to 
what is called the nuclear matrix. A class of sequences 
termed matrix association regions have been defined that 
may mediate loop attachment (Cockerill and Garrard, 1986).
10
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Interestingly, these sequences are sometimes found close 
to transcriptional enhancers. It has been suggested that 
genes within each loop could be coordinately regulated by 
the conversion of a whole loop from an inactive to an 
active chromatin configuration (see Gross and Garrard, 
1987). This provides an explanation of how enhancers are 
able to effect transcription over such large distances. 
Binding of trans-acting factors to an enhancer, that may 
be located at the base of a loop, could lead to the 
induction of an active chromatin domain that spans the 
whole loop. This in turn would lead to the activation of 
genes many thousands of base pairs away from the enhancer.
1.3 Liver-specific gene expression.
When I began this project very little was known about 
the mechanisms underlying liver-specific gene expression. 
In the past three years the development of new techniques 
for analysing the interactions between proteins and DNA 
has lead to tremendous progress in this field. In the 
section which follows I will describe what was known when 
I began this project, and then go on to describe in 
sections 1.3.2 and 1.3.3 the current state of research 
into liver-specific gene expression.
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1.3.1 Liver-specific gene expression is controlled mainly 
at the level of transcription.
In 1981 Darnell and his co-workers (Derman e_t al, 1981) 
isolated several cDNA clones encoding mRNAs that were 
enriched in mouse liver. cDNA was prepared from 
unfractionated mouse liver RNA, thus selecting for those 
mRNAs that were most abundant. The resulting cDNA clones 
were screened with polyA+ RNA prepared from mouse liver 
and mouse L-cells. In this way several cDNA clones 
specific to liver and several common to both liver and 
L-cells were isolated. Both groups of cDNA clones were 
used to determine the rate of transcription of their 
corresponding genes in mouse liver and brain. This was 
done by pulse labelling of the RNA being synthesised in 
isolated nuclei. The results showed that the nuclei from 
brain cells did not transcribe the liver-specific genes at 
ail or only at a very low level. The common genes were 
transcribed at similar rates in both cell types. This 
suggested that transcriptional control was responsible for 
the liver-specific expression of these moderately abundant 
genes. Tilghman and Belayew (1982) showed that the 
accumulation of alpha fetoprotein mRNA in the liver of the 
developing mouse foetus and its decline at birth was the 
result of alterations in the rate of transcription.
The finding that the tissue-specific expression of many 
liver-specific genes was controlled at the level of
12 -
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transcription lead to the search for the cis-acting DNA 
sequences responsible. Much progress has been made in this 
area and in the identification of the trans-acting factors 
that interact with them, and which may be ultimately 
responsible for liver-specific expression. This work is 
outlined in the following section.
1.3.2 The control of liver-specific transcription.
Several liver-specific genes have been studied in great 
detail with respect to the cis-acting DNA sequences 
required for their tissue-specific transcription and the 
factors that interact with them. These include the rat and 
mouse serum albumin genes, the human alpha-1 antitrypsin 
(o(lAT) gene and the rat alpha and beta fibrinogen genes.
The rat albumin gene has been studied by Yaniv and co­
workers (Cereghini £t a_l, 1987; Heard e_t a_l, 1987; 
Cereghini ej: al^ , 1988). Classical deletion analysis of the 
5' flanking region by transfection into hepatoma cell 
lines indicated that the first 150bp upstream of the 
transcription start site contained all of the critical 
sequences necessary for tissue-specific expression. DNasel 
footprinting experiments with nuclear proteins prepared 
from cell lines which express albumin showed that at least 
six distinct proteins were bound to this region. One of 
these covers the TATA box and a second covers the CAAT 
box. Three of the remaining footprints lie in the region
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upstream of the CAAT box and will be referred to as distal 
elements (DE) I, II and III. DEII appears to bind a 
protein related to the transcription factor NF-1. The 
sixth footprint lay in a region between the CAAT box and 
the TATA box and was designated the proximal element (PE). 
When footprinting was done with proteins prepared from de­
differentiated hepatoma cells that do not express the 
albumin gene a subtle difference was found. The pattern of 
DNasel protection on the three distal elements was 
identical to that seen with extracts from differentiated 
(albumin expressing) cell lines. However there was a clear 
difference in the interaction at the proximal element. The 
footprint in this region was significantly shorter with 
nuclear proteins prepared from albumin negative hepatoma 
cell lines. When footprinting was carried out with a 
mixture of extracts from albumin expressing and non­
expressing cell lines, the non-expressing pattern 
dominated. This suggested that albumin negative cells 
contain a dominant, negatively acting factor.
Further characterisation of the protein interactions 
occurring on the proximal element showed that two mutually 
exclusive proteins were interacting with this region. One 
of these, designated albumin promoter factor (APF) is 
found only in liver or differentiated hepatoma cell lines. 
The other protein termed variant APF (vAPF) is present 
only in those cell lines not expressing albumin. Both 
proteins have identical sequence specificities but differ
- 14 -
Introduction
in molecular weight and thermostability. It has been known 
for some time that when somatic hybrids are formed between 
differentiated hepatoma cells and cells not expressing 
liver-specific functions, the liver-specific functions are 
lost. This phenomenon, known as extinction, could reflect 
the presence of a dominant, negatively acting 
transcription factor in those cells not expressing liver- 
specific functions. In one such somatic hybrid it was 
shown that the APF protein was lost and that vAPF 
appeared. This suggests that vAPF is the negatively acting 
factor responsible for extinction of liver-specific 
functions.
In vitro transcription assays have shown that APF is 
essential for efficient transcription from the rat albumin 
promoter. In addition, both APF and vAPF will interact 
with homologous sequence elements present in the promoters 
of several other liver-specific genes (this will be 
discussed in more detail in section 1.3.3). The simple 
model prompted by these results is that vAPF is a negative 
transcription factor that is present in cells of non- 
hepatic lineage. By binding to the proximal element of the 
albumin promoter and similar elements in other liver- 
specific genes, it prevents the formation of an active 
transcription complex. In hepatic cells, vAPF is absent 
and APF binds to the PE. This is the crucial step which 
allows binding of all the other proteins in a productive 
way to form an active transcription complex. However, it
15
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cannot be as simple as this because extinction in somatic 
hybrids often involves the loss of only one liver-specific 
function. vAPF is known to interact with the promoters of 
several liver-specific genes so the simple model would 
predict that expression of all these would be 
extinguished. Also, extinction is seen in fusions with 
fibroblasts that do not have vAPF.
Deletion analysis of the human oflAT gene showed that 
sequences between 37 and 137bp upstream of the CAP site 
were crucial for liver-specific expression (Simone et al, 
1987; Monaci et al, 1988). Within this region two domains 
were identified by DNasel footprinting and site directed 
mutagenesis (Monaci £t al, 1988). These have been 
designated the A and B domains. In addition there are at 
least two other regulatory elements located upstream of 
the A and B domains that are required for maximal 
transcription. However, these two elements are active in 
both liver and non-liver cells. The protein which binds to 
the A domain has been called LFA1 and the protein which 
binds to the B domain was called LFB1. Both proteins have 
been partially purified. In an i_n vitro transcription 
system double stranded oligonucleotides corresponding to 
either the A or B domain inhibit transcription from the 
wild type promoter, indicating that binding of LFA1 and 
LFB1 is essential for transcription. When an 
oligonucleotide containing the B domain was used as a 
probe in gel retardation assays it was found that two
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distinct proteins found in liver nuclear extract were 
binding in this region. These two proteins were designated 
LFB1 and LFB2. By using shorter oligonucleotides derived 
from the B domain it was shown that that these two 
proteins had different but overlapping sequence 
specificities. LFB1 bound to a region on the right side of 
the B domain whilst LFB2 bound to a region on the left of 
the B domain. Further experiments indicated that the 
binding of LFB1 and LFB2 to the B domain was mutually 
exclusive. In an in vitro transcription reaction in liver 
nuclear extract, an oligonucleotide containing only the 
LFB1 binding site was as effective as the whole B domain 
at reducing transcription. This indicated that LFB1 was 
required for efficient transcription. In contr *, an 
oligonucleotide containing just the LFB2 binding s did 
not reduce transcription at all, indicating that b^ iing 
of LFB2 to the B domain was not required for transcription 
in liver nuclear extract. Nuclear extracts prepared from 
spleen, where the o(lAT gene is not transcribed, did not 
generate DNasel footprints in either the A domain or on 
the TATA box. However, spleen extract did protect the B 
domain from digestion with DNasel. This footprint was very 
similar (but not identical) to that seen with partially 
purified LFB2 on the B domain, and was specifically 
competed by an oligonucleotide containing the LFB2 binding 
site. The protein responsible for this footprint must 
therefore be very similar (if not identical) to the LFB2
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protein found in liver. This LFB2-like protein is more 
abundant in spleen than LFB2 in liver.
In summary, LFA1 and LFB1 are both required for 
efficient transcription in liver nuclear extract, and both 
are absent from spleen. LFB2 is found in both liver and 
spleen extracts, but is more abundant in spleen, and is 
not required for transcription. In liver extract, binding 
of LFB1 and LFB2 to the B domain is mutually exclusive. 
This suggests that LFB2 might be a repressor which acts by 
preventing the binding of the activator, LFB1. It could be 
that a fine balance between the concentrations of LFB1 and 
LFB2 is responsible for liver-specific transcription. In 
liver, where the concentration of LFB1 is high and LFB2 is 
low, transcription of the Of 1AT gene is activated. In 
spleen the concentration of LFB2 is high, and LFB1 is 
virtually non-existent resulting in repression. The 
sequence of the B domain from the human of 1AT promoter 
shows a high level of homology with the proximal element 
of the rat albumin promoter defined by Yaniv and co­
workers. The PE was also shown to bind two mutually 
exclusive proteins (called APF and vAPF) one of which 
could be a repressor.
Li e_t a_l (1988) also reported that two regions within 
the human °<1AT promoter were protected from DNasel 
digestion by liver nuclear extract. These regions 
correspond exactly to the A and B domains identified by 
Monaci et^  al^  (1988). Li et al (1988) showed that proteins
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binding to these domains are positive transcription 
factors. In extracts from various cells and tissues 
(including spleen) that do not express the o(lAT gene, they 
did not detect any proteins binding to either of these 
domains. This is in contrast to the results reported by 
Monaci £t al^  (1988) who reported that in spleen extracts 
the B domain did bind a protein, LFB2 that could be a 
repressor. This apparent contradiction must reflect slight 
differences in experimental technique.
By transfection into liver cell lines, Courtois e t al
(1987) showed that sequences between 117 and 78bp upstream 
of the CAP site of the rat ^-fibrinogen promoter were 
essential for liver-specific transcription. However, 
sequences outside of this region were required for maximal 
transcription. Extracts from differentiated liver cell 
lines produced two DNasel footprints in the first 300bp 
upstream of the CAP site. The regions covered by these 
footprints will be referred to as the distal element 
(centred around -135) and the proximal element (centred 
around -90). The proximal element (PE) thus corresponds to 
the region defined as being important for transcription in 
transfected liver cell lines. The footprint on the distal 
element was also generated with extracts from non-liver 
cell lines whilst the footprint on the PE was specific to 
liver cell nuclear extracts. The liver-specificity of the 
protein interacting with the PE was confirmed in gel 
retardation assays. This protein was designated HNF-1
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(hepatocyte nuclear factor 1). In further experiments 
(Baumhueter et al, 1988) it was shown that a de­
differentiated variant of the hepatoma cell line Fao had 
lost HNF-1 but gained a related protein, vHNF-1 (v for 
variant). Reversion of this de-differentiated cell line 
results in the re-expression of many liver-specific 
functions and is associated with the re-appearance of 
HNF-1. In somatic cell hybrids between liver cell lines 
and fibroblasts, which show extinction of liver-specific 
functions, HNF-1 is lost and vHNF-1 appears. Thus the 
presence of HNF-1 and the absence of vHNF-1 correlates 
with liver-specific transcription. vHNF-1 was shown to 
have the same or similar sequence specificity to HNF-1. 
These authors suggested that vHNF-1 may act as a repressor 
of liver-specific gene transcription by binding to the PE 
and preventing binding of HNF-1. It is tempting to 
speculate that since vHNF-1 is 20Kd smaller than HNF-1, it 
may lack a domain essential for the activation of 
transcription. These findings are analogous to those 
reported for the rat albumin promoter (APF/vAPF) and the 
human oflAT promoter (LFB1/LFB2). Indeed, the sequence 
elements recognised by these three pairs of factors in the 
three promoters show significant sequence similarity, and 
are almost certainly the same proteins. This will be 
discussed in more detail in section 1.3.3.
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The interaction of nuclear proteins with the mouse 
albumin promoter has been studied in great detail by 
Schibler and co-workers (Lichtsteiner et al, 1987; Gorski 
et al, 1986); Maire et al, 1989). Deletion analysis 
indicated that 170bp upstream of the CAP site were 
sufficient for efficient liver-specific in vitro 
transcription (Gorski et al, 1986). In contrast to these 
in vitro experiments, Pinkert et <al (1987) reported that 
in transgenic mice a region located between 10.4 and 8.5Kb 
upstream of the CAP site of the mouse albumin gene was 
essential for high level expression in adult liver. This 
far upstream region behaved like an enhancer in that its 
position and orientation relative to the albumin gene were 
not critical. Sequences between -8.5Kb and -0.3Kb were not 
required for efficient expression in adult liver. Thus it 
would seem that this enhancer is required Tn vivo but is 
not necessary for efficient transcription iii vitro. This 
could be interpreted as a requirement for an enhancer to 
generate an active chromatin configuration in the vicinity 
of the albumin gene, which is then accessible to other 
trans-acting factors closer to the CAP site.
Footprinting experiments with liver nuclear extracts 
(Lichtsteiner et^  a_l, 1987) indicated that there were at 
least six binding sites (A to F) for specific DNA binding 
proteins between the TATA box and nucleotide position 
-172. Deletion of site F had very little effect upon the 
rate of transcription (Gorski et ¿1, 1986). The identities
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of the proteins interacting with the six sites have been 
determined (Lichtsteiner and Schibler, 1989; in press). A 
comprehensive mutational analysis of the six binding sites 
has been carried out (Maire e_t al, 1989). Mutations within 
sites D and C (which bind C/EBP and NF-Y respectively) 
reduced in vitro transcription in both liver and spleen 
nuclear extracts. These sites must therefore bind proteins 
which are present in both spleen and liver. Mutation of 
site E which binds an NF-1 like protein, resulted in only 
a two fold reduction in transcription in liver nuclear 
extract. Site B had been shown to bind HNF-1 (hepatocyte 
nuclear factor 1), a protein first identified as being 
crucial for the liver-specific transcription of the rat 
^-fibrinogen gene (Courtois e_t al, 1987). Substitutions 
within site B had the greatest effect upon transcription 
in vitro in liver nuclear extract (about a 10 fold 
reduction). These mutations had no effect upon 
transcription in spleen nuclear extract. Gel retardation 
assays showed that the protein binding to site B (HNF-1) 
was indeed confined to liver cells (i.e. absent from 
spleen). In a second type of analysis each binding site 
was placed alone, upstream of the "core" albumin promoter 
(contains just the TATA box). Site B stimulated 
transcription more efficiently than any of the other sites 
in liver nuclear extract, but was completely silent in 
spleen nuclear extract. Site D (binds C/EBP) also 
stimulated transcription in liver nuclear extract but less
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so than site B. Site D was also able to stimulate 
transcription in spleen NE but to a much lesser extent. 
Site C was equally active in both spleen and liver nuclear 
extracts. Sites E and F increased transcription only 
slightly in liver nuclear extract and not at all in spleen 
NE. Clearly, site B which binds HNF-1, is the most 
important of the six binding sites in controlling liver- 
specific transcription. Site D and its cognate protein 
C/EBP are also important for liver-specific transcription. 
A number of the other sites are active in both spleen and 
liver NE and presumably are required to obtain maximum 
transcription in vivo. In fact there is some evidence that 
the various proteins may function cooperatively.
The liver-specific expression of the Xenopus 68Kd 
albumin gene promoter has also been investigated using 
similar approaches (Schorpp e_t a_l, 1988b). The 5' flanking 
region of the 68Kd albumin gene from +19 to -4200 was 
linked to the reporter gene CAT. Various deletions of the 
5' flanking DNA were prepared and assayed for CAT activity 
after transfection into one liver cell line and two non­
liver cell lines. Surprisingly, deletion of sequences 
between -4200 and -662 resulted in a large increase in CAT 
activity in the liver cell line. Sequences between +19 and 
-77 were sufficient for high expression in transfected 
hepatoma cells, and produced only low CAT activity in non­
liver cell lines. However, deletion down to position -62
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reduced CAT activity by five to ten fold. These results 
were confirmed at the RNA level. This deletion analysis 
defined a region between -77 and -62 as being crucial for 
efficient transcription in transfected liver cells, and 
this was designated the HP1 element (for hepatocyte 
promoter element 1). A series of point mutations within 
this region confirmed the importance of the HP1 element. 
An oligonucleotide corresponding to this sequence was used 
in gel retardation assays with nuclear extracts from 
various cell lines. The HP1 oligonucleotide bound a 
specific protein in nuclear extract from hepatoma cell 
lines but no specific binding occurred with extracts from 
non-liver cell lines. The HP1 element was also necessary 
for in vitro transcription in rat liver nuclear extract. 
The sequence of the HP1 element shows good homology with 
the binding sites for HNF-1 in the promoters of other 
liver-specific genes (see section 1.3.3 for more detail).
In the work described so far, sequence elements close to 
(within 200 bp of ) the transcription start site have been 
shown to play the major role in determining liver-specific 
transcription. However, it is clear that sequences 
upstream of this are required for maximum transcription in 
liver nuclear extracts or transfected cell lines. Darnell 
and his co-workers (Grayson £t al, 1988a; Grayson e£ al, 
1988b; Costa e_t a_l, 1988) have identified liver-specific 
enhancers in both the mouse transthyretin (TTR) gene and
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the mouse e*lAT gene. The enhancer in the TTR gene is 
located between 1.6 and 2Kb upstream of the CAP site and 
stimulates transcription ten to thirty fold in transfected 
liver cell lines. The oflAT enhancer is located between 
-190 and -500 and could stimulate transcription to a 
similar degree. Sequences downstream of -160 were 
sufficient for only a low level of liver-specific 
transcription. Thus, for these genes at least, sequence 
elements upstream of the proximal promoter elements 
(within 200bp of the CAP site) are required for efficient 
liver-specific transcription. Both enhancers appear to 
consist of three distinct binding sites for trans-acting 
factors. Oligonucleotides corresponding to these binding 
sites were able to cross-compete for binding in gel 
retardation assays. These experiments indicated that one 
site in each of the enhancers interacted with a similar 
protein that was present in many cell types. The sequence 
of the binding site suggests that this protein is probably 
API. The remaining four sites (two in each enhancer) 
appeared to bind the same liver-specific factor. It was 
therefore suggested that this liver-specific factor could 
play a major role in the coordinate expression of these 
two liver-specific genes (and perhaps others as well). 
Surprisingly, the four binding sites for this factor 
showed only weak sequence homology. The consensus sequence 
that was derived seemed to be significant because 
mutations at conserved residues severely reduced binding
25
Introduction
of the factor. This consensus sequence does not resemble 
the binding sites for other liver-specific transcription 
factors that have been identified (APF, HNF-1, LFB1, HP1)
1.3.3 Evidence for a common liver-specific promoter 
element.
As described in section 1.3.2, the liver-specific 
transcription of several liver-specific genes has been 
analysed in some detail. From this research it is clear 
that several or these genes all contain a related DNA 
sequence element that plays a crucial role in liver- 
specific transcription. These sequence elements are shown 
aligned for maximum conservation in figure 1. The five 
genes in which this element was initially identified are 
shown at the top of this figure. Also indicated are the 
names of the trans-acting factors which interact with 
these elements. In addition, this sequence element can be 
found in many other liver-specific genes and these are 
also shown in figure 1. Interestingly, the alpha 
fetoprotein gene promoters all have two copies of this 
element within 150bp of the CAP site. The human hepatitis 
B virus infects the liver, which explains the presence of 
this conserved element upstream of the gene coding for the 
surface antigen protein of this virus. It is not 
surprising to find such a conserved sequence in, for 
example the rat and mouse albumin genes, given that the
- 26 -
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whole of the proximal promoter region is well conserved. 
The same is true of the rat and mouse alpha fetoprotein 
(«FP) gene promoters. However, this element has clearly 
been conserved in the promoters of unrelated genes which 
resemble each other only in respect of the fact that they 
are expressed only or predominantly in liver. This 
sequence element has also been conserved during evolution 
between Xenopus and humans. From now on I will refer to 
this element as the HP1 element. From the comparison shown 
in figure 1 a consensus sequence can be derived as shown. 
This element appears to have a degree of dyad symmetry, 
which is a characteristic of the binding sites of many 
(although not all) transcription factors.
As outlined in section 1.3.2, four research groups have 
independently identified a trans-acting factor that 
interacts with the HP1 element of four different liver- 
specific genes. These factors have been called APF, LFB1, 
HNF1 and HP1 binding protein (HP1 BP). In almost all cases 
the source of this trans-acting factor was the rat (either 
rat liver nuclear extract or nuclear extracts from 
hepatoma cell lines). In the case of the rat albumin 
promoter it was demonstrated that this factor (APF) was 
also present in mouse and human liver cell lines. These 
trans-acting factors were found to be absent in tissues or 
cell lines not expressing liver-specific functions, 
although the number of tissues and cell lines tested was 
far from exhaustive. This would indicate that these trans­
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acting factors are restricted to cells or tissues that 
express liver-specific functions.
Several groups have noticed the presence of the HP1 
element in the promoters of several liver-specific genes. 
Prompted by this conservation they have tested these 
elements from the different genes in competition 
experiments for binding of their liver-specific factor 
(Kugler e_t al, 1988; Lichtsteiner and Schibler, 1989 in 
press; Courtois e_t al, 1987; Courtois e_t al, 1988; Hardon 
et al, 1988; Cereghini e_t al, 1988). Generally, these 
competition experiments have taken the form of gel 
retardation assays. The HP1 element from one gene is used 
as a probe and then the corresponding element from another 
liver-specific gene is used as a competitor. If 
competition occurs the two elements must be able to 
specifically bind the same factor. The results of all 
these experiments are summarised in figure 2. It should be 
noted that in no instance have the HP1 elements from two 
different genes been reported not to compete. The gaps in 
the table represent situations where cross-competition has 
not been tested. The results strongly suggest that APF, 
LFB1, HNF1 and HP1 BP are identical proteins (or at least 
proteins with identical sequence specificities).
In conclusion, it seems likely that a large number of 
liver-specific genes contain a common promoter element, 
the HP1 element, which is important for liver-specific 
expression. This provides for the coordinate regulation of
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A summary of the binding of four liver-specific 
transcription factors to the conserved HP1 element present 
in many liver-specific genes.
The results are those of Courtois £t al, 1987; Kugler et 
al. 1988; Courtois et al, 1988; Hardon et al^ 1988; 
Cereghini et al, 1988; Lichtsteiner and Schibler, 1989 in 
press). In most cases binding has been tested by gel 
retardation and competition with oligonucleotides 
containing the HP1 element from various liver-specific 
genes. There are no reports of any of these proteins not 
binding to a HP1 homologue.
Figure 2
Cross reaction of liver-specific transclptlon factors 
with the conserved HP1 element of various liver- 
speclfic genes.
FACTOR
GENE
LFB1
>~o-n
H
N
F1
HP1 BP
Rat alpha fibrinogen V
Human alpha—1 antitrypsin y y
Rat beta fibrinogen y y y y
Mouse albumin y y y
Human albumin y
Xenopus 68kd albumin y y
Rat alpha—fetoprotein ( — 65) y y
Rat alpha —fetoprotein ( —132) y
Rat albumin y y
Human alpha-fetoprotein (-60 ) y
Mouse transthyretin y
Mouse alpha—1 antitrypsin y
Hepatitis B virus y
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liver-specific transcription. Within a single species 
these elements interact with the same positive 
transcription factor that is present in liver cells, but 
not in non-liver cells. Non-liver cells may contain a 
negative factor (vAPF/vHNFl/LFB2), that is related to this 
positive factor in that it binds to the same DNA sequence, 
the function of which is to repress transcription. The HP1 
element and its cognate factor are certainly not entirely 
responsible for determining liver-specific transcription. 
For example, both the mouse 0(1AT genes and the mouse TTR 
genes contain this element within lOObp of the CAP site. 
Darnell and his co-workers (Costa e± al, 1986; Grayson et 
al. 1988a; Grayson ¿t al, 1988b) have shown that the first 
160bp of the mouse oil AT promoter and the first 202bp of 
the mouse TTR promoter direct only a low level of liver- 
specific transcription; tissue-specific enhancers are 
required for maximal transcription.
Watanabe et a_l (1987) identified a cell-specific 
enhancer in the human0(1AT gene. Domain B of this enhancer 
is located 3.5Kb upstream of the CAP site and has been 
shown to bind a nuclear factor from hepatoma cells 
(Sawadaishi et^  1988). The binding site for this 
protein bears strong sequence similarity to the HP1 
element (see figure 1). Indeed, in gel retardation assays, 
the HP1 element from the promoters of the human albumin 
gene and the human o< 1AT gene itself could compete for 
binding of this protein to the enhancer element (Sawadashi
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«t, «I» 1988). This suggests that the same protein which 
interacts with the HP1 element in the promoter of many 
liver-specific genes also interacts with a liver-specific 
enhancer. Thus, in the case of the human QflAT gene, a 
common sequence element, HP1, interacting with the same 
trans-acting factor is present in both the promoter and 
the enhancer. This is similar to the situation of the 
octamer motif in immunoglobulin genes.
- 30
Introduction
1.4 GENE REGULATION BY STEROID AND THYROID HORMONES. 
Introduction.
Steroid hormones are a group of structurally related 
molecules that have many diverse effects upon the 
physiology, development and differentiation of eukaryotes 
(see the review by Evans, 1988). Included in this family 
of molecules are the sex hormones estrogen, progesterone, 
and testosterone, glucocorticoids, androgens, mineral* 
ocorticoids, lP(-2,5 dihydroxyvitamin D3, and retinoic 
acid. Thyroid hormone, although not strictly a steroid 
hormone, is grouped with this family for reasons which 
will become clear later.
Thyroid hormone is synthesised in the thyroid gland by 
the iodination of tyrosine. In mammals, two forms of 
thyroid hormone are secreted by the thyroid gland; 
thyroxine (L-3,5,3',5'-tetraiodothyronine) and triiodo­
thyronine (L-3,5,3'-triiodothyronine). Triiodothyronine 
(T3) is more active than thyroxine (T4). One of the major 
effects of thyroid hormone in mammals is to increase the 
basal metabolic rate. Almost all organs are affected, the 
major exception being the brain. Both excessive secretion 
of thyroid hormone and deficiency in thyroid hormone 
result in disease states in humans.
The use of radiolabelled ligands showed that steroid 
hormones associated with specific intracellular 
receptors. Upon treatment with hormone these receptors
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became tightly bound to chromatin. This was associated 
with the induction and repression of specific genes 
(Ivarie and O'Farrell, 1978). It is now clear that at 
least some of the effects of steroid and thyroid hormones 
are the result of direct alterations in gene expression. 
Gene regulation by steroid hormones has been intensively 
researched over the last ten years and will be the subject 
of the rest of this chapter.
1.4.1 A simple model for the action of steroid hormones.
A widely accepted, general model exists for the mechanism 
of action of steroid hormones. Steroid hormones, being 
small hydrophobic molecules can pass freely across the 
cell membrane. Once inside the cell the hormone binds to a 
specific intracellular receptor protein. This binding 
causes a conformational change in the receptor, a process 
referred to as receptor "activation”. The activated form 
of the receptor has an increased affinity for specific DNA 
sequences termed hormone response elements (HREs), found 
near to genes that are regulated by that particular 
hormone. By binding to these sites the hormone-receptor 
complex is able to influence the rate of transcription of 
the linked gene.
Recent research has, in general, supported this model. 
However, there is some confusion as to how the receptor 
becomes activated by the hormone. There have been some
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contradictory results published in regard to whether 
hormone binding is strictly necessary for DNA binding. 
This will be discussed in a later part of this chapter.
1.4.2 The structure of steroid and thyroid hormone 
receptors.
Major support for the model of steroid hormone action has 
come from the isolation and characterisation of the 
specific intracellular receptors. The receptors for nearly 
all the known steroid hormones have now been cloned. The 
human glucocorticoid receptor was isolated from a cDNA 
expression library using an antibody raised against the 
purified receptor (Hollenberg £t al, 1985). The human 
estrogen receptor was isolated using antibodies against 
the purified receptor or synthetic oligonucleotides 
corresponding to ER peptide sequences (Green e£ al, 1986; 
Greene £t 1986). The human mineralocorticoid (Arriza 
et al, 1987) and androgen receptors (Chang et a^ ., 1988) 
were isolated by low stringency hybridisation with the 
highly conserved DNA binding domain from the GR. 
Homologues from other species have been isolated by cross­
hybridisation with the human receptor clones.
When the human estrogen receptor was sequenced (Green et^  
a 1, 1986) it was found that it contained a segment that 
was closely related to the erb-A oncogene of avian 
erythroblastosis virus (AEV). Similar homology was found
33
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in the chicken estrogen receptor and the human 
glucocorticoid receptor (Krust e_t al^ 1986 and Weinberger 
et al, 1985). The cloning of the chicken and human 
cellular homologues of the v-erb-A gene (Sap et a_l, 1986; 
Weinberger et al, 1986) lead to the discovery that they 
encoded receptors for thyroid hormone. Since then thyroid 
hormone receptor cDNA clones have also been isolated from 
rat and mouse either by homology to v-erb-A or to other 
previously isolated thyroid hormone receptors.
Comparison of the deduced amino acid sequences of 
different hormone receptors has indicated that they are 
structurally organised into distinct domains ( Weinberger 
et al, 1985; Krust £t a^ l, 1986; Kumar e_t a_l, 1986; 
Hollenberg e£ al, 1987; Rusconi and Yamamoto, 1987). The 
sizes of the various receptors exhibit considerable 
diversity; from 410 amino acids for the rat thyroid 
hormone receptor alpha 1 to 984 amino acids for the human 
mineralocorticoid receptor. However, all of the receptors 
show significant sequence homology and can be divided up 
into three main domains (see the reviews by Green and 
Chambon, 1988; Beato, 1989; Evans, 1988; and figure 3). 
The amino terminal domain, or A/B domain is the most 
variable in both sequence and size, and is primarily 
responsible for the large variation in the size of the 
different receptors. The function of this domain remains 
unclear, but it may be involved in modulating 
transcriptional activation. All steroid hormone receptors
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possess a short (66 or 68 amino acids), well conserved 
central domain which is rich in cysteine residues. This 
domain is responsible for the DNA binding function of the 
receptor. The c-terminal region beyond the DNA binding 
domain is also relatively well conserved between different 
hormone receptors, and contains a large number of 
hydrophobic residues. This domain is known to be 
responsible for ligand binding. Since the structures of 
the various steroid hormones show considerable diversity, 
the conservation of this domain presumably reflects a 
common overall structure required for hormone binding. 
Evidence suggests that this domain also contains regions 
required for receptor dimerisation, nuclear translocation 
and transcriptional activation.
There is conclusive evidence that steroid hormone 
receptors are phosphoproteins, and it appears that 
phosphorylation can modulate the affinity of the receptors 
for their cognate hormone (Beato, 1989).
1.4.3 The steroid hormone receptor superfamily.
The finding that steroid and thyroid hormone receptors 
have a common structure has lead to the proposal that they 
are part of a superfamily of genes that encode ligand 
dependent transcription factors (see Evans, 1988). Figure 
3 shows the structures of the human steroid hormone 
receptor family of proteins for which the ligands are
- 35 -
Figure 3.
The human nuclear receptor family of proteins and their 
ligands.
The structures of the various members of the human 
steroid hormone receptor superfamily are drawn 
schematically to show the locations of the different 
domains. The proteins have been aligned according to the 
position of the highly conserved DNA-binding domain. The 
sizes of the different proteins, in amino acids, and the 
positions at which the domains within them begin and end 
are also shown above each protein. The receptor 
superfamily can be divided in to two sub-groups, the "ER 
sub-family” and the ”GR sub-family”, based upon overall 
sequence similarity and DNA sequence specificity. The 
chemical structures of the ligands which are bound by the 
various receptors are also shown. The ligands of the PR, 
GR, MR and AR have a common structure that differs only in 
the identities of the side chain groups (R). Abbreviations 
used are: ER, estrogen receptor; PR, progesterone receptor; 
GR glucocorticoid receptor; MR, mineralocorticoid receptor; 
AR, androgen receptor; VitD3R, vitamin D3 receptor; RAR, 
retinoic acid receptor; TR, thyroid hormone receptor.
This figure is adapted from Green and Chambon (1988).
Fi
gu
re
 3
 
8^
io
lw
o>
tw
hu
m
w
w
ri
»r
io
^»
lo
rf
cm
ly
o>
pr
ol
*i
»«
id
tw
lr
lB
«i
te
.
known. Based upon overall sequence homology the different
receptors can be divided into two sub-families. The
receptors for progesterone (PR), glucocorticoid (GR),
mineralocort-icoid (MR), and androgen (AR) fall ihto one
sub-family. The receptors for estrogen (ER), vitamin D3
(VitD3), retinoic acid (RAR) and thyroid hormone (TR) are
more related to each other than to other members of the
receptor superfaraily, and make up the second sub-family..
Humans have at least two genes encoding slightly different
retinoic acid receptors designated alpha and beta.
Similarly, humans like the rat also have two genes
encoding thyroid hormone receptors.
The presence of the well conserved DNA binding domain has
promoted searches for other members of this superfamily.
Using low stringency hybridisation at least six new
members of this family have been isolated, for which the
receptor
ligands are unknown. The estrogen^related genes 1 and 2 
(ERR1 and ERR2) from human are more closely related to the 
steroid hormone receptors than the thyroid hormone 
receptors (Giguere et «1, 1988). The nur77 cDNA clone was 
originally isolated as one of a group of genes expressed 
during the Gq/Gj transition in mouse fibroblasts. One of 
them, nur77, turned out to be a member of the steroid 
receptor superfamily (Hazel et al, 1988). Miyajima et al
(1988) isolated four human cDNA clones designated earl, 
ear2, ear3, and ear7 which encode proteins that are 
members of the steroid hormone receptor superfamily.Three
Introduction
- 36
Introduction
of these genes have been classified as novel members of 
the superfamily. Interestingly, one of these unidentified 
receptors (earl) and the thyroid hormone receptor alpha 
gene (ear7) are transcribed from opposite strands of the 
same genetic locus (Miyajima et £l, 1989). Recently, it 
has been reported that the gap gene knirps of 
D.melanogaster has significant homology to the steroid 
hormone receptor superfamily (Nauber et ¿1, 1988). This 
gene is known to be involved in organising the posterior 
segmentation pattern of the embryo. The homology between 
knirps and the steroid hormone receptor superfamily lies 
only in the DNA binding domain. The homology is about 50X 
(depending upon which of the steroid hormone receptors it 
is compared to). Importantly, the cysteine residues which 
are invariant in the DNA binding domain of all members of 
the receptor superfamily, are also conserved in knirps. 
Unlike the steroid hormone receptors, knirps does not have 
an amino terminal domain; the DNA binding domain spans 
amino acids 5 to 67. The authors suggest that like the 
steroid hormone receptors, knirps may also be a ligand 
dependent transcription factor, although there is no 
evidence for this. It is tempting to speculate that the 
putative ligand of the knirps protein might be a 
morphogen, and that the function of knirps is to "read" a 
gradient of this morphogen within the abdominal region of 
the embryo. A second Drosophila gene, knirps-related, has 
also been shown to be a member of the steroid receptor
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superfamily (Oro £t al, 1988). This gene shows 85Z 
homology to knirps within the DNA binding domain and 92X 
homology to knirps in a stretch of 25 amino acids 
immediately to the C-terminal side of the DNA binding 
domain. The C-terminal regions of the two proteins are 
otherwise unrelated, and the C-terminal region of knirps- 
related shows no homology to members of the steroid 
receptor superfamily. A function has not yet been asigned 
to knirps-related.
The production of cholesterol is regulated by feedback 
mechanisms. Apparently, some of this regulation occurs at 
a transcriptional level (Sudhof e_t al, 1987). Cholesterol 
is structurally related to steroid hormones so it seems 
likely that these effects upon transcription could be 
mediated by a cholesterol receptor which is a member of 
the steroid receptor superfamily. The structure of the 
herbicide dioxin is closely related to that of thyroid 
hormones and some of its effects are caused by changes in 
gene expression. It seems likely that dioxin may also act 
via a receptor protein related to the steroid hormone 
receptors. The investigation of novel receptors may lead 
to the discovery of new hormone response systems.
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1.4.4 The DNA binding domain of steroid and thyroid 
hormone receptors.
The central cysteine rich domain is the most well 
conserved region within the steroid hormone receptor 
superfamily. The degree of homology within this 66 amino 
acid domain varies from a minimum of about 401 to a 
maximum of 94Z at the amino acid level. Several features 
of this region suggest that it might be responsible for 
DNA binding. Firstly it contains * lot of basic amino acids 
likely to interact with DNA. Secondly, the arrangement of 
cysteine residues is similar to that found in the DNA 
binding domain of the RNA polymerase III transcription 
factor TFIIIA (Weinberger et £l, 1986). When mutations
were made specifically within this region of the GR, DNA 
binding was prevented (Giguere et^  al^ 1986; Hollenberg and 
Evans, 1988). The ability of these mutated receptors to 
bind hormone was unaffected, indicating that the overall 
structure of the receptor was intact. Absolute proof that 
this region was responsible for DNA binding came from 
exchanging the putative DNA binding domains of different 
receptors. When the putative DNA binding domain from the 
human ER was swapped with that of the human GR, the 
resulting protein activated transcription from 
glucocorticoid responsive promoters in response to 
estrogen (Green and Chambon, 1987). For the majority of 
steroid hormone receptors it has not been directly
39
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demonstrated that the central cysteine rich region is 
responsible for DNA binding. However, given the strong 
conservation within this region this is a fair assumption. 
The assignment of the DNA binding domain has recently been 
shown to be functionally correct for the rat TR type JS 1 
(Thompson and Evans, 1989).
The most striking feature of the homology within the DNA 
binding domain of different receptors is the conservation 
of the cysteine residues (see figure 9). The nine cysteine 
residues are in fact invariant in all the steroid and 
thyroid hormone receptors that have been analysed. The 
positioning of the cysteine residues is reminiscent of a 
motif first identified in the 5S gene transcription factor 
TFIIIA (Miller e_t a_l, 1985). TFIIIA contains a series of 
repeating units rich in cysteine and histidine. Each unit 
is thought to be able to fold into a finger like structure 
supported by the tetrahedral coordination of a zinc ion. 
Each zinc ion would be coordinated by two histidine and 
two cysteine residues. This zinc finger motif has since 
been recognised in a number of DNA binding proteins (see 
the review by Evans and Hollenberg, 1988). The actual 
existence of zinc fingers has only been demonstrated for 
TFIIIA itself (Diakun e_t a_i, 1986; Lee £t^  al^ , 1989). 
Although related to TFIIIA, the DNA binding domain of the 
steroid hormone receptors forms a distinct class of zinc 
finger motifs. Each zinc ion would be coordinated by two 
pairs of cysteine residues rather than the histidine-
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cysteine arrangement found in TFIIIA. Also, the DNA 
binding domain of the steroid hormone receptor family 
contains only two zinc fingers whilst TFIIIA has nine. The 
proposal that the DNA binding domain of the steroid 
hormone receptors form a zinc finger structure similar to 
that of TFIIIA is supported by the finding that zinc is 
necessary for the ER to bind to DNA (Sabbah e_t al, 1987). 
Also, site directed mutagenesis of the conserved cysteine 
residues prevents DNA binding (Hollenberg and Evans, 
1988). Nuclease and chemical protection experiments with 
purified TFIIIA indicated that each finger binds in the 
major groove of the DNA double helix and interacts with 
five nucleotides (Fairall £t al_, 1986). The binding sites 
for steroid hormone receptors contain dyad symmetry (see 
the review by Evans, 1988), implying that the receptors 
bind as dimers. Thus each binding site may be contacted by 
four zinc fingers. Specific residues within the DNA 
binding domain have been implicated in determining the 
sequence specificity of the interaction. This will be 
discussed in more detail in section 1.4.13.
1.4.5 The ligand binding domain.
Sequence comparisons between different steroid hormone 
receptors, for example between the human and chicken ERs 
(Krust et^  a_l, 1986), suggested that the carboxy terminal 
region might be responsible for hormone binding.
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The functional assignment of the ligand binding domain to 
the carboxy terminal domain is based largely upon work 
with the human glucocorticoid and estrogen receptors. 
Giguere et al_ (1986) generated a random set of mutations 
covering the whole of the human GR. These were then 
expressed in cultured cells and assayed for their ability 
to bind hormone and to activate transcription from the 
mouse mammary tumour virus (MMTV) long terminal repeat 
(which is responsive to glucocorticoids). One set of 
mutations confirmed the importance of the DNA binding 
domain; receptors with mutations in this region could bind 
hormone but were unable to activate transcription. A 
second group of mutations resulted in the loss of hormone 
binding. These mutations defined a region spanning the 
last 200 amino acids of the protein as being crucial for 
hormone binding. This region was therefore designated the 
hormone binding domain. Rusconi and Yamamoto (1987) came 
to similar conclusions regarding the rat GR. The location 
of the ligand binding domain in the human ER has been 
determined by a similar mutational analysis (Kumar e_t al, 
1986), and corresponds to the position of the ligand 
binding domain in the GR. The location of the ligand 
binding domain in the majority of the other steroid 
hormone receptors has been assigned by homology to the 
human GR. This assignment was supported by experiments in 
which hybrid thyroid hormone/glucocorticoid receptors were 
created (Thompson and Evans, 1989). All possible
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combinations of the amino terminus, DNA binding domain, 
and ligand binding domain were created. The hybrid 
receptors were then expressed in tissue culture cells and 
tested for their ability to activate either a
glucocorticoid or a thyroid hormone responsive test gene 
in response to either glucocorticoid or thyroid hormone. 
Hybrid receptors containing the putative ligand binding 
domain of the thyroid hormone receptor always activated 
transcription in response to thyroid hormone, irrespective 
of the identity of the DNA binding domain or the amino 
terminal domain.
1.4.6 Cis-acting DNA sequences responsible for activation 
of gene expression by steroid hormones; hormone 
response elements.
A moderate number of genes whose expression is regulated
by steroid hormones have been cloned. Gene transfer
techniques have been used to identify DNA sequences
responsible for induction by steroid hormones (for
example; Klein-Hitpab e_t a_l, 1986; Ye e_t a_l, 1988; Kerner 
et al, 1989; for a review see Yamamoto, 1985). In a number 
of cases the DNA sequences defined as being necessary for 
hormonal regulation have been shown to specifically bind 
the partially purified hormone receptor (for example; 
Klein-Hitpass et al^ , 1989; see review by Beato, 1989 and 
references therein). The sequence elements defined in this
- 43
Figure 4.
Consensus steroid hormone response elements.
Numbers refer to the number of response elements 
that match the consensus sequence at each position.
Glucocorticoid
TRE half site p
(Norman G G G i C p  
et al, 1989)
VitD3 response ^  ^
element from GTGACTCACCGGGTGAACGGG
the osteocalcin ---------  --------
gene
(Kerner et aj, 1989)
response
element
(GRE) (Ten sequences compared)
Estrogen
response
element s ilj t <
(ERE) (Five sequences compared)
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way have often been shown to confer hormone inducibility 
on a heterologous promoter (for example; Klein-Hitpab et 
al, 1986; Brent e_t al, 1989a). The sequence elements 
defined by these approaches are known as hormone response 
elements (HRE). By comparing the HREs from different 
hormone responsive genes it has been possible to define 
consensus sequences (see reviews by Beato, 1989; Green and 
Chambon, 1988; Evans, 1988). The consensus for the 
glucocorticoid response element (GRE) is a 15-mer, 
partially palindromic sequence. This consensus is perhaps 
the most meaningful in that it has been derived from the 
largest number of responsive genes (see the review by 
Evans, 1988). The consensus estrogen response element 
(ERE) has been derived from five genes and consists of a 
13-mer also exhibiting partial dyad symmetry. These two 
consensus sequences are shown in figure 4. A consensus 
sequence has not yet been defined for the progesterone and 
androgen response elements. The DNA sequences responsible 
for induction of the human osteocalcin gene by vitamin D3 
have very recently been defined (Kerner et al^ , 1989). This 
consists of a 21bp element from the S' flanking region of 
the gene which was shown to confer vitamin D3 
responsiveness on the viral TK promoter. Since no other 
vitamin D3 response elements (VDRE) have been identified 
it is not possible to derive a consensus sequence. However 
the VDRE from the osteocalcin gene does resemble both the 
ERE and elements that mediate response to thyroid hormone
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4(see figure 4).
The precise DNA sequences that confer induction by 
thyroid hormone have only been determined for one T3 
responsive gene; the rat growth hormone (GH) gene (Glass 
et al, 1987; Brent e_t a_l, 1989a; Norman e_t a_l, 1989). The 
induction of the rat growth hormone gene by thyroid 
hormone has been studied in some detail by a number of 
groups and there is still some controversy as to the exact 
location of the TRE, and whether there is more than one.
Glass et al (1987) carried out a deletion analysis of 
the rat growth hormone gene promoter to determine 
sequences necessary for induction by T3. Their results 
indicate that sequences between -235 and -145bp were 
sufficient to confer a response to T3. They then used an 
avidin-biotin DNA binding assay (ABCD assay; see Glass e_t 
al, 1987 for details) to detect binding of thyroid hormone 
receptor (TR) to this region of the rat GH promoter. This 
assay indicated specific binding of both rat and human TR 
to sequences between -186 and -158bp. Furthermore, DNasel 
footprinting with nuclear extract (from cells that express 
the TR) showed that a protein was binding between -178 and 
-163bp. When this region was deleted from the rat GH 
promoter no induction by T3 occurred. An oligonucleotide 
containing the sequence between -178 and -163bp of the rat 
GH promoter could confer T3 induction upon the TK 
promoter. These results are in agreement with the prior 
identification of a T3 inducible DNase I hypersensitive
Introduction
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Figure 5
The region from the rat growth hormone gene promoter 
spanning nucleotides -210 to -150 showing footprints 
and various thyroid hormone responsive "elements".
-2 1 0
DNasel footprint 
(Glass et al. 1987) 
A
■’*' Alignment
OGAGGTGACACGA f<> ^  a _ M H C
-150
T GGCAAAGGCGGCGCT GCÀAAGGTAAGAT CAGCCACGTGACCGCAGGAGAGCAGTGOGCA
TRE Identified by 
Ye et al (1988)
AGCTAAQATCAQOQACOT 
AGGT AAGAT CAGGGACCT GA
Perfect direct repeat: AGGTAAGATCAGGtaaot
A B C
rGH54 AAAGGTAAGATCAGGTAA CTGACCT CAGGA
Fold Induction 
by T3
0
3.4
11
43
Nucleotides shown in 
red are altered from 
the wild type rat GH 
sequence.
pTK28 TCAGGTCATCACCTGA ¿ 6
pTK28mult tcagctcatg acctgatca g ctcatg acctga 125 
Adapted from Brent et al (1989a and 1989b)
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site 170bp upstream of the CAP site of the rat GH gene 
(Nyborg and Spindler, 1986). Moore and his co-workers 
(Brent et^  a 1, 1989a) carried out a similar deletion 
analysis of the rat GH promoter. They reported that 
sequences between 183 and 137bp upstream of the CAP site 
were required for induction by T3. However it is clear 
that when sequences between -237 and -183bp were included 
the response to T3 was much greater. A fragment from the 
rat GH promoter spanning nucleotides -200 to -157 was able 
to confer induction by T3 upon the TK promoter in an 
orientation independent manner (Brent et^  al, 1989a). These 
results are in agreement with those of Glass et^  a_l (1987). 
When this sequence element was narrowed down further to a 
region spanning -190 to -167 T3 induction still occurred 
but it was reduced by two fold. This region contains an 
imperfect direct repeat, designated the A and B domains 
(Brent £t a_l, 1989a) and an imperfect inverted repeat 
termed the C domain (Brent et al, 1989b). Point mutations 
and deletions within the A and B domains were shown to 
significantly reduce the response to T3. The C domain on 
the other hand did not appear to be strictly necessary for 
T3 induction. An oligonucleotide containing the complete A 
and B domains and only the first 3 bases of the C domain 
could confer induction by T3 although the level of 
induction was small (see figure 5). A 17-mer 
oligonucleotide that contained just the A and B domains 
could not confer a response to T3 (see figure 5).
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Interestingly, two point mutations which converted the B 
domain to a perfect direct repeat of the A domain resulted 
in a significant increase in the level of induction by T3. 
For example, the 17-mer oligonucleotide discussed above 
(containing just the A and B domains) conferred an eleven 
fold induction when it was altered so that it contained a 
perfect direct repeat (see figure 5). The corresponding 
sequence from the wild type rat GH promoter could not 
confer a response to T3 (see figure 5). This suggests that 
the TR has a higher affinity for the mutated element 
containing a perfect direct repeat than for the wild type 
element. These findings are in slight disagreement with 
those of Glass et al^  (1987) previously described. As shown 
in figure 5 the DNasel footprint detected by this group 
covers the B and C domains rather than the A and B domains 
identified as being the important regions by Brent e£ £_1 
(1989a). Izumo and Madhavi (1988) have localized sequences 
necessary for the thyroid hormone induction of the rat 
alpha myosin heavy chain (orMHC) gene to a region spanning 
-161 to -71bp. Within this is a 13bp element that matches 
a region of the rat GH promoter covering the B and C 
domains in 10 out of 13 positions (see figure 5). A region 
of the crfMHC gene that contains this 13bp element (-151 to 
-122) could specifically bind the rat thyroid hormone 
receptor (type alpha 1) that had been synthesised in vitro 
(Izumo and Madhavi, 1988). This would tend to emphasise 
the importance of the B and C domains for T3 induction.
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Further experiments carried out by Moore and his co­
workers (Brent e_t a_l, 1989b) indicate that all three of 
the domains (A, B and C) are important for induction by 
T3. A whole series of artificial constructs were made in 
which various combinations of these domains and mutated 
versions of them were placed in front of the TK promoter, 
and these were tested for T3 inducibility. An 
oligonucleotide containing all three domains from the rat 
GH promoter could confer a 3.6 fold induction by T3. When 
this sequence was altered such that the A and B domains 
were perfect direct repeats and the C domain matched the A 
domain in five out of six positions (rGH54) the induction 
by T3 was increased dramatically to 43 fold (see figure 5) 
When two copies of the C domain as present in rGH54 were 
placed as an inverted repeat in front of the TK promoter 
(TK28) the induction by T3 was 26 fold. With two copies of 
TK28 (pTK28mult) the induction was 125 fold (see figure 
5). We have obtained pTK28mult from Dr. Moore and it was 
used in some of the experiments that will be described 
later.
Based upon these sorts of experiments Brent et al^  (1989b) 
have proposed a consensus "half site" for the T3 response 
element. This half site is equivalent to either of the A, 
B or C domains of the rat GH promoter. The sequence of 
this consensus half site is AGGT(^/A)A and at least two 
copies of this element in close proximity are needed for a 
T3 response. It is unclear whether these half sites can
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Figur* 6
Thyroid hormone response element "half sites" In the 
rat growth hormone gene and other thyroid hormone 
responsive genes.
Artificial THE*
rGH half sites rGH54 pTK28
domain
domain
domain
AGGTAA I 
AGG '.A C  I 
Í G G TC A  -
AGGTAAI
AGGTAAI
A G G TfA -
AGGTCA ►  
AGGTCA
CONSENSUS AGGT^A
rat alpha-MHC í. AGGTi, A ( A Oír AGG ,1C A t í  . IGÍ CCT
-62
rat alpha-eubunlt TGGGC T 7'AGGTGC AGGTGGGA Gl A
rat alpha-MHC 
half alte*
AGGTt A I  
AGG 1C A I
A G G tC  T -
rat alpha-eubunlt
AGGT t'C I
a g g t í . í ; i
Arrows ( ► - ) Indicate orientation of the half sites 
within the promoter.
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function in either direct repeat or inverted repeat 
orientation, or both. The rat GH promoter has two copies 
of the half site in direct repeat orientation (the A and B 
domains) and a third (the C domain) is an inverted repeat 
of both of the others. The rat GH half sites are shown in 
figure 6 along with the half sites present in the
artificial TREs rGH54 and pTK28mult. That this consensus 
half site is meaningful in the context of other promoters 
is supported by the analysis of two other T3 responsive 
genes; the rat alpha myosin heavy chain gene (ratOfMHC) 
and the rat glycoprotein hormone alpha subunit gene (rat 
©(-subunit gene). As discussed earlier, the sequences
responsible for the T3 induction of the ratofMHC gene have 
been narrowed down to a region between -151 and -122bp. 
Within this 70bp region three "half sites" can be
identified in an identical arrangement to those in the rat 
GH promoter (see figure 6). The sequences responsible for 
the T3 induction of the rat o<-subunit gene have been 
localized to a region between -80 and +33bp and the
binding site for pure thyroid hormone receptor 
(synthesised ^n vitro from a cDNA clone) was localized to 
a region between -74 and -38 (Burnside et a_l, 1989). 
Within this region (-74 to -38) two "half sites" in direct 
repeat orientation can be identified (see figure 6).
In conclusion, the experiments carried out by Glass et aJL 
(1987) and by Moore and his colleagues (Brent et a_l, 1989a 
and 1989b) indicate that the TRE consists of a rather
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poorly conserved 6bp element with the consensus sequence 
AGGT(c/a )A. At least two copies of this half site in close 
proximity are required to generate a functional TRE. Both 
direct repeat and inverted repeats of the half site appear 
to be functional. The half site consensus sequence is 
similar to the consensus for the ERE, and the significance 
of this will be discussed in more detail in section 
1.4.12.
Ye et a_l (1988) reported that sequences between -208 and 
-178 from the rat GH promoter were sufficient to confer T3 
induction upon the minimal rat GH promoter (-104 to +7). 
This minimal promoter is not responsive to thyroid 
hormone, but does contain a binding site for a cell- 
specific transcription factor (Ye e_t a_l, 1988). Thus, the 
TRE that they have defined (see figure 5) contains only 
one of the half sites (the A domain) identified by Moore 
and his co-workers (Brent £t al, 1989a and 1989b). This 
region of the rat GH promoter (-208 to -178) identified by 
Ye ejt a^l (1988) does contain an imperfect inverted repeat. 
However, this element could only confer induction by T3 
when it was placed close to the rat GH promoter. Further 
experiments with the enhancerless Rous sarcoma virus (RSV) 
promoter suggested that sequences between -236 and -146 
of the rat GH promoter (which spans the whole of the 
thyroid hormone responsive region shown in figure 5) could 
only function as a TRE in association with other cis- 
acting sequences located between -146 and -47 of the rat
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GH promoter (Ye et al, 1988). Thla suggests that 
interaction between the TR bound at the TRE and other 
trans-acting factors is essential for induction by thyroid 
hormone (see section 1.4.8 for further discussion of 
this). This does not necessarily contradict Brent e£ al 
(1989a) who found that various fragments from within this 
-236 to -146 region could alone confer T3 inducibility on 
a heterologous promoter since they used the TK promoter 
whilst Ye et al (1989) used the RSV promoter. The TK 
promoter might well contain a binding site(s) for a trans­
acting factor with which the TR can interact. Clearly, how 
you define a TRE depends upon the environment in which it 
is tested.
Finally, it should be noted that the TR appears to bind 
to multiple sites within the S' flanking region of the rat 
GH gene (Lain et al^ , 1988). One of these binding sites 
lies between -181 and -149 which correlates with the work 
described so far. However, binding was observed at three 
additional sites; -1730 to -1230, -530 to -230 and -149 to 
♦12. In a very recent paper by the same group (Norman £t 
al, 1989) a comprehensive analysis of the region of the 
rat GH gene spanning -237 to +12 has been described. 
These workers have used gel retardation, footprinting 
assays, and mutational analysis to localise four TR 
binding sites centred at -180, -160, -60 and -20 within 
this region. This alters the previous view that there was 
only one TR binding site in this region (Brent £t al,
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1989a and 1989b; Glasa at al, 1987). However these 
findings do not essentially contradict the previous work. 
Highly purified rat liver TR was used in the deternination 
of these four binding sites, and it was confirmed that the 
sites really were binding TR (and not some other protein) 
by labelling with T3 (Norman e£ al^ 1989). I have 
summarised the binding data (gel retardation and 
footprinting) of Norman e_t al (1989) in figure 7. The 
mutational analysis was consistent with the binding data, 
and competition experiments indicated that all four sites 
were binding the same TR (there is more than one TR 
protein in rat liver) with similar affinities. The 
functional importance of these sites was tested by fusing 
the region of the rat GH gene from -237 to -«>11 containing 
various mutations, to the reporter gene CAT. The T3 
inducibility of these constructs was tested by transient 
expression in rat GC cells (which contain functional TRs). 
The results indicated that all four binding sites 
contributed to the T3 responsiveness of the promoter. 
However, it is clear that the two distal binding sites; 
"site -180" and "site -160" are the most important. A 
mutation in the "-160 site" reduced T3 induction to 69X, 
whilst a mutation in the "-180" site reduced T3 induction 
to 31Z. When both of these sites were mutated 
simultaneously, T3 induction was eliminated completely. 
Thus, of these two sites the "-180" site is more 
important. Mutations in the "-60" and "-20" sites reduced
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T3 induction to 59X and 74X respectively. Furthermore, 
when sequences spanning -141 to 4-11 of the rat GH gene, 
which contain only the "-60" and "-20" sites, were fused 
to CAT and tested in the same way no induction by T3 
occurred. This suggests that the two most proximal TR 
binding sites are functional only if they can interact 
with proteins bound to sequences within the -142 to -237 
region of the promoter.
The results of Norman et al (1989) tend to emphasise the 
importance of the **-180 site" which corresponds to the A 
and B half sites identified by Brent £t al (1989a). When 
the sequences of the four TR binding sites were compared 
(Norman e ± al, 1989) they were able to identify a 
conserved motifj GGGA/TC°/C (see figure 7). However they 
do admit that these four binding sites are very purine 
rich so multiple alignments are possible. The position of 
this conserved element differs by only one nucleotide from 
the A and B half sites. Perhaps Norman et ¿1 (1989) derive 
a different consensus from Moores' group because theirs is 
derived by comparing different TR binding sites within the 
same gene, the rat GH gene. The way in which the 
consensus sequence proposed by Brent et al (1989b) was 
derived is subtly different; it was based upon mutations 
that generate the most efficient TRE in the context of a 
heterologous promoter (TK). Since interactions between TR 
bound at a TRE and other trans-acting factors (including 
other TRs) is clearly important in determining the level
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of transcriptional activation, the context in which a 
putative TRE ia tested will have a major effect upon -the 
level of induction. Because of this the results of Norman 
et al (1989) are more likely to be meaningful in the 
context of the rat GH gene. The consensus proposed by 
Brent et^  al (1989b) is perhaps likely to be more generally 
applicable. Clearly, many related sequences can function 
as a TRE. It may not be possible to define a consensus TRE 
that is meaningful in the context of different genes from 
different organisms.
A number of genes are known to be regulated by retinoic 
acid at the level of transcription (Vang et al, 1985), but 
the sequences responsible for this regulation have not 
been determined. Therefore nothing is known at present 
about the characteristics of natural retinoic acid 
response elements (assuming they do exist, which is 
likely). However, it has been shown that retinoic acid can 
induce gene expression through an artificial, "consensus" 
thyroid hormone response element (Umesono £t al, 1988). 
Evidence suggests that this is mediated by binding of the 
retinoic acid receptor to the TRE (Umesono et al, 1988). 
Bedo et al^  (1989) demonstrated that treatment of a rat 
pituitary cell line with retinoic acid induced an increase 
in the rate of transcription of the chromosomal rat GH 
gene. Thus, transcription of the rat GH gene can be 
induced by retinoic acid as well as by T3. The results of
Introduction
Umesono et « 1  (1988) described above suggest that this 
induction by RA nay be mediated by the same cis-acting* DNA 
sequences previously identified as a TRE. Interestingly, 
treatment of cells with both T3 and RA produced a larger 
induction than either hormone alone, indicating that these 
hormones were acting synergistically. Similar results were 
obtained with a transiently transfected rat GH reporter 
gene containing 1.8Kb of S' flanking DNA. The significance 
of these findings for the regulation of the rat GH gene in 
vivo remain unclear.
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1.4.7 Steroid hormone receptors bind to hormone response 
elements as dimers.
Several lines of evidence suggest that a receptor dimer 
binds to a hormone response element. Many of the hormone 
response elements that have been identified show a degree 
of dyad symmetry which suggests that one monomer may 
contact each half site (see figure 4). Analysis of the 
contact sites between the receptor and DNA using 
methylation interference have supported this idea. For 
example, analysis of three of the four binding sites for 
thyroid hormone on the rat growth hormone promoter showed 
symmetrical contact sites on either side of the centre of 
dyad symmetry (Norman et al, 1989; and figure 7). 
Moreover, the positions of the contact sites are
consistent with the hypothesis that the receptor contacts 
the same face of the DNA on both halves of the palindrome 
(Norman et al, 1989). A similar symmetrical methylation 
interference pattern was found on the ERE (Kumar and 
Chambon, 1988). Mutations in one half of a palindromic ERE 
decreased the formation of stable complexes with the ER, 
suggesting that both halves of the palindrome were 
necessary for tight binding (Kumar and Chambon, 1988). It 
has now been shown directly that the ER does indeed bind 
as a dimer to a ERE (Kumar and Chambon, 1988). 
Furthermore, dimerisation was induced by estrogen. 
Experiments with various truncated receptors suggested
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that as well as the hormone inducible dimerisation 
function associated with the hormone binding domain, there 
was also a weak constitutive dimerisation function present 
in the DNA binding domain (Kumar and Chambon, 1988). 
Monomeric ERs did not bind to the ERE indicating that 
dimerisation was essential for DNA binding. By analogy, it 
seems likely that other steroid hormone receptors also 
bind to HREs as a hormone induced dimer, although this has 
not been directly demonstrated.
1.4.8 Multiple regions are important for activation of 
transcription.
Very little is known about the exact mechanism by which 
"activated” hormone-receptor complexes regulate the rate 
of transcription initiation. Most of the hormone 
responsive genes that have been cloned are activated by 
steroid hormones and so most work has concentrated on 
regions of the receptor responsible for activation. 
However, it should be remembered that some genes are 
repressed by steroid hormones (discussed in detail in 
section 1.4.9).
No clear picture has emerged regarding the locations of 
those regions of the receptor responsible for activation. 
It is now clear that multiple regions are involved and 
that there is considerable variation between different 
receptors. Indeed, the relative importance of different
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regions varies according to the target gene.
Mutational analysis of the human GR identified * two 
regions distinct from the DNA and hormone binding domains 
that were necessary for the receptor to activate 
transcription (Giguere et al, 1986). One of these domains, 
designated Tau 1 (Tl), is about 100 amino acids long and 
is located within the amino terminal (A/B) domain. 
Mutations within this region completely abolished 
transcriptional activation without affecting hormone 
binding. The second domain, Tau 2 (T2) is only about 20 
amino acids long and is located between the DNA binding 
domain and the hormone binding domain. Mutations in T2 
reduced transcriptional activation by 90X, again without 
affecting hormone binding. Thus, both these domains appear 
to be essential for activation of transcription. Both Tl 
and T2 could function independently of their position 
within the receptor and multimerisation caused an increase 
in the level of transcriptional activation (Hollenberg and 
Evans, 1988). Conclusive evidence that the Tl domain was 
an entirely independent transcription activation domain 
came from an experiment in which the Tl domain was
inserted into the amino terminal region of the rat TR type 
alpha 1 (Thompson and Evans, 1989). This resulted in a 
greater than ten fold increase in the level of
transcriptional activation. When two copies of the Tl 
domain were inserted activation was increased by fifty 
fold. The Tl and T2 domains have no obvious sequence
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similarity with the exception that both are acidic in 
character. Thus they bear some resemblance to -the 
activation domains identified in the yeast transcription 
factors GAL4 and GCN4. Indeed, a synthetic amphipathic 
alpha helix based upon the activation domain of GAL4 could 
function in the GR in place of the T2 domain (Hollenberg 
and Evans, 1988).
Removal of the ligand binding domain from the PR, GR and 
ER was found to generate a constitutively active 
transcription factor, i.e. hormone was not needed to 
activate transcription from a responsive promoter. In the 
case of the rat GR the constitutive activity was close to 
that observed with the wild type receptor (Godowski et al,
1987). This result showed that the hormone binding domain 
itself is not absolutely required for activation of 
transcription. This lead to the proposal that the function 
of the hormone binding domain is to suppress either DNA 
binding or transcriptional activation or both. In this 
model hormone binding would result in the un-masking of 
pre-existing DNA binding and/or transactivation domains. 
However, removal of the ligand binding domain from the 
human GR produced a constitutive receptor with only 20X of 
the activity of the wild type receptor (Hollenberg and 
Evans, 1988). Similarly, deletion of the hormone binding 
domain from the human ER did produce a constitutive 
receptor, but one with only 51 of the activity of the wild 
type receptor (Kumar et «_!, 1987). The ability of this
- 59 -
Introduction
mutant to bind to an ERE was unaffected. These results 
indicate that regions within the hormone binding domain do 
contribute to the activation of transcription. The DNA 
binding domain of the yeast transcription factor GAL4 when 
isolated from the rest of the protein can bind to its 
recognition site in DNA but fails to activate 
transcription. Chimeric receptors consisting of this DNA 
binding domain linked to the ligand binding domains of 
either the human GR or ER can stimulate transcription from 
GAL4 responsive reporter genes only in the presence of the 
appropriate hormone (Webster £t al, 1988). This confirms 
that there is a transcriptional activation function in the 
hormone binding domain and indicates that its activity is 
dependent upon hormone binding. Interestingly, either 
hormone or antihormone were necessary for binding of these 
chimeras to response elements in DNA but only the hormone 
caused transcriptional activation. Thus, in the absence of 
hormone or antihormone the hormone binding domain appears 
to mask the DNA binding domain. This suggests that the 
binding of hormone or antihormone first results in a 
transformation in the receptor which allows binding to the 
response element in DNA. The hormone but not the anti­
hormone can induce a transcription activation function 
present in the hormone binding domain. Thus, antihormones 
could function by competing for binding to the receptor.
In conclusion, the human GR appears to have at least 
three separate activation domains. One of these is in the
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hormone binding domain and is entirely dependent upon 
hormone binding. The second (Tl) is in the A/B domain, 
whilst the third (T2) is in the "spacer region". Both Tl 
and T2 appear to be constitutively active.
Interestingly, the requirement for the amino terminal 
domain appears to be gene specific. Activation of the 
estrogen responsive gene PS2 is severely reduced by 
removal of the A/B domain from the ER, whilst activation 
of the HSV TK promoter and a reporter gene containing the 
estrogen response element from the vitellogenin gene was 
unaffected (Kumar et al, 1987). Two forms of the human PR 
have been isolated which differ only in the amino 
terminus. Both forms can activate transcription from the 
MMTV promoter but only the A form can activate the 
ovalbumin promoter (Tora £t al, 1988). This suggests that 
the A/B domain may interact with other factors on the 
promoters of target genes. In this way the A/B domain 
could modulate the degree of transcriptional activation.
Steroid hormone response elements are often found 
clustered with binding sites for other trans-acting 
factors (see Schule et al, 1988 for references). There is 
now clear evidence that steroid hormone receptor complexes 
bound at response elements in DNA do interact with other 
transcription factors. Schule £t aJL (1988) constructed a 
series of artificial promoters in which various 
combinations of transcription factor binding sites were 
placed in front of the TK promoter linked to CAT. These
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constructs were transfected into HeLa cells, which possess 
all the the appropriate trans-acting factors, along wi-th a 
plasmid expressing a cloned GR. Induction of CAT activity 
by glucocorticoid treatment was then measured. None of the 
binding sites tested (except for the GRE) conferred any 
induction by glucocorticoids when placed alone in front of 
the TK promoter. A single GRE alone showed only a low 
level of induction by glucocorticoids. This induction was 
dramatically increased when the binding site for another 
transcription factor, or indeed a second GRE, was placed 
close to the GRE. All of the binding sites tested (sites 
for NF1, CPI, SP1, OTF and the CACCC box factor) had this 
strong synergistic effect. The degree of synergism varied 
between the different binding sites and was also altered 
by changing the spacing between the binding sites. It 
would be interesting to use this system to determine which 
regions of the receptor were required for this synergism. 
This would presumably define regions of the receptor which 
interact with the various trans-acting factors.
Almost nothing is known about the location of regions 
required for transcriptional activation in receptors other 
than the ER and GR. Deletion of the whole of the A/B 
domain of the rat TR type p 1 had no effect upon its 
ability to activate transcription from the MMTV promoter 
into which a thyroid hormone response element had been 
inserted (Thompson and Evans, 1989). This shows that the 
A/B domain is not required for transcriptional activation
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froa this promoter. It might, however be required for 
activation of other promoters.
1.4.9 Repression of genes by steroid hormones.
Glucocorticoids have been shown to negatively regulate 
the transcription of a number of genes, including the 
bovine prolactin gene (Camper et al, 1985), the pro­
opiomelanocortin gene (Israel and Cohen, 1985), the rat 
prolactin gene (Adler et a_l, 1988), and the gene encoding 
the alpha subunit of the glycoprotein hormones (Akerblotn 
et al, 1988).
Camper et al (1985) showed that 1Kb of 5' flanking DNA 
from the bovine prolactin gene was sufficient to mediate 
glucocorticoid repression of the reporter gene CAT in rat 
pituitary cells. DNasel footprinting with purified GR 
indicated that the receptor bound at seven distinct sites 
between -50 and -562bp (Sakai et al, 1988). These 
footprints define a negative glucocorticoid response 
element (nGRE). The seven nGREs show only limited sequence 
similarity and the consensus is poorly related to the 
consensus for a positive GRE. A single nGRE from the 
prolactin gene was able to confer glucocorticoid 
repression upon various heterologous promoters. In cells 
which lack an endogenous GR the repression by 
glucocorticoids was dependent upon co-transfection of a 
cloned GR. The nGRE resembled enhancer elements in that it
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could function in both orientations and when placed at a 
distance from the CAP site. Importantly, the nGRE 
dramatically increased expression from the TK promoter in 
the absence of glucocorticoids and in the absence of the 
co-transfected GR. In contrast, the positive GRE from the 
MMTV LTR did not have this stimulatory effect in the 
absence of glucocorticoids or the GR. It was therefore 
suggested that the nGRE is also a binding site for a 
positive transcription factor that enhances basal 
transcription. The repression by glucocorticoids could 
then be caused by the hormone-receptor complex either 
competing with and/or inactivating this positive factor. 
The question remains as to how the GR/hormone complex can 
activate transcription when bound at a GRE but fails to do 
so when bound at a nGRE. The authors proposed that the 
nGRE sequences might alter the structure of the bound 
receptor such that it did not act as a positive regulator 
when bound at these sites.
Glucocorticoid repression of the gene encoding the alpha 
subunit of the glycoprotein hormones (o<subunit) appears 
to be the result of competition between the GR and the 
cAMP-mediator protein for overlapping DNA sequences 
(Akerblom e_t 1988). The inhibition is mediated by a 
region of the o<subunit gene promoter that contains two 
cAMP response elements (CREs) that bind the cAMP-mediator 
protein and therby mediate activation by cAMP. 
Footprinting with purified GR indicated that each of the
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CREs overlapped with binding sites for GR. The sequence of 
these nGREs show only modest homology to the consensus *for 
the positive GRE. The inhibition by glucocorticoids is 
only seen in situations when the CREs are acting as 
enhancers, i.e. in the presence of raised levels of cAMP. 
Inhibition was clearly mediated by the same receptor that 
causes transcriptional activation of other genes, and was 
not observed when the DNA binding domain of the GR was 
mutated. This and other evidence (Akerblom et al, 1988) 
suggests that the negative regulation by glucocorticoids 
is the result of competition between the GR and the cAMP- 
mediator protein for binding to their respective, 
overlaping sites. Once again it is not clear why binding 
of the receptor to a nGRE fails to result in 
transcriptional activation. Possibly it is the context of 
the GRE with respect to the binding sites for other 
transcription factors which determines whether it mediates 
activation of transcription. As discussed earlier a single 
GRE alone confers only a small stimulation by 
glucocorticoids and a much bigger stimulation is generated 
by the synergistic interaction with other transcription 
factor binding sites (Schule et al, 1988).
A similar competition mechanism has been proposed by 
Drouin <it a_l (1987) to explain the glucocorticoid 
repression of the pro-opiomelanocortin gene. Here the GR 
could prevent the binding of the CAAT box transcription 
factor to its target sequence.
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Transcription of the mouse proliferin gene is induced by 
phorbol esters and repressed by glucocorticoids (Mordacq 
and Linzer, 1989 and references therein). Phorbol ester 
induction is mediated by a 31bp region of the S' flanking 
DNA that contains a binding site for the transcription 
factor API, and a number of sites similar to the SV40 SphI 
element. Both sites are necessary for phorbol ester 
induction (Mordacq and Linzer, 1989). Repression by 
glucocorticoids requires the presence of the GR, and this 
was shown to bind to a region of the proliferin gene 
promoter that overlaps with the API site. This 31bp region 
was sufficient for glucocorticoid repression. These 
results suggest, once again, that glucocorticoid 
repression of transcription is the result of the receptor 
preventing the functioning of a positive transcription 
factor. Gel retardation with extracts from mouse cells 
showed that a different complex formed on the 31bp element 
when the cells had been treated with glucocorticoid 
(Mordacq and Linzer, 1989). This is consistent with 
several mechanisms of glucocorticoid repression, including 
competition with API for binding to overlapping sites, 
protein-protein interaction between API and the GR, and 
glucocorticoid induction of a gene encoding another factor 
that binds at or close to the API site.
The rat prolactin gene is negatively regulated by 
glucocorticoids but is also positively regulated by 
estrogen (see Adler et al, 1988 for references). The ERE
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responsible for the positive regulation is located in a 
distal enhancer element. Expression of the prolactin gene 
ia confined to the anterior pituitary gland. This tissue- 
specific transcription is controlled by a series of 
related cis-acting sequences located in both the distal 
enhancer and in a region proximal to the CAP site (Nelson 
et al, 1988). These elements bind the positive 
transcription factor Pit-1 (a member of the POU class of 
transcription factors). As expected, deletion of the ERE 
in the distal enhancer eliminated the stimulation of 
expression by estrogen (Adler et al, 1988). However, in 
the presence of a high concentration of ER supplied by a 
co-transfected ER, expression from the prolactin promoter 
from which the ERE had been removed, was repressed by 
estrogen. The evidence presented (Adler £t al, 1988) 
suggests that two estrogen dependent processes are 
regulating the prolactin gene; classical activation which 
occurs via the ERE, and repression. Normally, the positive 
regulation masks the repression so that repression can 
only be observed when the ERE is inactivated. When the ERE 
in the prolactin enhancer was converted to a GRE the 
inhibitory effect of glucocorticoids was altered to a 
significant stimulation of expression. This same construct 
was repressed by estrogen. The authors then went on to 
determine which regions of the ER were required for the 
inhibitory effect. Surprisingly, the DNA binding domain of 
the receptor was not required for inhibition but was
67
Introduction
necessary for activation. Clearly this means that the 
inhibition by estrogen cannot be mediated by the classical 
binding of the hormone-receptor complex to a cis-acting 
element. The region required for inhibition was narrowed 
down to the so called hinge domain that lies between the 
DNA and hormone binding domains. The corresponding region 
from the GR could restore the inhibitory function to an ER 
from which the hinge region had been deleted.
Deletion analysis of the rat prolactin gene 5' flanking 
DNA (Adler et a 1. 1988) showed that multiple regions, each 
of which contains a binding site for Pit-1 could confer 
estrogen and glucocorticoid dependent inhibition. Indeed, 
three copies of the Pit-1 binding site could confer 
estrogen and glucocorticoid dependent inhibition on the TK 
promoter. This suggests a model for steroid hormone- 
mediated inhibition in which the hinge region of the GR/ER 
interacts in some way with the Pit-1 protein either bound 
to the promoter or free in solution. This interaction is 
dependent upon binding of the hormone to the receptor and 
would prevent Pit-1 from activating transcription from the 
prolactin promoter. The significance of the estrogen 
dependent inhibition i_n vivo is uncertain given that it is 
only observed when the ERE is inactivated and in the 
presence of high concentrations of ER. However, the 
glucocorticoid dependent inhibition is observed ijn vivo 
and clearly occurs by the same mechanism.
Thus the inhibition by glucocorticoids of the rat and
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bovine prolactin genes appear to occur by two distinct 
mechanises. This is not unlikaiy given that the* 5' 
flanking regions of the two genes differ considerably.
In all the systems described above inhibition of gene 
expression by glucocorticoids appears to be mediated by 
interfer ence with the function of a positive 
transcription factor. In three cases binding of the GR to 
so called nGREs competes with the binding of positive 
trans-acting factors to an overlaping site. The situation 
with the rat prolactin gene is more intruiging since it 
does not appear to involve binding of the GR to DNA.
1.4.10 The thyroid hormone receptor family.
As mentioned earlier, the cellular homologues of the v- 
erb-A gene are known to encode receptors for thyroid 
hormone (Sap et^  al, 1986; Weinberger et^  al, 1986). It is 
now clear that the human genome contains multiple genes 
homologous to v-erb-A (Dayton £t al, 1984; Miyajima et al, 
1988; Miyajima et al, 1989; Drabkin et al, 1988), not all 
of which necessarily encode thyroid hormone receptors. 
Accumulated evidence indicates that a number of these 
genes are clustered together on chromosome 17 (q21-25) and 
chromosome 3 (p21-25) (Green and Chambon, 1988; Miyajima 
et al, 1988; Benbrook and Pfahl, 1987; Miyajima e_t al, 
1989). Miyajima e_t £l (1988) isolated four human cDNA 
clones by homology to the v-erb-A gene. These were
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designated earl, ear2, ear3 and ear7. The genes encoding 
ear2 and ear3 are located on chromosomes 19 and 3 
respectively and are clearly members of the steroid 
receptor superfamily. However, the proteins encoded by 
these two cDNAs are distinct from any of the steroid or 
thyroid hormone receptors previously isolated. The ligands 
for these two novel receptors have not been determined. 
Both earl and ear7 are located on chromosome 17 at the 
same locus; 17q21. The predicted sequence of the protein 
encoded by ear7 is almost Identical to that of two 
independently isolated thyroid hormone receptor cDNA 
clones; erbA-T-1 (Benbrook and Pfahl, 1987) and hTRof2 
(Nakai e_t al, 1988). The predicted protein sequences of 
these three receptors contain several isolated differences 
which are probably the result of sequencing errors. 
Therefore it has been assumed that these clones all 
originated from the same mRNA species (Miyajima et al, 
1989). However, there are conflicting reports regarding 
the ability of the proteins encoded by these three clones 
to bind thyroid hormone. The erbA-T-1 and hTR0<2 proteins 
were reported to bind T3 with high affinity (Benbrook and 
Pfahl, 1987; Nakai e^ a_l, 1988). In contrast, the protein 
encoded by the ear7 cDNA did not bind to T3 (Miyajima e_t 
»1« 1989). This apparent paradox remains unresolved at
present.
Comparison of the sequence of the earl and ear7 cDNA 
clones indicated that they could be encoded by opposite
Introduction
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strands of the same genetic locus. This was confirmed by 
the cloning of the corresponding genomic fragment 
(Miyajima et al, 1989). Analysis of this genomic fragment 
suggested that the primary transcript of the ear7 gene 
(the thyroid hormone receptor alpha gene) might undergo 
differential splicing to generate two thyroid hormone 
receptor proteins, designated ear71 and ear72. This was 
confirmed by northern blot analysis; a probe taken from a 
region common to both proteins hybridised to two mRNA 
species of 5 and 2.5Kb. A probe taken from a region 
specific to ear71 hybridised to only the 5Kb mRNA whilst a 
probe specific to ear72 detected only the 2.5Kb mRNA. The 
predicted ear72 protein is 490 amino acids long and 
corresponds to the ear7/erbA-T-l/hTRGf2 cDNA clones. The 
ear71 protein is predicted to be 410 amino acids long, and 
differs from ear72 only in the carboxy terminus (the 
hormone binding domain). As yet no cDNA clones 
corresponding to ear71 have been isolated. In order to 
test the T3 binding capability of the ear71 protein an 
artificial construct was prepared that contained all the 
sequences predicted to be present in ear71. This was used 
to synthesise ear71 protein iji vitro, and this was shown 
to bind T3 with high affinity (Kd-10'1 2 M). The earl cDNA 
clone hybridised to a single mRNA species of 2.9Kb. The 
protein encoded by earl is also a member of the steroid 
receptor superfamily and the putative ligand binding 
domain shows 40X homology to the corresponding region in
Introduction
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the chicken TR. The earl protein did show specific T3 
binding, in that binding was competed by excess unlabelled 
T3. However, the affinity of this binding was too low to 
calculate a dissociation constant. Thus the true ligand 
for the earl protein remains to be identified.
A second distinct human thyroid hormone receptor has 
been isolated by Weinberger et al (1986). This cDNA clone 
encodes a protein of 450 amino acids that is more 
distantly related to the viral v-erb-A gene than the alpha 
type TR isolated by Benbrook and Pfahl (1987), Nakai et al 
(1988), and Miyajima et al^  (1988). This receptor has been 
designated as a beta type (hTRJJ) and is located on 
chromosome 3 (p21-25). The hTRJS protein binds thyroid 
hormone with high affinity.
Two distinct human retinoic receptor cDNA clones have 
also been isolated (Petkovich e_t a_l, 1987; Brand e_t al. 
1988; Benbrook £t ¿1, 1988). The clone isolated by 
Petkovich e_t £l (1987) has been designated hRARo< and the 
gene encoding it is located on chromosome 17 q21.1 (see 
Brand et: al^ , 1988 for refs.). The second retinoic acid 
receptor designated hRAR^, was original^ identified as 
being at the site of integration of hepatitis B virus in a 
hepatocellular carcinoma (Dejean et^  a_l, 1986). The gene 
encoding this receptor is located on chromosome 3 p24 (see 
Brand £t al, 1988 for refs.). In conclusion, these two 
loci at 17q21-25 and 3p21-25 both contain one gene 
encoding a retinoic acid receptor and another encoding a
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The rat thyroid hormone receptor family.
The structures of the six rat c-erbA-related proteins 
that have been isolated to date are drawn schematically to 
show the different domains. All the proteins are drawn with 
the amino terminus to the left- of the page and have been 
aligned according to the location of the DNA-binding domain 
(blue box). Numbers above each region indicate the amino 
acid residue at which the region begins or ends. The 
receptors are divided into two groups; the alpha types and 
the beta types (which are encoded by two genes). Within 
each of these sub-groups (but not between), regions drawn 
in the same colour or shading have identical amino acid 
sequences. The column titled "T3-dependent trans­
activation" refers to experiments in which the ability of 
the cloned receptor to activate expression of a thyroid 
hormone-responsive promoter in response to T3 has been 
tested in co-transfected cell lines. It has been shown that 
the rTR*2 will inhibit the T3-dependent activation mediated 
by rTR*l or rTRJJl (Koenig et £l, 1989). The brackets around 
the amino terminal and DNA binding domains of rTRHVII 
denotes the fact that the sequence of this region has not 
been determined, but has been assumed to be the same as 
that of rTROfvI. Abbreviations used are T3, 
triiodothyronine; nt, not tested. References to the 
structures (nucleotide sequences and predicted amino acid 
sequences) of the various rat thyroid hormone receptors 
are: rTRo<l, Thompson e_t aJL (1987); rTRtf2, Izumo and Mahdavi 
(1988); rTRaivI and rTRofvII, Mitsuhashi et al (1988); rTR^l, 
Koenig et al (1988); rTRB2, Hodin et al (1989).
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thyroid hormone receptor. This suggests that the two loci 
have evolved after a chromosome duplication event.* In 
addition, a novel steroid hormone receptor is encoded on 
the opposite strand to the hTRO< gene at 17q21. The primary 
transcript of the hTRO< gene is alternately spliced to 
generate two slightly different receptor proteins that 
(according to the results of Miyajima et al^ , 1989) differ 
in their ability to bind thyroid hormone.
A total of six distinct thyroid hormone receptor cDNA 
clones have been isolated from various rat tissues (see 
the legend to figure 8 for references). Comparison of the 
predicted amino acid sequences of these six receptors 
indicates that they are probably derived from two distinct 
genes designated alpha and beta. A genomic clone 
encompassing the 3' end of the rat TRo< gene has been 
isolated (Mitsuhashi et al, 1988). The alpha gene gives 
rise to at least four isoforms of the receptor by 
alternate splicing (see figure 8 ). In this figure 
identical shading or colour indicates identical amino acid 
sequences but only within the alpha and beta families. The 
four alpha proteins are identical from the amino terminus 
through to a position 182 amino acids into the hormone 
binding domain, except that rTROCvI and rTRDfvII are 38 
amino acids shorter at the amino terminus. It is not known 
how the difference at the amino terminus is generated. The 
sequences of the four isoforms diverge at corresponding 
positions within the hormone binding domain. The splicing
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pathway that generates the TRP<1, THaivI and TRofvII mRNAs 
has been deduced from the DNA sequence of the 3' end of 
the rat TR gene by Mitsuhashi et al (1988). However they 
do not take into account the existence of the rTR0<2 cDNA 
clone (Izumo and Mahdavi, 1988), which is clearly a 
product of the same gene. However, Mitsuhashi and Nikodem
(1989) mention that they have isolated another rat alpha 
type TR cDNA clone that is generated by alternative 
splicing at the carboxy terminus. This clone which they 
call rTRo(vIII could be the same as rTR©<2. The three 
isoforms rTRO(2, rTRPfvI and rTRtfvII all have a common 81 
amino acid c-terminal region. The rTR«<2 and rTIWvI forms 
also have in common a stretch of 30 amino acids (indicated 
by the blue hatched box in figure 8 ). In addition, rTRtfvI 
contains a block of 1 0 amino acids identical to the c- 
terminal 10 amino acids of rTR«<l (indicated by the red box 
in figure 8 ), whilst the corresponding region of rTR«(2 
appears to be unique.
Of the four alpha type isoforms, -*nly TR®<1 actually 
binds thyroid hormone with high affinity. This suggests 
that sequences within the c-terminal 40 amino acids of 
rTR®il are crucial for hormone binding. The ^n vitro 
translation products of rTRoCl, rTRJJl and rTRP<2 will bind 
specifically to a thyroid hormone response element in 
vitro (Izumo and Mahdavi, 1988; Lazar et al, 1988; Koenig 
et al, 1989 (references therein)). It is not known whether 
hormone is required for binding of rTRJSl and rTRoil to a
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response element. Presumably the non-hormone binding rTIb<2 
binds to response elements NconstitutivelyN (i.e. in-the 
absence of hormone) since it is unable to bind T3. It has 
been demonstrated that rTIWl can activate transcription 
from the thyroid hormone responsive ol-myosin heavy chain 
(o(-MHC) gene promoter in response to T3 (Izumo and 
Mahdavi, 1988). Thus, rTRo<l appears to be a conventional 
hormone dependent transcription factor. In contrast, rTR®<2 
did not activate transcription from the ©<-MHC gene 
promoter (Izumo and Mahdavi, 1988).
The alpha type rat TRs are expressed with differing 
abundance in virtually all the rat tissues that have been 
tested, including brain, heart, liver, spleen and kidney 
(Murray et al, 1988; Thompson et al, 1987; Mitsuhashi et 
•1» 1988; Mitsuhashi and Nikodem, 1989). The existence of 
several differentially spliced mRNAs makes alot of the 
earlier data difficult to interpret with respect to which 
mRNA species is actually being detected. However it is 
clear that in the brain, the variant (non-hormone binding) 
receptor mRNAs are much more abundant than the functional 
receptor mRNA (Mitsuhashi and Nikodem, 1989). These 
authors reported that the ratio of variant (all types) to 
functional receptor mRNA in rat brain was 6:1. The non­
binding variants were also more abundant in kidney (ratio 
5:1), and liver and heart (ratio 2:1). The abundance of 
the alpha type TR mRNAs in the liver but not in the brain 
was affected by the thyroid state of the animal
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(Mitsuhashi and Nikodem, 1989). In hypothyroid rata the 
levals of both the variant and functional receptor mRNAs 
were increased by 501 compared to normal rats. Similarly, 
Lazar and Chin (1988) found that the level of the rTIW2 
mRNA in a pituitary cell line decreased by SOI following 
T3 treatment. The significance of these changes is unclear 
at present.
The function of one of these non-hormone binding 
isoforms has been tested in a co-transfection experiment 
(Koenig e_t al, 1989). The rTR*<2 protein was expressed in a 
cell line that is functionally defective in T3 response 
either alone or in combination with the rTRotl and rTRBl 
proteins (see figure 8 ). Both rTRotl and rTRJJl are 
functional receptors in that they can bind hormone and 
activate transcription from a responsive promoter. By co­
transfection with an artificial T3 responsive test gene 
the ability of the cells to respond to T3 was assayed. In 
cells transfected with rTRo<l or rTRJJl alone, expression of 
the test gene was strongly induced by T3 treatment. 
However, when the cells were also co-transfected with a 
five fold excess of the rTR<*2 plasmid (in a triple co­
transfection) the test gene was not induced by T3. In 
addition, this repression of the test gene by rTRo(2 was 
shown to be dose dependent, i.e. cells transfected with 
more rTRo<2 relative to rTRp<l or rTR^l, showed a greater 
repression of the test gene. Furthermore, the activation 
mediated by rTR^l was more sensitive to repression by
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rTRo<2 than the activation mediated by rTWl. There are 
several explanations for these results. It is possible 
that the rTR<X2 receptor could compete with the functional 
receptors for binding to the TRE. Alternatively, rTRoQ 
could form inactive heterodimers with the functional 
receptor. The authors speculate that the inhibitory effect 
of rTRo(2 could be modulated by the binding of an as yet 
unidentified ligand to this protein. These findings 
provide an explanation for the long standing paradox that 
the brain (of mammals) contains significant amounts of 
hormone binding TRs but does not exhibit an increased 
metabolic rate in response to T3. Northern blot analysis 
indicates that high levels of the rTRo<2 mRNA (Lazar et al,
1988) and the vl and vll mRNAs (Mitsuhashi et al, 1988) 
ore present in rat brain. It seems likely that the non­
hormone binding variants repress the functional TRs in the 
brain so that it does not show the classical response to 
T3. Why this should be the case is unclear. Presumably the 
non-hormone binding variants must be involved in 
regulating the response of the brain to T3.
A recent paper (Lazar et al, 1989) reports that a novel 
member of the steroid hormone receptor superfamily is 
encoded on the opposite strand of the rat thyroid hormone 
receptor alpha transcriptional unit. This receptor, 
designated Rev-ErbAot, was initially identified as a cDNA 
clone. The predicted amino acid sequence of the 56Kda 
Rev-ErbAo< protein is similar to the receptors for thyroid
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hormone and retinoic acid, but the protein does not bind 
either of these ligands ijn vitro. The coding regions of 
Rev-ErbA«< and rTRo<2 overlap by only 269bp within a single 
exon that encodes part of the carboxy terminus (hormone 
binding domain) of both proteins. The mRNA encoding 
Rev-ErbA<* is present in many tissues, being particularly 
abundant in brown fat and skeletal muscle. Thus, in both 
rat and humans, a novel steroid hormone receptor is 
encoded by the opposite strand of the thyroid hormone 
receptor alpha gene.
The two rat beta type thyroid hormone receptor cDNA 
clones are closely related to the alpha type clones just 
described. However, the predicted protein sequences differ 
from the alpha types throughout the length of the protein, 
indicating that they are derived from a distinct gene. The 
rTR^l (pi) and rTRp2 (^2) proteins are identical from a 
position 12 amino acids before the start of the DNA 
binding domain through to the c~terminus of the protein 
(see Hodin et al, 1989 and figure 8 ). The amino terminal 
domains are however entirely unrelated. This strongly 
suggests (but does not prove) that the Jll and ^ 2 mRNAs are 
generated by alternative splicing. The DNA binding domain 
of the p  type proteins is 8 8X identical at the amino acid 
level to the DNA binding domain of the o(type rat TRs. The 
first 176 amino acids of the hormone binding domain of the 
p  types show 82X amino acid identity to the corresponding 
region of the °< type TRs. The c-terminal 37 amino acids
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of the beta types are identical to the corresponding 
region of rTIWl (marked in red in figure 8 ). Both pi* and 
p 2  have been shown to bind thyroid hormone with high 
affinity ^n vitro (Koenig et al, 1988; Hodin e£ al,
1989).Both of the beta type TRs can activate transcription 
from a T3 responsive reporter gene in response to T3 
(Koenig £t al^ 1988; Hodin et^  al, 1989).
Northern blot analysis of RNA from various rat tissues 
using probes specific for either the TRJJ1 or TRJJ2 mRNAs 
indicated that the B2 mRNA is expressed only in the 
anterior pituitary gland (Hodin et al, 1989). In contrast, 
the p i  mRNA was present at different levels in all the 
tissues analysed, highest levels being in the brain, heart 
and brown fat. The rat pituitary tumour cell line GH3 
contains equivalent levels of pi and p 2 transcripts. 
Treatment of these cells with T3 reduced the level of p2 
transcripts by 85Z whilst the level of pi transcripts 
actually increased slightly (Hodin et al, 1989). The 
significance of this differential effect of T3 on the two 
beta type TRs for thyroid hormone physiology is not clear. 
It is possible that the two forms of the beta type TR (pi 
and p 2 ) are transcribed from the same gene but from 
alternative promoters. Differential regulation of these 
promoters could then be responsible for both the distinct 
tissue distribution of the two mRNAs and the differential 
effect of thyroid hormone. Alternatively, the pituitary 
specific expression of the p2 mRNA could be the result of
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tissue-specific differential splicing.
Presumably, the different tissue distributions of the p i  
and p 2  mRNAs reflect a role for the two receptors in the 
tissue-specific regulation of thyroid hormone responsive 
genes. Uith this in mind it is interesting that the only 
difference between the p i and p i  proteins lies in their 
amino terminal (A/B) domains. As mentioned earlier in this 
chapter the A/B domain of steroid hormone receptors has 
been implicated in modulating the transactivation of 
target genes. Receptors with different A/B domains may 
differ in their ability to activate various target genes.
1.4.11 Differential expression of the alpha and beta 
retinoic acid receptors.
Two human retinoic acid receptors (RARs) designated 
alpha and beta have been characterised (Petkovich e^ al, 
1987; Benbrook et^  al, 1988; Brand £t al, 1988) and these 
are encoded by two genes (see section 1.4.10). These two 
receptors (designated hRAR* and hRAR^) have almost 
identical DNA and hormone binding domains but differ 
considerably in their n-terminal (A/B) domains. Retinoic 
acid (RA) is a vitamin A derivative that is believed to 
have an important role in the differentiation and 
development of vertebrates. For example, a gradient of RA 
is thought to act as a morphogen to supply positional 
information to the developing chicken limb bud (see The et
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alt 1989 for references). The two human RARs appear to 
have different affinities for retinoic acid in that 
different concentrations of RA are required to get similar 
levels of activation of a CAT linked reporter gene (Brand 
et al. 1988). The mRNAs encoding the alpha and beta hRARs 
show different tissue distributions (The £t al^ 1989). 
Also, treatment of human hepatoma cells with RA caused a 
10 to 50 fold increase in the level of RAW* mRNA without 
effecting the level of RAR^ mRNA (The £t al, 1989). The 
induction of RARo< mRNA occurs at the level of 
transcription and does not require protein synthesis (The 
et al, 1989). Therefore RA directly regulates 
transcription of the hRAR°< gene, possibly by the binding 
of a retinoic acid receptor/ligand complex to a response 
element in the promoter of this gene. The significance of 
this regulation is not known. This phenomenon is similar 
to the differential regulation of the rat TRs p i  and p 2  by 
thyroid hormone (Hodin £t al, 1989), although here the 
levels of p 2  mRNA are reduced by T3 treatment.
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1.4.12 Promiscuous recognition of hormone response 
elements by steroid hormone receptors.
In section 1.4.6 I described the sequences in DNA called 
hormone response elements (HREs) that are the binding 
sites for steroid hormone receptors and mediate 
transcriptional activation of a linked gene. There has 
been an un-stated assumption that the target gene 
specificity of steroid hormone receptors would be entirely 
determined by the specificity of binding to distinct HREs. 
Recently this assumption has been challenged by the 
finding that a number of the steroid hormone receptors 
have the capability to bind to common HREs.
It has been known for some time that the MMTV-LTR is 
responsive to a number of steroid hormones, including 
glucocorticoids, progesterone, androgens and mineralo- 
corticoids (see review by Beato, 1989). The HRE within the 
MMTV-LTR is a rather large sequence element of 
approximately 70 to lOObp (Scheidereit and Beato, 1984; 
Cato et al, 1986; Chalepakis et al, 1988). The binding 
sites for PR, GR, AR and MR do overlap within this region 
but it is clear that there are distinct differences in the 
interaction of the different receptors within this region 
(Chalepakis et al^ , 1988). In addition, mutations within 
the HRE indicated that there were differences in the 
importance of particular residues for the binding of the 
PR and GR (Chalepakis e_t a_l, 1988). It would therefore
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appear that the various hormone receptors are binding to 
overlapping but not identical sequences within the MMTV 
HRE.
A much clearer indication of the promiscuous recognition 
of HREs by steroid hormone receptors comes from the 
finding that a consensus GRE can mediate transcriptional 
activation by progesterone, androgens and mineralocorti- 
coids as well as glucocorticoids (Strahle et al, 1987; Ham 
ct al, 1988). As mentioned earlier, no natural response 
elements for PR, AR or MR have been identified.
Glass et al (1988) investigated the binding of the 
thyroid hormone receptor to various synthetic hormone 
response elements. They found that the receptor could bind 
with high affinity to both the ERE from the vitellogenin 
gene (vitERE) and the GRE from the metallothionein gene. 
The affinity of the TR for the vitERE was equivalent to 
that of the ER for this element. The affinity of the TR 
for the GRE was lower, but still significant. It was 
noticed that the sequence of the TRE from the rat GH gene 
(in this case the TRE they are referring to is the B and C 
domain half sites; see figure 5) resembled the vitERE 
(Glass e_t ¿1, 1988). The homology between the two response 
elements was greatly increased by introducing a gap of 3bp 
in to rat GH TRE at the centre of the dyad symmetry. Thus 
the sequence of an ERE is much like that of a TRE except 
that the ERE has an extra 3bp at the centre of the 
palindrome. Furthermore, methylation interference
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experiments indicated that the TR made similar contacts 
with the vitERE and a perfectly palindromic TRE (Glass et 
al, 1988). In transfection experiments the rat GH TRE 
could confer induction by T3 upon the TK promoter. When 
the TRE was mutated to the sequence of the vitERE, 
expression became responsive to estrogen. However, 
treatment with T3 actually reduced the induction by 
estrogen. This negative effect was also found when 3bp 
were inserted into the TRE at the centre of dyad symmetry. 
This suggests a model in which the TR binds to an ERE in a 
transcriptionally inactive form. In this way it competes 
with the ER for binding to the ERE and reduces induction 
by estrogen.
In the rat GH TRE the gap between the two half sites 
that are in inverted repeat orientation (the B and C 
domains) is 1 bp (see figure 5). The affinity of the TR 
for the rat GH TRE into which between 1 and 6 bp had been 
inserted at the centre of the half sites, was not 
significantly reduced (Glass et al, 1988). It is generally 
accepted that steroid hormone receptors bind to HREs as 
dimers, with each monomer contacting one half site of the 
palindrome. Inserting extra nucleotides between the half 
sites not only increases the distance between the half 
sites, but also rotates them relative to each other. The 
TR dimer must therefore be astoundingly flexible to be 
able to bind to a palindrome separated by anything between 
1 and 6bp. Clearly, when an extra 3bp are inserted into
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the TRE it stops functioning (although it can still bind 
the TR), and instead can confer induction by estrogen. 
This finding has interesting implications for the 
organisation of TRE half sites in T3 responsive genes (see 
figure 6). The A and B half sites of the rat GH TRE are 
separated by 4bp and might therefore be expected to 
function as an ERE and not as a TRE. However, the 
experiments performed by Brent et (1989a) showed that 
the A and B half sites (containing two point mutations 
that create a perfect palindrome) could confer induction 
by T3. In the ratOiMHC gene, the two TRE half sites in 
inverted repeat orientation have a 2bp gap (see figure 6). 
The physiological relevance of the finding that the TR can 
(in the presence of thyroid hormone) inhibit 
transcriptional activation from an ERE by the ER remains 
unproven.
I have already mentioned that the retinoic acid receptor 
can activate transcription via a TRE. This is further 
evidence that HREs are not as distinct as we might have 
expected, but form a family of related sequences. A 
comparison of all the response elements indicates that 
they are all distantly related (see review by Beato, 1989; 
and figure 4). As mentioned earlier in this chapter, the 
steroid hormone receptors can be sub-divided into two 
groups based upon overall sequence similarity (see figure 
3). One group contains the GR, PR, AR and MR, whilst the 
second group consists of the ER, TR, RAR, and VitD3R.
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Interestingly, all the members of the first group can 
activate transcription through the MMTV-LTR. A comparison 
of the DNA binding domains of all these receptors shows 
that the members of the first group always have the amino 
acid sequence Gly-Ser between the two cysteine residues 
that form the C-terminal half of the first zinc finger 
(figure 9). Among members of the second group the sequence 
here is always Glu-Gly (figure 9). This suggests that 
these residues play an important role in determining DNA- 
binding specificity, and recently it has been demonstrated 
that this is the case (see the review by Berg, 1989; and 
section 1.4.13).
The research described in this section suggests 
unexpected connections between the actions of different 
steroid hormones. However, different hormones do have 
distinct biological effects which raises the question of 
how specificity is determined when different receptors can 
recognise the same HRE. There are a number of 
explanations, all of which may contribute to determining 
specificity. Firstly, steroid hormone receptors are not 
expressed ubiquitously thus precluding some cells from 
responding to particular hormones. Also, intracellular 
levels of hormones do not necessarily follow the level of 
circulating hormone because some cells have the ability 
to convert some hormones to inactive or more active 
derivatives. In the case of thyroid hormone, deiodination 
of circulating thyroxine to the much more active analogue
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T3 can occur in some tissues. It has also been suggested 
that small differences in the affinity of different 
receptors for the same HRE could be significant ijn vivo. 
Throughout this chapter experiments have been described 
which indicate that steroid hormone receptors modulate the 
rate of transcription by interacting with other 
transcription factors. It seems likely that this
interaction plays a major role in determining which genes 
can be activated by a particular hormone receptor. Many 
experiments have indicated that hormone receptors can bind 
to a HRE without necessarily activating transcription 
(discussed in detail in section 1.4.14). Thus, several 
receptors may be able to bind to a HRE but only one (the 
"correct** one) may be able to interact productively with 
other (cell-specific or basal) transcription factors bound 
at nearby sites. The finding that different receptors are 
able to bind to the same DNA sequence with, in at least 
one case, opposite transcriptional effects does not 
contradict the simple model but indicates that gene 
regulation by steroid hormones is much more complicated 
than had been envisaged.
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1.4.13 Receptor determinants of DNA binding specificity.
Investigations into the DNA sequence requirements for 
binding of different steroid hormone receptors has lead to
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Figure  9
A schematic representation of the first zinc finger of the 
estrogen receptors’ DNA binding domain showing the 
"discriminating” amino acids. Also shown Is an amino 
acid sequence comparison of sub-region Cl from 
various members of the human steroid receptor family.
Discriminating amino add* ora shown In rsd. 
Arrows show changss which altar spsclfldty  
of ths ER to that of ths CR. Discriminating 
amino acids
"GR
sub­
family"
hPR
hMR
hAR
hGR
C L 
C L 
C L 
C L
I C 0
V C 0 
I C 0
V C S
OCA 
0 E A 
0 E A 
DEA
S 0 C H Y 
S 0 C N Y 
S 0 C H Y 
S 0 C H Y
0
0
0
0
V L T
V V T 
A L T
V L T
C G S C K V F F
C G S C K v r F
C G S C K V F F
C G S C K V F F
K R 
K R
K R 
K R
A M E 0
A V E 0 
A A E 0 
A V E 0
"ER
sub­
family"
V C N D V A S
V C 0 D K • S
V C 0 D K A T
V C 0 D R A T
0 Y 
0 Y 
0 Y 
0 F
N Y 
H Y 
H Y 
H F
0 V W 
0 V S 
R C I 
N A M
S C E
A C E  
T C E 
T C E
G C K 
G C K 
G C K 
G C K
A F F 
O F F  
G F F
G F F
K R S I Q G 
R R S I OK 
R R T I Q K 
R R S M K R
The cysteine residues that are believed to coordinate with zinc are shown blue. 
Amino acids which ore common to only one of the sub-families are shown red.
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the conclusion that HREs are a family of related 
sequences. Some progress is now being made towards 
understanding the other half of the equation; i.e. 
determining which amino acid residues within the receptors 
determine target gene specificity. By combining these two 
approaches we can begin to unravel the molecular 
interactions that underlie target site recognition by
steroid receptors.
As described in section 1.4.4, the DNA binding domain is 
believed to form two sine finger-like structures. By
swapping each of these fingers individually between two 
different receptors it was shown that the C-terminal 
finger (Cl) and not the second finger (CII) determined 
target gene specificity (Green et al, 1988). In the 
context of this finding it is interesting from an 
evolutionary point of view that the two fingers are 
encoded by separate exons (Green and Chambon, 1988 and 
references therein). This analysis has been extended 
further by altering specific amino acids within the Cl
sub-region and testing the effect upon target gene 
specificity (Mader et al, 1989; Umesono and Evans, 1989; 
Danielsen £t ¿1, 1989). Analysis of the human estrogen 
receptor in this way (Mader et al., 1989) showed that the 
identity of three amino acid residues were crucial for 
determining target gene specificity (Figure 9). Two of 
these lie between the two cysteine residues on the c- 
terminal side of the first finger that are thought to
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coordinate with zinc. The third "discriminating" residue 
is at the base of the first finger, again on its- c- 
terminal aide (figure 9). When the two residues between 
the cysteines were altered from Glu-Gly to Gly-Ser (as 
found in the GR) the receptor could weakly activate 
transcription from a reporter gene containing a GRE but 
not at all from one containing an ERE. Vhen the third 
discriminating residue was also altered from Ala to Val 
(as found in the GR) the receptor could activate 
transcription from the GRE containing reporter gene more 
strongly, still without activating transcription from the 
ERE containing reporter gene. Similar results were 
obtained when essentially the same experiments were 
carried out on the glucocorticoid receptor (Umesono and 
Evans, 1989; Danielsen et al, 1989). When the Gly-Ser 
sequence between the two cysteines was altered to Glu-Gly 
(as found in the ER) the resulting receptor strongly 
activated transcription from an ERE containing reporter 
gene and only weakly activated a GRE containing reporter 
gene. In addition, when only the Glu to Gly change was 
made the resulting receptor could activate transcription 
from both reporter genes. Although the identity of these 
three residues is clearly sufficient to discriminate 
between a GRE and a ERE the data does not exclude the 
possibility that other residues play a role. It is perhaps 
surprising that residues at the base of the fingers rather 
than at the tips are apparently responsible for
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interacting with specific bases in the HRE.
As discussed previously, the steroid hormone receptor 
superfamily can be sub-divided into two sub-families both 
structurally and according to their ability to activate 
transcription from the MMTV LTR (see sections 1.4.12 and 
1.4.3). The three discriminating amino acids identified in 
these studies are conserved within (but not between) the 
two sub-families (figure 9). Thus the "GR sub-family" has 
Gly-Ser and Val whilst the "ER sub-family" has Glu-Gly and 
Gly/Ala (figure 9). Furthermore, all four members of the 
"GR sub-family" can activate transcription of a reporter 
gene containing a consensus GRE (Strahle et al, 1987; Ham 
et al. 1988). Similarly, three of the four members of the 
"ER sub-family", namely the ER, TR, and RAR can bind to a 
common responsive element (a "TRE") (see section 1.4.12). 
This leads to the conclusion that these three 
discriminating residues are involved in recognising bases 
that differ between the consensus GRE and the consensus 
ERE/TRE. The half sites for these are: TGTTCT for the GRE 
and: TGACCA for the ERE/TRE. These differ by three bases 
(shown underlined) so it may be that it is these that are 
recognised by the discriminating amino acids in the 
receptor.
The identification of these discriminating amino acids 
also helps attempts to understand structural aspects of 
the interaction between steroid receptors and DNA. It has 
been predicted that the ten amino acids that follow the C-
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terminal cysteines of the Cl finger could form an 
amphipathic alpha helix (see the review by Berg, 1989). 
This is an alpha helix in which one side is hydrophobic 
and the other hydrophilic. This may be analogous to the 
"recognition helix" identified in the helix-turn-helix 
motif of prokaryotic transcription factors. The 
hydrophilic side of this helix is thought to interact with 
DNA, recognising specific bases. In the predicted 
structure of the alpha helix for the human ER the 
discriminating Ala residue lies on the hydrophilic face 
where it could contact DNA. The second zinc finger (CII) 
does not determine target gene specificity so it may 
interact with DNA in a non sequence-specific manner, 
helping to stabilise binding. Alternatively, it has been 
proposed that its sole function is in dimerisation by 
making protein-protein contacts with another receptor 
monomer (Berg e_t ¿1, 1989)
1.4.14 The role of the hormone in "activating" the 
receptor.
The simple model for the action of steroid hormones 
states that the unbound receptor is in a conformation that 
precludes DNA binding. Binding of hormone to the receptor 
in the cytoplasm alters its conformation such that it is 
able to bind to DNA. This is accompanied by transfer of 
the receptor/hormone complex to the nucleus, possibly in
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an active process. Several lines of evidence indicate that 
the process of receptor activation is not * as 
straightforward as this model suggests.
The sub-cellular localisation of steroid hormone 
receptors has been studied for many years, and it was 
initially thought that in the absence of ligand the 
receptor was localised to the cytoplasm. However, when 
monoclonal antibodies became available it was found that 
the estrogen and progesterone receptors were intranuclear 
in the absence of hormone where they were relatively 
weakly bound (King and Greene, 1984; Welshons et al, 1984; 
Kumar et a^, 1986). Following hormone treatment the 
estrogen receptor became tightly bound to chromatin 
(Jensen and DeSombre, 1973; Welshons e£ al, 1984; King and 
Greene, 1984; Kumar at al, 1986). The TR and VitD3R are 
also mainly nuclear in the absence of hormone, but were 
reported to be tightly bound to chromatin (Samuels and
Tsai, 1973; Charles et al, 1975; Walters et al,. 1981).
Although there has been M O 3 1» controversy in the
literature, it is now agreed that in contrast to the ER,
PR, TR and VitD3R, the GR is mainly cytoplasmic in the 
absence of hormone and nuclear after hormone treatment 
(Picard and Yamamoto, 1987; Guiochon-Mantel e£ al^ , 1989 
and references therein). Thus for the ER, PR, TR and 
VitD3R hormone binding is not necessary for nuclear 
localisation.
The exclusion limit for passive diffusion of proteins
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through nuclear pores is thought to be about 70Kd (Lang et^  
al, 1986). The human GR, PR, MR, and one form of the AR 
all exceed this limit so one might expect that an active 
nuclear translocation process would be required for them 
to enter the nucleus. The ER, TR, RAR and VitD3R are all 
smaller than the exclusion limit, so might be expected to 
diffuse freely into the nucleus.
The hormone dependent nuclear localisation of the GR is 
dependent upon specific regions of the receptor (Picard 
and Yamamoto, 1987). These workers transiently expressed 
various mutated versions of the rat GR in tissue culture 
cells and monitored their sub-cellular localisation with 
antibody. One region required for nuclear localisation was 
mapped to a region between the DNA binding and the hormone 
binding domains. This domain, designated nuclear 
localisation signal 1 (NL1), is close to but distinct from 
the Tau 1 activation domain identified in the human GR 
(Hollenberg and Evans, 1988). The NL1 domain has 50X 
sequence similarity to a nuclear localisation signal 
identified in SV40 (Picard and Yamamoto, 1987). This 
sequence is absolutely conserved in the human, mouse and 
rat GRs. Furthermore, when other steroid hormone receptors 
are aligned according to the position of the DNA binding 
domain, this eight amino acid sequence is identical in the 
corresponding regions of the rabbit and human PRs and 
there is only one change in the chicken PR (Guiochon- 
Mantel £t a_l, 1989). Significant homology is also seen
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with the AR and MR, whilst homology to the various ERs is 
poor. This region has also been shown to function as a 
nuclear localisation signal in the rabbit PR (Guiochon* 
Mantel, 1989; and see next paragraph). When the hormone 
binding domain was removed from the rat GR leaving NL1 
intact, the truncated receptor was localised in the 
nucleus in the absence of hormone (Picard and Yamamoto, 
1987). Thus, NL1 is a constitutively active nuclear 
localisation domain (In that it functions in the absence 
of hormone) which is normally masked by the hormone 
binding domain. A second nuclear localisation domain (NL2) 
was coincident with the hormone binding domain, and was 
entirely dependent upon hormone binding.
The PR is mainly nuclear in the absence of hormone, and 
a recent report (Guiochon-Mantel et al^ , 1989) shows that 
two major mechanisms are responsible for its nuclear 
localisation. A nuclear localisation signal was located 
between the DNA and hormone binding domains. This region 
of the PR is exactly homologous to the NL1 domain in the 
GR, but in contrast to NL1 it is constitutively active in 
the intact protein. This sequence is responsible for the 
observed nuclear localisation of the PR in the absence of 
hormone. When this sequence is deleted the receptor is 
entirely cytoplasmic in the absence of hormone, but can be 
shifted to the nucleus by hormone treatment. Thus, there 
is a second nuclear localisation function that is entirely 
hormone dependent. Removal of both the hormone binding
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domain and the constitutive NL1 domain from the PR 
produced a protein that was nuclear in the absence* of 
hormone. Therefore, the hormone dependent nuclear 
localisation function must be located in the DNA binding 
domain itself. When the receptor was truncated further so 
that the DNA binding domain was also removed, the protein 
was entirely cytoplasmic, showing that nuclear 
localisation of the truncated receptors was not simply due to 
reduction in size resulting in passive diffusion. Thus 
there are clearly two nuclear localisation functions, one 
of which is independent of hormone. The other is located 
in the DNA binding domain (perhaps it is the DNA binding 
domain per se), and is only functional in the presence of 
hormone. This suggests that the hormone binding domain 
masks the DNA binding domain, and hormone binding causes a 
conformational change that unmasks the DNA binding domain 
and results in nuclear localisation. Some elegant 
experiments (Guiochon-Mantel et al, 1989) showed that the 
hormone independent nuclear localisation of the PR 
involved movement of receptor monomers into the nucleus.
In contrast, the hormone induced nuclear localisation 
appeared to involve the movement of receptor oligomers 
(the number of receptor subunits interacting could not be 
determined). What significance this has to the in vivo 
situation where most of the PR molecules are nuclear in 
the absence of hormone is unclear.
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Nothing is known about the nuclear localisation of other 
steroid hormone receptors.
There is now some evidence that in vitro, purified 
steroid hormone receptors can bind to their specific 
binding sites on DNA (hormone response elements) in the 
absence of hormone. For example, using DNasel footprinting 
it was shown that GR prepared from rat liver could bind to 
the GRE of the MMTV-LTR in the absence as well as the 
presence of hormone (Willmann and Beato, 1986). 
Furthermore, binding to the GRE was also observed when the 
GR was bound to a glucocorticoid antagonist. The DNasel 
footprints were indistinguishable in all three situations 
(Willmann and Beato, 1986). This indicates that hormone is 
not strictly required for binding of the receptor to the 
GRE. Whether binding of unliganded receptor to a GRE 
actually results in transcriptional activation is an 
entirely different question. It was also shown that in 
order to obtain binding of the receptor, either free or 
bound to hormone, to the GRE, it was essential to treat 
the receptor preparation at 25°C for 30 minutes. Without 
this heat "activation" of the receptor, no binding 
occurred (Willmann and Beato, 1986). The requirement for 
heat treatment to "activate" binding of the GR to a GRE 
has been confirmed (Denis et aJL, 1988). At physiological 
body temperatures receptor activation ^n vivo should be 
spontaneous. This is an important point which I will
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return to later. Affinity purified PR has also been used 
to examine whether hormone is required for binding of -the 
receptor to the HRE (Bailly et ai, 1986). Once again it 
was reported that the receptor could bind to the HRE in 
the presence of hormone and hormone antagonist, and in the 
absence of hormone. However, binding was hormone dependent 
when "crude cell extracts" were used (Bailly £t aJL, 1986 
and references therein).
In dramatic contrast to these i n vitro results, genomic 
footprinting showed that the GR will bind to a GRE (in the 
rat tyrosine amino transferase gene) in vivo only after 
hormone treatment (Becker et al, 1986). A possible 
explanation of the difference between the in vitro and in 
vivo results is that i_n vivo, in the absence of hormone, 
the receptor is complexed with some cellular component 
that prevents it from binding to the HRE. The hypothesis 
would be that hormone binding induces dissociation of the 
receptor from this complex. Partially purified receptor 
preparations could have dissociated from this component 
during the extraction or purification procedure resulting 
in a constitutively binding receptor. This would account 
for the finding that "crude cell extracts" in which 
dissociation had not occurred were dependent upon hormone 
for DNA binding. There is now considerable evidence that 
suggests (but does not prove) that ligand-free steroid 
receptors are complexed with a heat shock protein. The 
evidence for this is outlined below.
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In **cytosoIic preparation«" (a high «peed supernatant of 
a tissue homogenate) the hormone-free progesterone and 
glucocorticoid receptors have a sedimentation coefficient 
of about 8 Svedbergs (S) (Joab et al, 1984; Sullivan et 
al, 1985; Catelii et al, 1985). The way in which these 
cytosolic preparations are made does not preclude nuclear 
components, so both nuclear and cytoplasmic receptors are 
present. The size of pure steroid receptor is only 4 to 
5S, indicating that PR and GR prepared in this way are 
complexed with another entity. This complex is stabilised 
by molybdate and peroxide (Tienrungroj et al, 1987) but is
dissociated by heat treatment (25°C for 30 minutes),
dilution of the extract and increased ionic strength
(0.25M KC1) (Joab et £i» 1984; Groyer et ±1» 1987). In
most reports this 8S receptor complex has been isolated in 
the presence of molybdate. However, it is also possible to 
isolate it in the absence of molybdate, indicating that it 
is not just an artefact of the molybdate treatment (Denis 
et a l , 1988). Various biochemical and immunological 
experiments have shown that the 8S receptor complex is 
unable to bind to both non-specific DNA (Mendel e£ al, 
1986; Housley £t al., 1985; Groyer et al^ , 1987) and hormone 
response elements (Denis e_t al, 1988). Upon binding of 
hormone or heat treatment the 8S complex is converted to 
the 4S receptor which is now able to bind to non-specific 
DNA (Mendel et a_l, 1986; Housley e_t a_l, 1985; Groyer et^  
al, 1987). However, there have been apparently conflicting
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reports regarding the conversion of the 8S receptor 
complex to a form which can bind specifically to hormone 
response elements. Binding of the partially purified PR to 
a GRE was reported to occur independently of the hormone 
and in the presence of an antagonist (Bailly et al, 1986). 
Heat treatment was not required to "activate" the 
receptor. However, in these experiments it is not clear 
whether the receptor preparation used was in the form of 
the 8S complex or not. Villmann and Beato (1986) found 
that the 8S GR complex in crude cytosol that had not been 
stabilised with molybdate would bind specifically to the 
MMTV GRE only if "heat activated" by incubation at 25°C 
for 30 minutes prior to the binding reaction. Binding of 
the "heat activated" GR to the GRE occurred in both the 
presence and the absence of hormone, and also in the 
presence of a glucocorticoid antagonist. In contrast to 
these results it was reported (Denis £t al, 1988) that 
using molybdate stabilised 8S GR complexes, binding of GR 
to the MMTV GRE only occurred if the receptor preparation 
was first treated with the hormone and then incubated at 
elevated temperature (25°C for 30 minutes). No binding was 
detected if the complexes were heat treated first and then 
incubated with hormone, or when treated with either 
hormone or elevated temperature alone (Denis e^ t a_l, 1988).
When a crude extract,prepared from HeLa cells that had 
been transiently transfected with a plasmid expressing the 
human ER, was used in a gel retardation assay, binding of
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the ER to the vitellogenin ERE was hormone dependent 
(Kumar and Chambon, 1988). No binding of the ER to the-ERE 
was detectable unless the cells had been treated with 
estrogen before preparing the cell extract. Interestingly, 
binding also occurred with extracts prepared from cells 
that had been treated with the anti-estrogen tamoxifen, 
suggesting that this antagonist acts by inhibiting the 
activation function of the receptor. These whole cell 
extracts were prepared by homogenisation or freeze-thawing 
in a simple buffer that did not contain peroxide or 
molybdate. Binding reactions were at 20°C for 15 minutes, 
but otherwise no "heat activation" was carried out. 
Binding to the ERE was also hormone dependent when the 
hormone was added after preparing the extracts (Kumar and 
Chambon, 1988).
Despite these worrying discrepancies it is clear that 
the GR and the PR in the 8S complex cannot bind to a HRE. 
When it is converted to the 4S form it can bind 
specifically to a HRE. The conversion from the 8S to the 
4S form was found to be accompanied by the liberation of a 
90Kd, non-steroid binding phosphoprotein (Joab £t al, 
1984). There is now overwhelming evidence that this non­
steroid binding protein is the heat shock protein HSP90 
(Catelli e£ al^ , 1985; Sanchez et a^, 1985; Mendel et al, 
1986). It has been shown that this same heat shock protein 
is also associated with the chicken estrogen and androgen 
receptors in a similar 8S complex in cytosolic
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preparations (Joab e_t al, 1984).
It has been proposed (Catelli et al, 1985; Sanches et 
al, 1985; Mendel e_t al, 1986) that in the absence of 
hormone, steroid hormone receptors are bound to HSP90 in 
an 8S complex, and that this prevents the receptor from 
binding to DNA. Possibly the heat shock protein blocks the 
DNA binding domain of the receptor. Upon hormone binding, 
HSP90 would be displaced thereby unmasking the DNA binding 
domain. This provides an attractive explanation for why 
the purified (i.e. non-complexed) receptor can bind to 
HREs in vitro in the absence of hormone, whilst in vivo, 
and with crude extracts that were not heat treated, 
binding was hormone dependent. Thus the role of hormone in 
receptor activation may simply be to dissociate the 
receptor from HSP90; the receptor itself is constitutively 
active unless complexed to HSP90. Although this mechanism 
is attractive it has not been proven unambiguously that 
the HSP90 receptor complexes detected in cytosolic 
preparations actually exist in vivo and are not an 
artefact of the isolation procedure. If the HSP90 theory 
is correct then the HSP90-receptor complex must be stable 
under physiological conditions. Clearly, the complexes 
isolated from cells using procedures that are as 
undisruptive as possible are remarkably unstable. In 
particular, heat treatment at 25°C causes the dissociation 
of HSP90. So, at face value, one would not expect the 
complex to exist inside the cell. Therefore, the HSP90-
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receptor complex would have to be somehow stabilised in 
vivo if it is to play its proposed role in receptor 
activation. Furthermore, since most steroid hormone 
receptors are mainly nuclear in the absence of hormone, 
HSP90 would have to be present in the nucleus. As far as 
is known, HSP90 is mainly cytoplasmic (see Bailly et al, 
1986). However this does not mean that a small amount of 
HSP90, sufficient to complex all the steroid receptors is 
present in the nucleus. As yet it has not been possible to 
reproduce the interaction between HSP90 and the receptor 
in vitro, (see Bresnick £t al, 1989). Conditions which 
disrupt the receptor-HSP90 complex have been found to 
inactivate the ability of cytosols to bind steroid 
hormones, suggesting that the complex may be necessary for 
hormone binding (Bresnick £t al, 1988). Further evidence 
that the receptor must be complexed to HSP90 in order to 
bind hormone has recently been published (Bresnick e_t al, 
1989). Partially purified GR was subjected to various 
treatments and then assayed for its ability to bind 
hormone. Under no conditions was an HSP90-free receptor 
able to bind hormone. Moreover, receptors that had been 
inactivated could not be reactivated, once again 
suggesting that the dissociation of HSP90 is irreversible. 
If the conclusion from this work is correct it raises the 
question of how various steroid hormone receptors 
synthesised in vitro from cDNA clones are able to bind 
hormone. As far as I know, all hormone binding assays have
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been done with protein synthesised in rabbit reticulocyte 
lysate, and this is known to contain HSP90 (Bresnick et 
al, 1989).
The human ER expressed in yeast is able to mediate 
activation of a co-transfected gene containing an ERE in 
response to estrogen (Metzger £t al, 1988). Furthermore, 
in vitro, binding of ER prepared from yeast expressing the 
human ER, to an ERE, was shown to be hormone dependent 
(Metzger et al, 1988). Thus, if HSP90 is necessary for the 
inactivity of the unliganded ER, then the analogous yeast 
heat shock protein must also be able to interact with the 
ER.
Finally, two recent papers (Danm et al, 1989; Graupner 
e_t al^ , 1989) appear to show that thyroid hormone receptor 
can bind to a TRE in the the absence of hormone in vivo, 
which is not consistent with the HSP90 theory. When a 
reporter gene (TK promoter linked to CAT) containing an 
artificial TRE was transfected into CV1 cells a high basal 
level of CAT activity was detected, and this was only 
marginally stimulated by T3 treatment (Damm et al, 1989). 
When this reporter gene was co-transfected with a plasmid 
which expresses the rat TRc<l under control of the RSV 
promoter, CAT activity was reduced by 801 in the absence 
of hormone compared to that seen without the receptor 
(Damm et al, 1989). Hormone treatment caused a 20 fold 
stimulation of CAT activity. This suggests that the 
receptor functions as a repressor in the absence of
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hormone. The TR was then expressed in COS cells from a 
high copy number SV40 vector in order to ensure high 
intracellular levels of the receptor. Whole cell extracts 
from the transfected COS cells were used in a gel 
retardation assay with the artificial TRE. This showed 
that the TR could bind to the TRE even when the cells had 
not been treated with T3 (Damm et al, 1989). This result 
appears to suggest that, at least for TR, hormone is not 
required ^n vivo for binding to the response element. 
However, activation of transcription does not occur in the 
absence of hormone so presumably T3 binding is required to 
"induce” a trans-activation function in the TR. This is 
consistent with the report that in the absence of hormone, 
the TR, like the VitD3 receptor is tightly bound to 
chromatin in the nucleus (Walters et al, 1981). It might 
also be argued that the ligand independent binding 
observed in these experiments is the result of the high 
intracellular concentration of the TR. Under these 
conditions the cells might not have sufficient HSP90 to 
complex all of the TR, leaving some uncomplexed TR to bind 
to the TRE.
In similar transfection experiments it was shown that a 
reporter gene containing the TRE of the rat o<-myosin heavy 
chain gene could be induced by retinoic acid in the 
presence of the co-transfected retinoic acid receptor beta 
(Graupner e_t j^ l, 1989). It has already been demonstrated 
that RAR could act through a TRE (Umesono e_t a_l, 1988;
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Bedo jet al, 1989). The unexpected finding was that when a 
thyroid hormone receptor (hTRe< or hTRJJ) was also expressed 
in these cells (in triple transfections), induction of CAT 
by retinoic acid was repressed in the absence of T3. In 
contrast, CAT activity was induced by T3 in the presence 
of the TR. Importantly, this induction by T3 was not 
repressed by the presence of the unliganded RAR. This 
again suggests that the unliganded TR can bind to a TRE 
and that in doing so it can repress activation by the RAR. 
This was confirmed by gel retardation assays. Furthermore, 
the use of hybrid receptors showed that the inhibitory 
effect of the TR was mediated through the DNA binding 
domain of the RAR. This strongly suggests that the 
unliganded TR competes with the liganded RAR for binding 
to the TRE. Once bound at the TRE the unliganded TR is 
unable to activate transcription. In contrast, the 
unliganded RAR cannot compete with the liganded TR for 
binding to the TRE. This suggests an essential difference 
between the mode of action of TR and RAR; TR can bind to a 
TRE in the absence of hormone whilst the RAR cannot. 
However it is possible that the unliganded RAR is able to 
bind to a genuine retinoic acid response element (none 
have yet been identified), but not to a TRE. Another 
aspect of these experiments is that the RAR and the TR are 
behaving differently in the same cell. Assuming that HSP90 
is responsible for preventing the RAR from binding to the 
TRE in the absence of hormone, then theV'C is clearly
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sufficient HSP90 available to accomplish this. Yet, the TR 
is still able to bind to the TRE in the absence of 
hormone. This strongly suggests that HSP90 does not form a 
complex with the TR which prevents it binding to the TRE 
in the absence of T3. Of course, this does not mean that 
HSP90 is not involved in the activation by hormone of 
other steroid receptors, particularly those that are only 
loosely bound to chromatin in the absence of hormone or 
the GR which is cytoplasmic in the absence of hormone. It 
is looking more as if the mechanism of receptor activation 
by hormone may be different for different receptors.
1.5 The role of thyroid hormone in amphibian 
metamorphosis.
Amphibian metamorphosis is a rapid and dramatic 
developmental process that involves many biochemical, 
cellular and morphological changes. Presumably this 
involves changes in the pattern of gene expression. Unlike 
many of the changes in gene expression that occur in adult 
organisms which are often transient, it is generally 
believed that many of the changes that occur at 
metamorphosis are irreversible (see Morris, 1987; Lyman 
and White, 1987).
It has been known for many years that thyroid hormone 
plays a major role in initiating amphibian metamorphosis. 
Removal of the thyroid gland from pre-metamorphic larvae 
prevents metamorphosis indefinitely, and this can be
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relieved by very low concentretions (10"^M) of thyroid 
hormone (T3). Also, inhibitors of thyroid hormone 
biosynthesis (thiourea and thiouracil) prevent 
metamorphosis (Gordon et^  al, 1943). Furthermore, 
metamorphosis can be induced prematurely by incubating 
Xenopus laevis larvae in thyroxine (May and Knovland, 
1980). By analogy with other vertebrate systems it seems 
likely that thyroid hormone exerts its effects upon 
amphibian metamorphosis by modulating the expression of 
specific genes at a transcriptional level. However it is 
clear that the changes that occur during metamorphosis are 
so complex that they cannot all be regulated directly by 
thyroid hormone alone. It seems more likely that thyroid 
hormone is the trigger which sets in motion a complex 
developmental program. As yet it has not been demonstrated 
that any genes are regulated directly by thyroid hormone 
at the level of transcription during metamorphosis.
Both spontaneous and thyroxine induced metamorphosis is 
associated with a switch from ammonotelic to ureotelic 
excretion of amino-group nitrogen. This switch is made 
possible by increases in the levels of several enzymes in 
the liver which are essential for the formation of urea. 
One of these is carbamoyl phosphate synthetase (Metzenberg 
et al, 1961; Vixom e_t al^ , 1972; Mori e_t a_l, 1979). It has 
been reported that significant structural and biochemical 
changes occur in the liver of amphibia during 
metamorphosis (see Lyman and White, 1987 for references).
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For example, there is an increase in the synthesis of 
secreted liver proteins such as albumin and transferrin. 
The increase in the level of carbamoyl phosphate 
synthetase that is associated with thyroid hormone 
treatment was shown to be due to an increase in the level 
of the mRNA encoding this enzyme (Mori et ai, 1979). More 
recently, Morris (1987) has assayed the levels of two urea 
cycle enzymes during the thyroxine induced metamorphosis 
of Rana catesbeiana using cross-hybridisation with 
mammalian cDNA clones. Over a three day period following 
the start of treatment with T3 the levels of mRNA in the 
liver encoding the enzymes carbamoyl phosphate synthetase 
and arginosuccinate synthetase increased coordinately by 
ten fold. The level of liver mRNA encoding another enzyme, 
phospoenolpyruvate carboxykinase (PEPCK) fell by 90X 
following T3 treatment. This is in contrast to what has 
been observed in rat liver, where the level of PEPCK mRNA 
is increased by T3. These results suggest that T3 may 
cause changes in the levels of specific gene products by 
altering the level of their mRNAs. However, because these 
experiments were done with whole animals it is possible 
that the effects of T3 are indirect. In fact Morris (1987) 
suspected that the reduction in the level of PEPCK mRNA 
was the result of the T3 induced release of insulin. Lyman 
and White (1987) employed differential screening of a 
liver cDNA library prepared form T3 treated Rana 
catesbeiana to isolate cDNA clones corresponding to mRNAs
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whose levels are altered by thyroid hormone. Three clones 
corresponding to mRNAs whose levels are increased after T3 
treatment were isolated, and the levels of two of these 
mRNAs were found to increase at metamorphic climax. Two 
clones corresponding to mRNAs that are repressed by T3 
were also isolated, and the level of one of these mRNAs 
was found to decline to undetectable levels during 
metamorphic climax. Once again it is not possible to say 
that the level of any of these mRNAs is directly regulated 
by thyroid hormone. Clearly these changes are occurring at 
a pre-translational level, but this could be the result of 
post-transcriptional events or regulation of transcription 
or both.
Another change that occurs at metamorphosis is the 
formation of the adult skin, the composition of which is 
entirely different from that of the larva. This is 
associated with the appearance of adult keratins. In 
Xenopus laevis. adult keratins first appear between stages 
48 and 52 (see Mathisen and Miller, 1989). Thyroid hormone 
has been shown to induce the synthesis of adult keratins 
both iji vivo, and in skin explants cultured iji vitro 
(Mathisen and Miller, 1989). Their results suggest that 
two steps are involved in the induction of adult keratins. 
The first step results in the synthesis of low levels of 
keratins and does not require thyroid hormone. After 
addition of T3 there was a lag period of two days before 
levels of adult keratin mRNA started to increase. During
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normal metamorphosis there was a 1000 fold increase in the 
level of adult keratin mRNA between stages 48 and 52% It 
is not known whether this induction is the result of an 
increased rate of transcription or post-transcriptional 
events such as mRNA stabilisation. In mammalian systems 
induction of transcription by thyroid hormone is a very 
rapid process; induction can often be detected within a 
few hours of administering the hormone (for example see 
Bedo e£ a_l, 1989). The lag period observed by Mathisen and 
Miller (1989) suggests that perhaps T3 is not activating 
keratin gene expression in a similar way. Perhaps the 
action of T3 is indirect so that a lag period occurs while 
the hormone is acting on some other process. For example, 
T3 might directly regulate a small number of genes, the 
products of which are involved in activating (and 
repressing) structural genes such as the adult keratins. 
Once the adult keratin genes had been induced thyroid 
hormone was not required to maintain expression, 
indicating that, unlike the action of steroid hormones in 
adult mammals, induction was irreversible.
It has been demonstrated that most tadpole tissues, 
including the liver, contain receptors for thyroid hormone 
(Kistler et a_l, 1975; Galton and St. Germain, 1985). Based 
upon various biochemical changes it was shown that 
X.laevis larvae first aquire competence to respond to 
exogenous thyroid hormone between stages 36 and 41 (Tata, 
1968). This presumably corresponds to the appearance of
-110-
Introduction
the receptor. Indeed, by using radiolabelied T3 it was 
shown that high affinity binding sites for T3 first 
appeared in whole Xenopus larvae between stages 31 and 34 
(Tata, 1970). During this period there was a large 
increase in the binding of labelled T3 by the larvae 
(Tata, 1970). Thyroid hormone first appears in the blood 
of X.laevis larvae at about stage 50 (see Mathisen and 
Miller, 1989), which is some considerable time after the 
appearance of the receptor.
As noted above, it has not yet been demonstrated that 
any of the genes whose expression increases (or decreases) 
during metamorphosis are directly regulated by thyroid 
hormone. Perhaps the only unambiguous way to demonstrate 
this is to test prospective T3 responsive genes in 
transfected cell lines or in ill vitro transcription 
systems. It would be a major step forward if the specific 
nuclear receptor for thyroid hormone was cloned. This 
would enable the involvement of the receptor in the 
regulation of genes that are activated or repressed by 
thyroid hormone during amphibian metamorphosis to be 
investigated.
1.6 Evidence that the Xenopus albumin genes are regulated 
by thyroid hormone.
In adult liver, expression of albumin is repressed by 
estrogen (May e^ al^ , 1982b; Wolffe ejt a^, 1985). This
- 111-
Introduction
repression has been reported to be the result of a 
decrease in the levels of albumin mRNA in the liver (Hay 
et al, 1982b; Wolffe et a 1, 1985), although another group 
(Philipp e£ al, 1982) found that levels of albumin mRNA 
were unaffected by estrogen. There is also disagreement as 
to whether the proposed reduction in the level of albumin 
mRNA is the result of purely post-transcriptional events 
(Kazmaier et al, 1985), or a combination of a decreased 
transcription rate and post-transcriptional events (Uolffe 
et al, 1985).
Albumin is the major protein in the blood of 
vertebrates. Very early work on amphibian metamorphosis 
showed that the levels of serum proteins in the blood of 
pre-metamorphic Rana catesbeiana were remarkably low, and 
that the amounts increased dramatically during 
metamorphosis (Herner and Frieden, 1960; Frieden e_t al, 
1975). Further studies showed that the major change in 
serum proteins associated with either spontaneous or T3 
induced metamorphosis was a dramatic increase in the level 
of albumin (Frieden e£ ¿1, 1975). However, it should be 
noted that albumin was only identified by its mobility in 
paper chromatography. Some of these experiments were on 
Xenopus laevis. and the data indicate a 40 fold difference 
in the level of albumin protein in the blood of pre- 
metamorphic larvae and adults. However, the exact time 
course of the induction of albumin synthesis (and 
secretion) during metamorphosis was not investigated. When
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pieces of adult Xenopus liver were maintained in tissue 
culture, synthesis of liver-specific proteins decreased 
over a period of time (Vangh, 1982). Albumin synthesis 
could be restored with various hormones. Dexamethasone (a 
glucocorticoid) and thyroid hormone appeared to act 
together to re-introduce albumin synthesis, suggesting 
that albumin expression may be up-regulated by thyroid 
hormone (Wangh, 1982). Obviously, this might not be a 
direct effect, and it was not known at which level albumin 
synthesis was being offected.
Investigations into the function of thyroid hormone in 
amphibian metamorphosis would be significantly advanced by 
the cloning of the thyroid hormone receptor. The deduced 
structure might lend support to the proposal that some of 
the effects of thyroid hormone are the result of direct 
modulation of transcription of specific genes. Also, the 
ability to express the receptor in a more defined system 
such as cultured cells might enable the effect of thyroid 
hormone on specific hormone responsive genes to be 
studied. Our laboratory has been studying the Xenopuj« 
laevis 68Kda albumin gene with respect to its tissue- 
specific expression in adult liver. The albumin genes of 
amphibians are unique in that as well as being expressed 
in a tissue-specific manner they also appear to be 
activated at metamorphosis. I have shown that the X.laevis 
albumin genes are first transcribed at the onset of 
metamorphosis, and I have isolated a full length clone
-113-
Introduction
from a X.laevis cDNA library that encodes a high affinity 
receptor for thyroid hormone. This receptor mediates the 
the induction by T3 of the expression of a reporter gene 
containing an artificial thyroid hormone response element. 
This shows that the Xenopus receptor functions in an 
analogous way to the mammalian thyroid hormone receptors, 
lending support to the idea that thyroid hormone regulates 
the transcription of specific genes during metamorphosis. 
Furthermore, preliminary experiments suggest that thyroid 
hormone may directly induce the expression of the Xenopus 
albumin genes at a pre-translational level, by a mechanism 
that requires the thyroid hormone receptor.
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C H A P T E R  2 
MATERIALS.
2.1 General materials.
Restriction enzymes were from Amersham International 
(U.K.), Northumbria biologicals limited (NBL) and Bethesda 
research laboratories, Maryland U.S.A. (BRL). E.coli DNA 
polymerase I and T4 DNA ligase were obtained from Amersham 
International, T3 and T7 RNA polymerases were from BRL, 
sequencing grade DNA polymerase Klenow fragment was from 
NBL and AMV reverse transcriptase was from Life sciences 
Inc. (U.S.A.).
The lambda in vitro packaging kit (Giga Pack Gold) was 
from Stratagene (La Jolla, CA, U.S.A) supplied through 
NBL.
All radioisotopes were supplied by Amersham 
International at the following specific activi t ies ; 0 <[ 3 2 P] 
dGTP and c*[3 2P] dCTP; 3000 Ci/mmol, &[ 3 2 P] ATP; 5000 
Ci/mmol, CX[3 2P] rUTP; 3000 Ci/mmol, [3 5 S] dATP; 1000 
Ci/mmol, [*2^I] triiodothyronine; >1200pCi/ug, [3 3 S]
methionine; >1000 Ci/mmol, [3 H] rTTP; 30Ci/mmol.
Nitrocellulose sheets (Hybond-C) and Nylon filters 
(Hybond-N) were obtained from Amersham. Type II agarose 
(medium EE0) was supplied by Sigma chemical company and 
low melting point agarose was from FMC Bioproducts or ICN 
Biomedicals Inc. Materials for bacteriological media were 
from Difco laboratories (Michigan, U.S.A.) and Oxoid 
limited (England).
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E«coli transfer RNA (type XX) was supplied by Signs. 
X-ray film was from Fuji photo company limited (Japan)
All other chemicals and reagents were from BDH ("Analar" 
grade) or from Sigma chemical company unless otherwise 
stated.
2.2 Stock Solutions.
Deionised formamide - Formamide was stirred with Amberlite 
monobed resin MB-3 or MB-4 (5g per 100 ml of formamide) 
until the pH was 7, filtered through Whatman No. 1 filter 
paper and then stored at -20°C.
Filtered formaldehyde - A 40X (w/v) solution of
formaldehyde was filtered through Whatman No. 1 paper.
TE - lOmM Tris.HCl (pH7.5), ImM EDTA (pH8 )
10*TBE - 108 g/1 Tris base, 55 g/1 boric acid, 9.5 g/1 
EDTA, pH8.
20*SSC - 3M NaCl, 0.3M Na Citrate, pH7
50 * Denhardts - IX each of Ficoll, polyvinylpyrolidone, 
bovine serum albumin.
10*M0PS - 0.2M 3-(N-morpholino) propanesulphonic acid,
50mM sodium acetate, lOmM EDTA, pH7
2.3 Bacteriological Media.
LB was prepared by dissolving lOg of NaCl, lOg of 
bactotryptone and 5g of yeast extract in 1 litre of 
distilled water. For LB plates this was supplemented with 
15g/litre of bacto agar.
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2*TY was prepared by dissolving 8g of NaCl, 16g of 
bactotryptone and lOg of yeast extract in 1 litre* of 
distilled water.
H-Agar was made by adding 8g of NaCl, lOg of 
bactotryptone and 15g of bacto agar to 1 litre of 
distilled water
NZY broth was prepared by dissolving 5g of NaCl, 2g of 
M8S04 .7H20, 5g of yeast extract and lOg of NZ amine in 1 
litre of water. For NZY plates this was supplemented with 
15g per litre of bacto agar. NZY top agarose was made by 
adding 0.7g per 100 ml of agarose (type II) to NZY broth.
H-top agar was prepared by dissolving lOg of 
bactotryptone, 8g of NaCl and 6g of agar (or 6g of agarose 
for H-top agarose) in 1 litre of distilled water.
Terrific broth (TB) was occasionaly used to grow 
bacteria for large scale plasmid isolation. It was 
prepared by dissolving 12g of bactotryptone and 24g of 
yeast extract in 800 ml of distilled water, adding 3ml of 
glycerol and then autoclaving. Just before innoculating 
this with bacteria, 100ml of 0.17M KH2P04 and 100ml of 
0.72M K2HP04 (both previously sterilized by autoclaving) 
were added.
All media were autoclaved before use.
Antibiotics were used in plates and media at the 
following final concentrations. Ampicillin; 100^ig/ml, 
tetracycline; 15ug/ml.
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2.4 Bacterial, plasmid and phage genotype».
2.4.1 coli «train«.
JM101 - supE, thi, A  (lac-proAB), [F‘, traD36,pro A B ,
LACiqZDMIS] 17-18 ditto, not tra D36.
MC1061 - F", ara D139, A (ara, leu)7696, A la c  Y74, gal U", 
gal K”, hsr", hsm+, strA.
DHl - F*, endAl, hsdRIFtrk'.mk*), supE44, thi-1, X ", 
recAl, gyrA96, relAl.
Y1090 - [ A  Lac U169, proA*, Ion, araD139, strA, supF,
trpC22 sTnlO(pMC9)].
BB4 - supFS8, supE44, h«dR514 (rk“,mk“), galK2,
galT22,trpR55, metBl, tonA, lambda*, D(arg-lac)U169 [F', 
proAB, lacIqZDMl5, TnlO(tetr)].
XLl-blue - endAl, hsdR17(rk".mk*), supE44, thi-1, lambda", 
recAl, gyrA96, relAl, (lac“) [F', proAB, lacIqZDMIS, 
TnlO(t«tr)].
2.4.2 Plasmid vector«.
pBR322 - General purpose cloning vector.
pSP64/pSP65 - SP6 i_n vitro transcription vectors (Promega 
Biotech, Madison U.S.A)
pGEMl/pGEM2 - SP6/T7 ^n vitro transcription vectors 
(Promega Biotech, Madison U.S.A)
pGEM3Z/pGEM4Z - SP6/T7 iji vitro transcription vectors also 
incorperating the LacZ colour selection system (Promega 
Biotech, Madison U.S.A)
pSVL - an SV40 late expression vector designed for high
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level transient expression in eukaryotic cells (Pharnacia 
,U.S.A.) The "poisonM sequence of pBR322 is not present 
resulting in an increased plasmid copy number and a higher 
level of transient expression in COS cells. 
pBluescript SK~ - The plasmid generated by automatic 
excision from XZAP. Has an extensive polylinker, the lacZ 
colour selection system and promoters for both T3 and T7 
RNA polymerases (Stratagene, La Jolla, CA U.S.A)
2.4.3 Bacteriophage vectors.
AZAP - a bacteriophage lambda insertion vector 
(Stratagene, La Jolla, CA, U.S.A). Cloned inserts can be 
automatically excised from the phage vector and converted 
to the plasmid vector pBluescript for ease of handling 
(Short £t al, 1988). This was purchased in the form of DNA 
that was pre-digested with EcoRl and de-phosphorylated. 
M13mpl8 and M13mpl9 - bacteriophage M13 vectors designed 
for sequencing by the dideoxy chain termination method 
(Messing ¿t ¿1, 1981)
M13mpl0 and M13mpll - earlier versions of the mpl8/19 
vectors differing only in the polylinker (Messing e£ al, 
1981).
2.4.4 Plasmid and Bacteriophage Recombinants.
\x68.206 - a Xenopus laevis genomic clone in the lambda 
vector charon 4A containing the complete 6 8 KDa albumin 
gene kindly provided by Dr. G. Ryffel (May et al, 1982a).
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pSVL- 8  - a DNA fragment from a Xcnopus laevia histone 
gene cluster containing a functional H3 gene inserted in 
the SV40 vector pSVL2
pTK28mult - A plasmid in which two copies of an 
oligonucleotide containing an idealised thyroid hormone 
response element have been inserted just upstream of the 
TK promoter linked to the reporter gene CAT (Brent et al, 
1989b). This was kindly provided by D. Moore. 
pUMSAEl - a rat albumin promoter/CAT fusion construct 
kindly donated by M. Weiss. (Heard £t aj. (1987).
B5400 and B120 - Plasmids containing the rat ^ -fibrinogen 
promoter (numbers refer to the length of DNA upstream of 
the transcription start site in nucleotides), linked to 
the reporter gene CAT (Courtois et al, 1987). These 
plasmids were kindly provided by G. Crabtree.
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C H A P T E R  3.
METHODS.
3.1 Oocytes. Eggs And Embryos.
3.1.1 Oocytes
Oocytes were obtained by anaesthetising a female Xenopus 
laevis with MS222 and carrying out a partial ovariectomy. 
The oocytes were manually stripped from the ovary, washed 
and maintained in full strength 6 arth-X.
3.1.2 Eggs and embryos.
Female X^ laevis were induced to ovulate by subcutaneous 
Injection with 250 units of serum gonadotrophin (Intervet 
U.K. Ltd) 48 hours before laying followed by 250 units of 
chorionic gonadotrophin B (Intervet U.K. Ltd) 16 hours 
before laying. Male X_^  laevis were injected with 250 units 
of chorionic gonadotrophin 8 hours before laying.
For in vitro fertilisation a male X^ laevis was killed by 
injection with 0.5ml of 250mg/ml phenobarbitone (euthatal, 
May and Baker), and the testis removed into full strength 
8arth-X on ice. 50 to 100 eggs layed in full strength 
8arth-X were transferred to a petri dish and dredged with 
pieces of teased testis for 30 seconds. After leaving for 1 
minute a small amount of distilled water was added to 
activate the sperm. Two minutes later the dish was flooded 
with distilled water.
Fertilised eggs were de-jellied in 2Z (w/v) cysteine (pH
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adjusted to 8 with ffaOH) and then washed at least 4 times in
full strength barth-X or one tenth barth-X.
Prior to gastrulation embryos were transferred to one
tenth barth-X to avoid exogastrulation. After hatching
larvae were fed on vegetable soup added to the water.
w
Embryos were staged according to Nieijkoop and Faber 
(1956).
3.2 Microlnjection Of Xenopus Oocytes.
Oocytes that had been obtained as described in section 3.1 
were microinjected using a fine, drawn out glass capillary 
mounted on a micro manipulator. The needle was linked via a 
thin gauge pipe to a syringe driven by a vernier, and the 
system partially filled with oil. Oocytes were transferred 
to a piece of moist filter paper placed on a microscope 
slide and injected with about lOnl of DNA or RNA dissolved 
in sterile water, under a binocular microscope. For nuclear 
injections the needle was inserted a small distance into 
the animal pole where the germinal vesicle usually lies. 
Cytoplasmic injections were into the vegetal half of the 
oocyte.
3.3 Microinjection Of Fertilized Eggs.
Batches of eggs were fertilized in vitro and de-jellied 
soon after rotation. Embryos just beginning the first 
cleavage were transferred to 1*BX supplemented with 5X 
(w/v)ficoll (m.w 40,000) and injected in the animal pole
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with about lOnl of DNA dissolved in 80aM NaCl. Eabryos were 
injected only between the 2 cell and 4 cell stages* 
Immediately after injection embryos were transferred to a 
14°C incubator. They were kept in 5X ficoll at 14°C until 
they had reached stage 6 to 8 since this was found to 
reduce leakage of cytoplasmic material from the hole made 
by microinjection. However, continued incubation in 5X 
ficoll was found to be toxic. The embryos were then washed 
several times in barth-X and incubated in
barth-X at 14°C for several days. Dead or abnormal embryos 
were discarded regularly. When the embryos reached stage 45 
they were transferred to tanks of frog water and reared as 
normal.
3.4 Tissue Culture Techniques (COS cells).
COS cells (a monkey kidney cell line) were grown in 
Dulbecco's modified Eagles medium (DMEM) supplemented with 
10X (v/v) fetal calf serum (ECS), glutamine, penicillin, 
and streptomycin at 37°C in 5X carbon dioxide. This
fibroblast cell line grows as a monolayer and was divided 
(1 in 3) about every four days using the following
procedure. The media was removed and replaced with 2.5ml of 
versene which was left in place for about 2 minutes. This 
was removed and replaced with 2.5ml of a versene:trypsin 
mix (1:1). The flask was agitated several times over a 
period of about 5 minutes to help release the cells from
the surface of the flask. 60ml of DMEM + FCS was then added
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and the cells dispersed in to a fine suspension by shaking 
vigorously and pipetting the media up and down several 
times. It was important to do this in order to obtain an 
even monolayer of cells. Vhen growing up a number of flasks 
for a single experiment the trypslnized cells were pooled 
at this stage so that the flasks would be as identical as 
possible. 2 0ml aliquots of the cell suspension were then 
transferred to fresh flasks and grown for at least 2 days 
before transfection.
3.5 Isolation Of RNA.
3.5.1 Isolation of liver RNA
RNA was isolated from larval and adult Xcnopus liver using 
the guanidiniun thiocyanate/caesium chloride method of 
Chirgwin et al^  (1979). The liver was removed from an animal 
that had been killed with euthatal and cut into pieces in 
phosphate buffered saline (PBS). The pieces were washed 
several times in PBS and then homogenised in five tissue 
volumes of lysis buffer ( 6  M guanidiniun thiocyanate, lOmM 
Tris.HCl pH7.5, IraM ^J-mercaptoethanol) that had been 
prepared one day earlier. After adding 0.1 volumes of 
sarcosyl NL the homogenate was made 15X (w/v) with caesium 
chloride and centrifuged at 2 0 0 0 rpm in a bench centrifuge 
to pellet the debris. The supernatant was carefully layered 
on to 2ml of 5.7M ceesiura chloride, lOOmM EDTA (pH8 ) in an 
ultracentrifuge tube. The tube was centrifuged for 12 to 18 
hours in a swing out rotor at 36,000 rpm at 20°C. ,The
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following day the supernatant was aspirated off until about 
lal remained, which was then very gently poured off.* The 
tube was left inverted on a piece of tissue to allow the 
remaining fluid to drain away. The RNA pellet was 
resuspended in sterile water or DEPC treated water and then 
extracted with an equal volume of neutral phenol. The 
aqueous phase was extracted with an equal volume of water 
saturated ether and then precipitated with 2.5 volumes of 
ethanol in the presence of 0.3M sodium acetate (pH6.5) at 
-20°C for at least 2 hours. The RNA was recovered by 
centrifugation at 10,000 rpm for 15 minutes, dried under 
vacuum and resuspended in sterile water or DEPC treated 
water. The RNA concentration was determined by measuring 
the absorbance at 260 nanometers assuming a reading of 1 
for a 40pg/ml solution. Finally, the RNA was ethanol 
precipitated as before and stored (in 70% ethanol) at -20°C 
until required.
3.5.2 Isolation of RNA from Xenopus ovary, eggs and 
embryos.
Groups of eggs or embryos or pieces of dissected ovary 
were transferred to a glass homogeniser and homogenised in 
approximately 4 volumes of Kressmans buffer (lOtnM Tris.HCl 
pH7.5, 1.5tnM MgCl2 » lOmM NaCl, lmg/ml proteinase k 
(Boehringer)). After adding SDS to a final concentration of 
2% (w/v) the homogenate was centrifuged at 1 0 , 0 0 0  rpm for 1 
minute and then either incubated at 37°C for 30 minutes or
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extracted immediately with an equal volume of neutral 
phenol. Several more phenol extractions were performed as 
required. For latter stage embryos it was necessary to 
shear the DNA using a syringe fitted with a fine gauge 
needle. The aqueous phase was extracted at least once with 
chloroform and then nucleic acids precipitated with 2.5 
volumes of ethanol in the presence of 0.3M sodium acetate 
(pH6.5).
3.5.3 Isolation of RNA from microinjected oocytes.
Groups of 10 to 20 healthy oocytes were transferred to 
eppendorf tubes and excess medium removed. 0.5ml of NaE 
(0.3M sodium acetate pH6.5( ImM EDTA pH8 ) was added and the 
oocytes homogenised by squirting them up down a yellow 
eppendorf tip. SDS was then added to a final concentration 
of 2 2 (w/v) and the homogenate extracted immediately with 
an equal volume of neutral phenol. The aqueous phase was 
taken and extracted with an equal volume of chloroform and 
then nucleic acids precipitated by adding 2 volumes of 
ethanol.
3.5.4 Isolation of RNA from cultured COS cells.
The attached cells were washed twice with 10ml of ice cold 
PBS and then scraped off in 10ml of PBS using a rubber 
policeman. The cell suspension was transferred to a sterile 
plastic universal and centrifuged at 2000 rpm for 4 minutes 
at room temperature. The cell pellet was resuspended in 1
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ml (per 75cm^ tissue culture flask) of lysis buffer (140mM 
NaCl, lOmM Trls.HCl pH8 .6 , 1.5mM MgCl2, 0.5X [v/v] NP40), 
vortexed briefly and then left on ice for five minutes. The 
suspension was then transferred to an eppendorf tube and 
centrifuged in a minifuge at 1 2 , 0 0 0  g for 1 minute to 
pellet the nuclei. The supernatant was transferred to a 
fresh tube and an equal volume of 2*PK buffer (200mM 
Tris.HCl pH7.5, 25mM EDTA pH8 , 300mM NaCl, 2X (w/v) SDS) 
was added. Proteinase K was added to a final concentration 
of 0.2mg/ml and the tubes incubated at 37°C for 30 minutes. 
The solution was then extracted once with neutral phenol 
and the aqueous phase re-extracted with water saturated 
ether. After allowing any remaining ether to evaporate, RNA 
was precipitated by adding 0.1 volumes of 3M NaAc (pH 6.5) 
and 2.5 volumes of ethanol and leaving at -20°C for at 
least 2 hours. RNA was recovered by centrifugation at 12000 
g for 15 minutes, dried under vacuum and resuspended in 
DEPC treated water. The concentration was determined by 
measuring the absorbance at 260 nanometers in a Beckman 
mini-cell quartz cuvette.
3.6. Isolation Of Genomic DNA From Adult Xenopus Blood.
An adult female was anaesthetised by immersion in 0.2X 
(w/v) MS222 for 20 to 30 minutes. The thorax was then 
opened on the ventral side to expose the heart. A 10 ml 
syringe was filled with 3ml of lmg/ml heparin in NMT 
(lOOmM NaCl, lOmM Tris.HCl pH7.4, 3mM MgCl2) and the needle
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insarted into tha still baating heart. Blood was gently 
collected into tha syringe and transferred to -cold 
universals which were centrifuged at 2000 rpm for 5 
minutes. The cell pellet was resuspended in 10ml of cold 
NMT and re-centrifuged. This was repeated until the 
supernatant was no longer pink. The cells were lysed by 
resuspending in 1 0ml of distilled water and leaving at room 
temperature for 5 minutes. 100ml of neutral phenol was 
transferred to a glass bottle and the lysed cell suspension 
added to this. After nixing vigorously the DNA was sheared 
by twice taking the emulsion in to a syringe through a 
coarse grade needle. The emulsion was transferred to 
oakridge tubes and centrifuged at 8000 rpm for 2 0 minutes 
at room temperature. The aqueous phase was carefully 
transferred to a fresh tube and re-extracted with an equal 
volume of neutral phenol as before. The aqueous phase was 
transferred to a glass beaker and approximately two volumes 
of ethanol was added to precipitate the DNA. High molecular 
weight DNA was spooled on to the end of a pasteur pipette 
and transferred to a plastic universal. The DNA was 
dissolved in 10ml of TE (lOmM Tris.HCl pH7.5, ImM EDTA) by 
shaking gently at room temperature for several hours. 
Ribonuclease A was added to a final concentration of 5^ ig/ml 
and the solution incubated at 37°C for 30 minutes. An equal 
volume of 2*PK buffer was added along with 0.1 volumes of 
2mg/ml proteinase K and the solution incubated at 37°C for 
1 hour. The solution was then extracted with an equal
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volume of neutral phenol and the phase* separated by 
centrifugation at 8000 rpn for 20 minutes. The aqueous 
phase was transferred to corex tubes and the DNA 
precipitated with ethanol and recovered by centrifuging at 
10 000 rpm for 20 minutes. The tubes were allowed to drain 
on a piece of tissue and the pellets resuspended in 5ml of 
TE. The DNA concentration was determined by measuring the 
absorbance at 260 nanometers assuming that a 50yjg/ml 
solution has an A2 5 0 of 1 and the DNA solution stored at 
4°C.
3.7. Selection Of Polyadenylated RNA By Oligo dT 
Cellulose Chromatography
This was carried out essentially as described by Maniatis 
et al (1982). A 2ml oligo (dT) cellulose column was poured 
in a disposable plastic column and equilibrated with 
loading buffer (20mM Tris.HCl pH7.6, 0.5M NaCl, ImM EDTA, 
0.1Z SDS in DEPC treated water). Such a column was used 
several times and stored at 4°C. RNA was dissolved in DEPC 
treated water and an equal volume of 2 * loading buffer 
(40mM Tris.HCl pH7.6f 1M NaCl, 2mM EDTA, 0.2Z SDS) added. 
This solution was applied to the column, warming the column 
with a heating lamp as necessary. The column was washed 
with 5 to 10 column volumes of loading buffer and then with 
5 column volumes of wash buffer (20mM Tris.HCl pH7.6, 0.1M 
NaCl, ImM EDTA, 0.1Z SDS), collecting the flow through in 1 
ml aliquots throughout. The A2 5 0 these fractions was
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measured as they were collected so that the amount of RNA 
coming off the column could be assessed. The column' was 
washed with loading buffer and then with wash buffer until 
the A2 6 0 was less than 0.1. Polyadenylated RNA annealed to 
the column was then eluted with 2 to 3 column volumes of 
elution buffer (lOuM Tris.HCl pH7.6, ImM EOTA (pH8), 0.051 
SDS). These eluted fractions were pooled and the RNA 
concentration determined by measuring the Finally the 
RNA was split in to aliquots, precipitated with ethanol and 
stored at -20°C until required.
3.8 Formaldehyde Agarose RNA Gels.
RNA samples (up to 20^ ig) were resuspended in lOjil of DEPC 
treated water to which was added 20jil of denaturing mix 
(661 deionised formaraide pH7, 1.3*M0PS, 201 formaldehyde) 
and 3jil of loading mix (501 glycerol, 0.21 bromophenol 
blue). The samples were loaded immediately on a 21 (w/v) 
agarose, 151 formaldehyde gel made in 1*M0PS buffer (1*M0PS 
is 20mM Mops, 5mM sodium acetate, ImM EDTA). The samples 
were electrophoresed at 40mA (100 volts) for 5 to 6 hours 
and the gel stained by first soaking in 250ml of 101 
glycine for 10 minutes then adding lOO^ il of lOmg/ml 
ethidium bromide. After 10 minutes the gel was destained by 
washing twice, for 15 minutes each, in distilled water and 
then photographed on an ultraviolet light box.
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3.9 Northern Blotting.
After staining with ethidium bromide, RNA gels were soaked 
in 250ml of 20*SSC for 20 minutes and the RNA transferred 
to nitrocellulose (Hybond-Cv Amersham) as described by 
Thomas (1980). Four sheets of filter paper (3MM, Whatman) 
were placed in the bottom of a large plastic tray and 
moistened with 20*SSC avoiding the formation of bubbles. 
The gel was placed on the paper and the exposed 3MM paper 
between the gel and the edge of the tray covered with cling 
film. The cling film overlapped the edge of the gel by at 
least 3mm all the way round. The surface of the gel was 
dried and a piece of nitrocellulose, cut to the same size 
as the gel, lowered carefully on to the gel, again ensuring 
that no air bubbles formed. A piece of 3MM the same size as 
the gel was soaked in 20*SSC and layed on top of the 
nitrocellulose. Tissue paper was stacked on top of this to 
a depth of about 5cm and weighed down with a house brick. 
The gel was left to blot overnight after which the 
nitrocellulose filter was briefly dried at room temperature 
and then baked at 80°C under vacuum for 2 hours.
Filters were prehybridised and hybridised in heat sealable 
plastic bags containing the appropriate solution, weighed 
down in a water bath set to the required temperature. 
Prehybridisation was in 20 to 50ml of 5*SSC, 5 * Denhardts, 
50X deionised formaraide (pH7), 21mM sodium phosphate 
(pH6.5), lOOpg/ml E.coli tRNA, 50jjg/ral denatured, boiled 
herring testis DNA (Sigma) for 4 to 48 hours. The
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prehybridisation solution was discarded and replaced with 5 
to 12ml of the same solution to which radiolabelled probe 
had been added and the filters hybridised for 16 to 48 
hours.
For DNA probes prehybridisation and hybridisation was at 
42°C whilst for single stranded RNA probes it was at 60°C. 
Filters were initially washed twice in 2*SSC, 0.1X SDS for 
5 minutes each at room temperature and then twice for 30 
minutes each in the final wash conditions (which depended 
upon the stringency required). After the final wash filters 
were blotted on 3MM, and while still damp, wrapped in cling 
film and exposed to X-ray film with one or two intesifying 
screens at -70°C.
3.10 Non-denaturing Agarose Gels.
DNA samples, to which 0.1 volumes of loading buffer (SOX 
glycerol, 1*TBE, 0.1X bromophenol blue) had been added, 
were separated in 0.5 to 2X (w/v) agarose gels containing 
0.2^ig/ml ethidium bromide made in 1*TBE buffer. Gels were 
run in 1*TBE buffer supplemented with O.S^ig/ml ethidium 
bromide and examined and photographed on an ultraviolet 
light box.
3.11 Southern Blotting.
DNA samples separated in non-denaturing agarose gels as 
described in section 3.10 were transferred to 
nitrocellulose or nylon membranes using the method of
132
Materials And Mathoda
Southern (1975). To increase the efficiency of transfer of 
high molecular weight DNA (especially with genomic southern 
blots) the gel was first treated with 0.25M HC1 for 15 
minutes at room temperature on a shaker. This partially 
hydrolyses the DNA, generating smaller fragments which 
transfer more efficiently. After a brief wash with 
distilled water the gel was incubated in a large volume of 
denaturing solution (1.5M NaCl, 0.5M NaOH) with gentle 
shaking for 40 minutes. This was repeated with fresh 
denaturing solution, the gel rinsed with distilled water 
and then neutralised by gently shaking in a large volume of 
neutralising solution (3M NaCl, 0.5M Tris.HCl, ImM EDTA, pH 
7) for 40 minutes. This neutralising step was repeated with 
fresh neutralising solution and the gel was then capillary 
blotted using 20*SSC as the transfer buffer, exactly as 
described for northern blotting (see section 3.9).
DNA was fixed to nitrocellulose filters by baking at 80°C 
under vacuum for 2 hours. Nylon membranes were wrapped in 
cling film and exposed to ultraviolet light DNA side down 
on a trans-illuminator for 3 minutes, which cross-links the 
DNA to the membrane.
Prehybridisation and hybridisation was carried out in heat 
sealed plastic bags weighed down in a water bath set to the 
appropriate temperature. Filters were prehybridised in 10 
to 30ml (depending upon the size of filter) of 5 * 
Denhardts, 6*SSC, 0.1Z SDS, lOOjig/ml coli tRNA at 65 to 
68°C for 3 to 48 hours. The prehybridisation solution was
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discarded and replaced with 5 to 12ml of the same buffer 
containing radiolabelled nucleic acid probe. The bag- was 
re-sealed and hybridised at the same temperature for 16 to 
48 hours. Alternatively, prehybridisation and hybridisation 
were carried out in the same buffer supplemented with SOX 
deionised formamide (pH7) at 42°C.
Filters were first washed twice in 2*SSC, 0.1X SDS at room 
temperature for 5 minutes each and then twice for 30 
minutes each in the final washing conditions (which 
depended upon the stringency desired). Finally, the filters 
were blotted on 3MM and while still damp, wrapped in cling 
film and exposed to X-ray film with one or two intensifying 
screens at -70°C.
3.12 Low Melting Point Agarose Gels.
These gels were used in the isolation of DNA fragments 
which were subsequently radioactively labelled and used as 
probes, or used for sub-cloning purposes.
DNA samples to which 0.1 volumes of agarose gel loading 
buffer had been added, were loaded on to a 0.4Z (w/v) low 
melting point agarose gel made in 0.5*TBE buffer and 
containing 0.2^ig/ml ethidium bromide. Gels were run in 
0.5*TBE buffer containing O.S^ig/ml ethidium bromide at a 
maximum of 40 mA. The gel was examined under U.V. light and 
the required bands excised in as small a gel slice as 
possible. Exposure of the gel to U.V. light was kept to a 
minimum to avoid U.V. induced DNA damage. Gel slices were
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transferred to 1.5al eppendorf tubes and weighed to 
calculate the volume of the slice (assuming lg - 1ml)* 0.4 
volumes of water was added and the slices melted by heating 
at 6S°C for 10 to 40 minutes. After cooling to 37°C an 
equal volume of neutral phenol was added, the solution 
whirlimixed vigorously and left on ice for 10 minutes. The 
tubes were then centrifuged at 12 000 rpm for 5 minutes and 
the aqueous phase transferred to a fresh tube, carefully 
avoiding the white precipitate at the interphase. The 
volume of the aqueous phase was reduced to about 300^1 by 
several extractions with butan-l-ol and the DNA 
precipitated by adding 0.1 volumes of 3M NaAc (pH6.5) and
2.5 volumes of ethanol.
The effectiveness of this procedure was found to depend 
very much upon the quality of the low melting point 
agarose, with some batches failing to melt or giving very 
low recoveries of DNA.
3.13 Primer Extension Analysis Of RNA.
The single stranded oligonucleotide to be used as the 
primer was end labelled with %  [^P] ATP (see section 
3.37.2) and finally resuspended in 3*PEB (1*PEB is 0.4M 
NaCl, lOtnM PIPES (pH6.4), 0.5mM EDTA (pH8)). Hybridisation 
reactions were set up by mixing the RNA sample (40pl volume 
in water), 5jil of the labelled primer and 7.5^ il of 5*PEB 
in a 0.5ml eppendorf tube. The tubes were closed tightly 
and incubated overnight at the desired temperature. For the
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albumin and albone oligonucleotide primers (which are both 
17 mers) 45°C was found to be optimal.
After hybridisation llOpl of ethanol was added and the 
tubes were left at -20°C for 30 minutes. Nucleic acids were 
recovered by centrifugation for 12 minutes in a minifuge 
and dissolved in 20pl of reverse transcriptase reaction 
buffer (SOmM Trls.HCl pH8.3, 6mM MgCl2, 10mM DTT, ImM each 
of dATP, dCTP, dTTP, dGTP). To thi# was added 5 unita of 
AMV reverse transcriptase and the tubes incubated at 37°C 
for 30 minutes. Ribonuclease A was added to a final 
concentration of 2pg^il and the tubes incubated for a 
further 10 minutes at 37°C after which DNA was precipitated 
by adding an equal volume of isopropanol. The pellet was 
resuspended in 4jil of sequencing gel loading dye (90Z 
deionised formamide, lOmM EDTA (pH8), 0.01Z xylene cyanol, 
0.01Z bromophenol blue), heated at 100°C for 5 minutes and 
then loaded on to a 8Z polyacrylamide sequencing gel. The 
gel was run at 38 watts until the bromophenol blue was 
about 2 inches from the bottom of the plate. The plates 
were prised apart and the gel covered with cling film and 
exposed to x-ray film with one intensifying screen at 
-70°C.
3.14 SI Nuclease Protection Assays.
The RNA samples to be analysed were precipitated from 
ethanol, dried thoroughly under vacuum and resuspended in 
lOjil of hybridisation buffer (40mM PIPES pH6.4, ImM EDTA
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(pH8), 0.4M NaCl, 80X deionised formamide). The duplex DNA 
probe was also precipitated with ethanol, dried - and 
resuspended in an appropriate volume of the same buffer. 
Hybridisation reactions were set up by mixing lOjil of RNA 
solution and 5jil of probe and transferring this to a 
capillary tube which was then heat sealed. The tubes were 
immersed in a water bath at 80°C for 5 minutes to denature 
the probe and RNA, and then transferred to a second water 
bath at the hybridisation temperature. Hybridisation was 
carried out overnight, after which the contents of the 
capillary tubes were expelled in to 1.5ml eppendorf tubes 
containing 150pl of SI buffer (0.28M NaCl, 50mM NaAc pH6.4, 
4.5mM ZnS04, 20pig/ml sonicated, denatured herring testis 
DNA.) and 100 units of SI nuclease. The reactions were 
incubated at 30°C for 30 minutes and then stopped by adding 
3^1 of 0.4M EDTA (pH8). The solution was then extracted 
with an equal volume of neutral phenol and the aqueous 
phase precipitated with ethanol. After centrifuging in a 
minifuge for 12 minutes the pellet was dried under vacuum, 
dissolved in 3jil of sequencing gel loading dye, heated at 
100°C for 5 minutes and analysed on an 81 sequencing gel.
3.15 Transient Transfection Of COS Cells.
COS cells grown in medium (75 cm^) tissue culture flasks 
were transfected using DEAE-dextran (Susstnan and Milman, 
1984). Cells which had been split 3 to 4 days earlier 
(cells near to confluence) were washed twice with 10ml of
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serum-free DMEM. To each flask was added Sml of 
transfection mix that contained 0.2mg/ml DEAE-dextran and 
up to 12jig of ceasium chloride purified plasmid DNA, in 
serum-free DMEM. The flasks were then returned to the 
incubator for 3 hours. During this period they were gently 
tilted several times, about every 30 minutes, to try and 
keep the bottom of the flask covered with the transfection 
mix. The cells were then washed twice with 10ml of serum- 
free DMEM. For the receptor binding experiments the cells 
were then incubated in DMEM containing serum for 48 hours 
before harvesting. It is almost certain that fetal calf 
serum contains thyroid hormone, and so it was decided to 
incubate in serum-free DMEM when testing the effect of 
exogenously added thyroid hormone upon transactivation of 
transcription. In initial experiments cells were incubated 
in serum-free DMEM (♦ or - triiodothyronine) immediately 
after transfection. Under these conditions the cells began 
to come off the bottom of the flask within 24 hours. To try 
and overcome this, transfected cells were initially 
incubated in DMEM containing serum for 24 hours, then 
washed twice with 10ml of serum-free DMEM (incubating for 
40 minutes in serum-free DMEM after the first wash). They 
were then cultured in serum-free DMEM (♦ or 
triiodothyronine) for a further 24 hours and harvested.
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3.16 Preparation Of Whole Cell Extract« Froa Transfected 
COS Cell» For U«e In Thyroid Hormone Binding A««ay».
The cells were washed twice in situ with 10ml of ice cold 
PBS and then harvested by scraping them off with a rubber 
policeman in 10ml of ice cold PBS. The suspension was 
transferred to a plastic universal and the cells were 
pelleted by centrifuging at 2000 rpm for 4 minutes at room 
temperature. The supernatant was discarded and the tubes 
left to drain, inverted on tissue paper for up to 5 
minutes. The pellet was then resuspended in 160pl per^flask 
of ice cold T3 binding buffer (20mM Tris.HCl pH7.6, SOmM 
NaCl, 2mM EDTA (pH8), 171 glycerol, O.SmM PMSF, 5mM 
^JJ-raercaptoethanol), transferred to a fresh universal and 
pooled with cell suspensions from other flasks as 
appropriate. The cells were lysed by freezing in liquid 
nitrogen (20 seconds to 1 minute depending upon volume of 
cells) and then thawing immediately in a water bath at 
37°C. This freeze thaw process was repeated twice more and 
the suspension pipetted up and down vigorously using a 
gilson P200. After transferring to 1.5ml eppendorf tubes 
the lysed cells were centrifuged at 12000 rpm for 10 
minutes at 4°C. The supernatant was transferred to fresh 
tubes on ice and then either used immediately or stored at 
-70°C. The extract remained active for several weeks and 
through several freeze/thaw cycles. Before use the 
"concentration" of the extract was determined by measuring
-139-
Materials And Methods
the absorbance at 280 nanometers, and equal A2gQ amounts 
used in each binding assay.
3.17 Thyroid Hormone Receptor Binding Assays On Extracts 
From Transfected COS Cells.
Whole cell extracts prepared as described in section 3.16 
and stored at -70°C, were thawed on ice and assayed for 
triiodothyronine binding activity essentially as described 
by Sap et ¿1 (1986). Standard reactions were in T3 binding 
buffer in a final volume of 250^ il containing 0 to 8jil of
triiodothyronine (25nM, in solution in 3:1 ethanol: 
water) and 0 to 100^1 of extract. For competition 
experiments the reactions also contained 2.5^ il of the 
appropriate analogue. The reactions were assembled at room 
temperature, always adding the extract last to the other, 
pre-mixed components. The tubes were then incubated at 4°C 
for 6 to 7 hours. The amount of bound [*^l]
triiodothyronine was then determined using the 
nitrocellulose filter binding assay of Inoue et al (1983). 
This procedure was carried out at 4°C in a cold room using 
pre-chilled T3 binding buffer that lacked PMSF. 1ml of T3 
binding buffer was added to the reaction, which was mixed 
by pipetting and then filtered under vacuum through a 
millipore nitrocellulose filter that had been pre-washed 
with 3ral of T3 binding buffer. The rate of flow was 
previously adjusted to be about 5ml in 15 seconds. The 
filter was immediately washed 3 times with 5ml of T3
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binding buffer. The filters were dried at room temperature 
and then counted in a gamma counter for 10 minutes each.
Unlabelled analogues for competition experiments were all 
obtained from Sigma and dissolved as follows. 
Triiodothyronine was dissolved and diluted in sterile 
water, triiodoacetic acid (TRIAC) was dissolved and diluted 
in 50X DMSO. Reverse T3 was found to dissolve in lOmM NaOH 
at a maximum concentration of 3mM» and was then diluted as 
appropriate in lOmM NaOH. All these analogues were stored 
at -20°C but it was found that TRIAC at concentrations 
greater than ImM irreversibly precipitated out of solution 
after overnight storage.
3.18 Preparation Of "CAT" Extracts From Transfected COS 
Cells
The flasks of cells were washed twice with 10ml of cold
PBS and then scrapped off the surface of the flask using a
rubber policeman into 10ml of cold PBS. The suspension was
transferred to a sterile plastic universal and for mosti5c*1
experiments V 3 rd of the cells (from a single^flask) used
to prepare "CAT" extracts whilst RNA was isolated from the
remainder. The cells were first pelleted by centrifuging at
2000 rpm for 3 minutes at room temperature. The supernatant
was discarded and the tubes drained for several minutes on
tissue paper. The pellet was resuspended in 65jil (per ’^^ rd 
T5ci»*x
of a^flask) of cold 0.25M Tris.HCl (pH7.5) by pipetting up 
and down in a gilson P200 and transferred to 1.5ml
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eppendorf tub««. These were frozen in liquid nitrogen 
(about 30 seconds) and immediately thawed in a 37°C water 
bath. This freeze thaw procedure was repeated 3 times to 
ensure that the cells had lysed and the tubes were then 
centrifuged at 4°C in a minifuge for 10 minutes. The clear 
supernatant was transferred to fresh tubes on ice and the 
"concentration** determined by measuring the absorbance at 
280 nanometers. Equal A2go amounts were used in each assay. 
The extracts were either used immediately or stored at 
-70°C until required.
3.19 CAT Assays On Extracts From Transfected COS Cells.
Chloramphenicol acetyltransferase activity in extracts 
prepared as described in section 3.18 was determined 
essentially as described by Gorman et al (1982). Reactions 
contained (in a final volume of 100^1) 0.125M Tris.HCl 
(pH7.5), 0 to 60pl of cell extract, and 5jil of [**C] 
chloramphenicol. Controls contained no extract or ljil of 
chloramphenicol acetyltransferase (10 u^il, Pharmacia). A 
lmg aliquot of solid acetyl coenzyme A (Sigma) which had 
been stored at -20°C for not more than 2 months was 
dissolved in 1.5ml of sterile water to give a 0.66mg/ml 
stock solution. A sufficient volume for use in the current 
assays was transferred to an eppendorf tube and the rest 
stored at -70°C. This frozen stock solution was only used 
within one week of initially dissolving the solid. Acetyl 
CoA deteriorates rapidly on longer storage resulting in
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very insensitive CAT assays (N. Lakin, pers. comm.)* The 
acetyl CoA solution and the reaction mixes were - then 
incubated separately at 37°C for 5 minutes, after which 
the reactions were started by addition of 5jil of acetyl CoA 
to each reaction mix. The reaction was allowed to proceed 
at 37°C for 1 hour and then terminated by the addition of 
90pl of 0.25M Tris.HCl (pH7.5) and 1ml of ice cold ethyl 
acetate. The solutions were mixed extensively by vortexing 
several times which extracts the chloramphenicol in to the 
ethyl acetate. The tubes were centrifuged for 5 minutes in 
a minifuge and the upper (ethyl acetate) phase transferred 
to fresh tubes. These were dried in a vacuum desiccator 
until all the solvent had evaporated (about 1 hour). The 
chloramphenicol was then dissolved in 20jil of ice cold 
ethyl acetate, vortexing the tubes several times. The 
samples were then spotted on to a thin layer chromatography 
plate (aluminium backed silica gel 60, 0.2 mm thick, E. 
Merck, FRG) using drawn out glass capillaries. 
Approximately 1 to 2jil were applied at a time allowing the 
spots to air dry between applications. The TLC plate was 
then placed in a chromatography tank containing 200ml of 
95Z chloroform, 5Z methanol, and a vertical piece of 3MM 
which helps to saturate the chamber with solvent. This tank 
was filled with solvent and allowed to equilibrate for at 
least 1 hour before use. The TLC plate was left in place 
until the solvent front was about 2 inches from the top of
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the plate, then removed and thoroughly air dried. The plate 
was then autoradiographed at room temperature.
3.20 Preparation Of CAT Extracts From Microinjeeted 
Oocytes.
This method was obtained from Nick Lakin. Groups of 5 to 
15 oocytes were transferred to eppendorf tubes and any 
remaining media carefully removed. They were then 
homogenised in 50jil per oocyte of 0.25M Tris.HCl (pH7.5) by 
pipetting up arW down in a gilson P1000. The homogenate was 
kept on ice when possible and then centrifuged in a 
minifuge at 4°C for 10 minutes. This produced a pellet 
which is mainly yolk, and a clear supernatant with a layer 
of white coloured lipid floating on top. At 4°C the lid of 
the tube was opened and a syringe needle used to make a 
small hole in the side of the tube just above the pellet. 
The clear supernatant was drained from this hole into a 
fresh eppendorf tube taking care to avoid the layer of 
lipid (touching the hole against the side of the tube helps 
to get the flow started). The extract was frozen at -70°C 
until required and appeared to be stable for several weeks.
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3.21 Assays For Chloramphenicol Acetyltransferase In 
Extracts From Xenopus Oocytes.
Extracts prepared as described in section 3.20 were 
assayed for CAT activity exactly as described in section 
3.19 except that 50jil of extract (1 oocytes worth) was used 
in each assay.
3.22 Large Scale Preparation Of Plasmid DNA And 
Purification By Caesium Chloride/Ethidium Bromide 
Centrifugation.
The method used was the alkaline lysis method as described 
by Maniatis £t al^  (1982). A single colony was inoculated in 
to 10ml of sterile LB containing the appropriate 
antibiotic, and grown overnight at 37°C. The next day 
0.25ml of this overnight culture was used to inoculate 25ml 
of LB, and this culture grown on a shaker at 37°C for 2 
hours or until the absorbance at 550 nanometers was about 
0.5. This 25ml culture was tipped into a 2 litre flask 
containing 500ml of LB or TB which was then shaken (200 
rpm) overnight at 37°C. The next day, the cells were 
pelleted by centrifugation at 5000 rpm for 10 minutes. In 
the description which follows all volumes relate to a 
single 500ml bacterial culture. The pellets were
resuspended in a total of 18ral of ice cold solution I (50mM 
glucose, 25mM Tris.HCl (pH8), lOmM EDTA (pH8), 5mg/ml 
lysozyme) and equal volumes transferred to two oakridge 
centrifuge tubes. After incubating at room temperature for
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five Minutes 2 volumes of freshly prepared solution II 
(0.2M NaOH, IX SDS) was added and the contents of the -tubes 
mixed by inverting several times. The tubes were left on 
ice for 10 minutes after which 9ml of ice cold 5M potassium 
acetate (pH6) was added to each tube. The tubes were mixed 
by inverting several times and left on ice for 10 minutes. 
The pH of the solution was then tested with pH paper to 
ensure that the sodium hydroxide had been completely 
neutralized, adding more potassium acetate if necessary. 
Bacterial debris and chromosomal DNA w then pelleted by 
centrifuging at 13 000 rpm for 30 minutes. The supernatant 
was transferred to 30ml corex tubes and nucleic acids 
precipitated by adding 0.6 volumes of isopropanol. After 15 
minutes at room temperature the tubes were centrifuged at 
10 000 rpm for 30 minutes at 20°C and the resultant pellets 
washed with 70Z ethanol. After briefly drying under vacuum, 
the pellets were resuspended in a total of 33ml of TE. 
Exactly 33 g of caesium chloride was dissolved in this and 
0.6ml of ethidium bromide (lOmg/ml) added. Using a syringe, 
this solution was transferred to a 40ml, Beckmann, 
polyalomer, self-sealing centrifuge tube. The tubes were 
then balanced to within lOmg and the tops heat sealed. They 
were then centrifuged at 45 000 rpra in a vertical rotor for 
18 hours at 20°C.
The tubes were carefully removed and viewed under U.V. 
light. The lower band, which is supercoiled plasmid was 
removed from the gradient using a syringe, and extracted at
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least three tines with water saturated butan-l-ol to renove 
the ethidium bronide. The solution was then dialysed 
against 2 litres of TE for at least 5 hours at roon 
temperature, transferred to corex tubes and the DNA 
precipitated with ethanol. The DNA was recovered by 
centrifuging at 10,000 rpm for 30 minutes at 4°C, dried 
briefly under vacuum and resuspended in 1ml of TE. The 
solution was then extracted with neutral phenol, and 
precipitated once more with ethanol. The DNA was pelleted 
by centrifugation in a minifuge for 12 minutes, dried under 
vacuum and finally dissolved in 1ml of TE. The DNA 
concentration was determined by measuring the A2 6 q .
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3.23 Standard Sub-Cloning Techniques.
3.23.1 Restriction enzyme digests.
These were carried out according to the manufacturers 
instructions. Plasmid DNA's were generally digested for 1 
hour, whilst genomic DNA for southern blotting was 
digested for 4 hours, adding a second aliquot of enzyme 
after 2 hours.
3.23.2 Preparation of plasmid vectors for sub-cloning. 
Vectors that had been digested with two enzymes were run
on a low melting point agarose gel and the linear vector 
fragment recovered. Vectors cut with a single restriction 
enzyme were treated with calf intestinal alkaline
phosphotase (CIAP) by adding 1 or 2 units directly to the 
the restriction enzyme digest 1 hour after the start of 
the reaction and incubating for a further 40 minutes at 
37°C. For enzymes that generate 5( overhangs this was 
followed by an incubation at 60°C for 30 minutes. After 
adding 200pl of NaE the reactions were extracted with 
neutral phenol, and then with ether and finally
precipitated with ethanol.
3.23.3 Ligations.
These were carried out in a lOpl reaction containing 1*C 
buffer (6 6 mM Tris.HCl pH7.6, 6 .6mM MgCl2, 10mM DTT), lmM
rATP, vector DNA, target DNA and T4 DNA ligase. Normally,
2 0ng of vector and a range of target concentrations was
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used. A control that contained vector alone was always 
Included. For sticky end ligations, 0.1 units of T4-DNA 
ligase was used in each ligation, and the reactions were 
incubated at 14°C overnight. Blunt end ligations contained 
1 unit of T4 DNA ligase and were incubated at 4°C 
overnight. When doing ligations with dephosphorylated 
vectors it was often found useful to include an additional 
control in which the vector was ligated in the absence of 
target but in the presence of 5 units of T4 polynucleotide 
kinase.
3.24 E.coli Plasmid Transformation.
3.24.1 MgCl2/CaCl2 Mediated Transformation.
This method was used when a high transformation 
efficiency was not required or when using the E.coli 
strain MC1061. Efficiencies of up to 3*10^ transformants 
per jig of DNA were obtained using this method with MC1061. 
An appropriate volume of 2*TY or LB was inoculated with a 
1 /i0 0 th volume of an overnight culture of the host 
bacteria and incubated at 37°C with vigorous shaking until 
the A5 5 0 reached 0.5. The culture was then cooled on ice 
for 1 0 minutes and the cells pelleted by centrifugation at 
2000 rpm for 5 minutes. The tubes were drained briefly on 
tissue paper and the pellet resuspended in a half volume 
of ice cold 0.1M MgC^. The cells were re-pelleted 
immediately and resuspended in a half volume of ice cold 
0.1M CaCl2 * The tubes were centrifuged immediately and the
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cells resuspended in a 1 /2oth volume of ice cold 0.1M 
CaCl2 * After incubeting the cell suspension on ice for 90 
minutes or longer, 0 .2ml aliquots were transferred to 
eppendorf tubes on ice. T6 each of these was added half of 
the appropriate ligation (5pl), and after mixing the tubes 
were incubated on ice for 30 minutes. The cells were then 
heat shocked at 42°C for 2 minutes, quenched on ice for S 
minutes, and spread on to dried L-agar plates containing 
the appropriate antibiotic using an ethanol sterilized 
glass spreader. The plates were incubated upside down in a 
37°C incubator overnight.
Competent cells prepared by this method were stored by 
adding glycerol to 15X (v/v) and freezing 0.2ml aliquots 
in liquid nitrogen. These were then stored at -70°C for 
several months with a gradual drop in transformation 
efficiency over time. When required the tubes were thawed 
slowly on ice and the DNA added. The tubes were then 
simply left on ice for 40 minutes, heat shocked and the 
cells plated as above.
3.24.2 High Efficiency Plasmid Transformation.
This method was routinely used for the transformation of 
JM101 with M13 vectors and is essentially as described by 
Hanahan (1983). An appropriately sized culture of host 
cells was grown as described in section 3.24.1, and when 
the A5 5 Q reached between 0.3 and 0.4 the culture was 
cooled on ice for 15 minutes. The cells were then pelleted
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by centrifugation at 2000 rpm for 5 minutes at room 
temperature and resuspended in ^^rd the original culture 
volume of transformation buffer (TFB) (TFB is lOmM KMES 
pH6 •3 f lOOmM KC1, 45mM MnC1.4H20, lOmM CaCl2, 3mM 
HAC0 CI3 ). The suspension was left on ice for 15 minutes 
after which the cells were pelleted as before and 
resuspended in */2 2 .5 th oi the original culture volume of 
TFB. At this point the cell suspension was transferred to 
a polypropylene tube and left on ice for 1 0  minutes after 
which dimethylformamide (DMF) was added to a final 
concentration of 4.75Z (v/v). The suspension was well
mixed immediately after adding the DMF and then left on 
ice for 10 minutes. A solution of 2.25M DTT in lOmM 
potassium acetate was added to 4.1Z (v/v), mixing
immediately after addition and the suspension left on ice 
for a further 10 minutes. A second aliquot of DMF was then 
added as before so that the final concentration of DMF was 
9.5Z (v/v). The suspension was incubated on ice for 20 
minutes and then 0 .2ml aliquots transferred to eppendorf 
tubes. Half of the appropriate ligation mix was added to 
each tube, the contents mixed well and the tubes left on 
ice for 30 minutes. The cells were then heat shocked at 
42°C for 2 minutes, quenched on ice and either spread on 
dried agar plates or in the case of M13 transformations 
plated in top agarose (see section 3.25).
u -  w a s n o t /> © » ;< * : h i Stz>r*
A competent cells prepared using this method
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by adding glycerol to 15Z (v/v), freezing in liquid 
nitrogen and storing at -70°C.
3.25 Plating E.coli Transformed Or Infected With 
Bacteriophage M13.
For each transformation or infection, 3ml of molten H- 
top agar, that had been cooled to 60°C, was placed in a 
»terile glass tube in a heating block at 45°C. After 
allowing the top agar to equilibrate to 45°C, 50jil of X- 
gal (20rag/ral in DMF), 25jj1 of IPTG (24mg/ml in water) and 
200^j1 of exponential host cells were added in this order. 
The transformed or infected host cells were then added to 
each tube in turn, the contents mixed by covering the top 
with nesco film and inverting several times, and poured on 
to a dried H-agar plate. The plate was tilted gently to 
get an even covering of top agar and then allowed to set 
f or 15 minutes at room temperature, before incubating 
upside down at 37°C overnight.
3.26 Small Scale Isolation Of Plasmid DMA And M13 RF DNA.
Single bacterial colonies were inoculated into 2ml of 
2*TY containing the appropriate antibiotic using a sterile 
toothpick, and grown in a shaking incubator at 37°C for 6 
hours. For preparing M13 RF DNA 2ral of 2*TY was inoculated 
with 20pl of an overnight culture of the host cells. A 
single plaque was stabbed with a sterile toothpick and 
this toothpick placed in the tube of innoculated media.
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Alternatively lOpl of a stock of phage particles (in 2*TY) 
was added to the tube of media and host cells. *M13 
cultures were grown at 37°C with vigorous shaking (300 
rpm) for 5 to 7 hours. The cultures were then transferred 
to 1.5ml eppendorf tubes and centrifuged in a minifuge for 
5 minutes. In the case of M13 infected cells^ an aliquot of 
the supernatant (which contains bacteriophage particles) 
was removed and kept frozen at -20°C. This supernatant was 
also used for the preparation of single stranded 
bacteriophage DNA (see section 3.27). The pellets were 
resuspended in 0.2ml of STET (81 sucrose (w/v), 0.5Z 
triton x-100 (v/v), 50mM EDTA (pH8 ), lOmM Tris.HCl (pH8 )) 
and lQpl of a lOmg/ml solution of lysozyme was added. The 
tubes were mixed, incubated on ice for 1 0 minutes, and 
then heated at 100°C for 40 seconds. Bacterial debris and 
chromosomal DNA was then pelleted by centrifuging in a 
minifuge for 10 minutes. This viscous pellet was removed 
using a toothpick and nucleic acids in the supernatant 
precipitated by adding 0.1 volumes of 3M NaAc (pH6.5) and 
1 volume of isopropanol. The tubes were left at -20°C for 
at least 1 hour and then centrifuged in a minifuge for 1 0  
minutes. The pellet was resuspended in 0.2ml of NaE and 
the solution extracted with an equal volume of neutral 
phenol. The aqueous phase was extracted with ether and 
nucleic acids precipitated by adding 2 volumes of ethanol. 
After at least 1 hour at -20°C, nucleic acids were 
recovered by centrifuging in a minifuge for 1 0 minutes.
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The pellet was dried under vacuus and dissolved in 40jil of 
TE. If necessary, RNA was removed by treatment with 
ribonuclease A at a final concentration 0.2^ig/ml for IS 
minutes at 37°C.
3.27 Preparation Of Single Stranded M13 Template DNA,
Glass tubes containing 2ml of 2*TY were inoculated with 
2 0pl of an overnight culture of the host strain, usually 
JM101. Phage particles from a single plaque were 
transferred to the media using a sterile toothpick. 
Alternatively, lOjil of a frozen phage stock was added to 
each tube. The tubes were then incubated at 37°C with 
vigorous shaking (300 rpm) for 5 to 6 hours. The bacteria 
were pelleted by centrifugation in a minifuge for 5 
minutes and 1 .1ml of the supernatant transferred to a 
fresh tube. This was centrifuged as before and 1ml of the 
supernatant removed to a fresh tube, avoiding any debris 
at the bottom of the tube. Bacteriophage particles were 
then precipitated by adding 2 0 0 i^l of 2 0X (w/v) 
polyethylene glycol in 2.5 M NaCl and leaving the tubes at 
room temperature for 20 minutes. The phage were pelleted 
by centrifuging in a minifuge for 1 0 minutes and the 
supernatant removed using a gilson P1000. The tubes were 
re-centrifuged for 1 0  seconds to bring down the remaining 
liquid which was carefully removed using a gilson P20. 
After another 10 second centrifugation any remaining 
supernatant was removed using a drawn out glass capillary.
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The white pellet was then resuspended in 0.2ol of NaE by 
vortexing the tube vigorously, and the suspeneion 
extracted with an equal volume of neutral phenol. The 
aqueous phase was extracted twice with an equal volume of 
chloroform and the DNA precipitated by adding 2.2 volumes 
of ethanol. After at least 1 hour at -20°C the DNA was 
recovered by centrifuging in a minifuge for 1 0  minutes, 
dried under vacuum and dissolved in lOjil of TE. Template 
DNA was always checked on a IX agarose gel prior to 
sequencing.
3.28 Complementation Tests On Single Stranded M13 DNA
This test was used to determine the orientation of DNA
fragments inserted in to M13 vectors. lOpl of phage 
supernatant from each of the two clones to be tested was 
mixed with 2jil of IX SDS and heated at 65°C for 1 hour. 
After adding 2pl of loading dye the samples were analysed 
on a IX agarose gel. The presence of a slower migrating 
band (not present in either phage supernatant alone) 
indicated that the two clones contained the same insert in 
opposite orientations.
3.29 Colony Lifts Onto Nitrocellulose.
A piece of nitrocellulose was cut to just fit a 10cm 
petri dish, marked with a grid and autoclaved. This grid 
was duplicated on the bottom of an L-amp plate, which was 
used as the master plate. The nitrocellulose disc was
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lowered on to another L-amp plate and then sterile 
toothpicks were used to streak out individual colonies 
(independent transformants) on to the nitrocellulose. One 
colony was transferred to each square on the grid and then 
replica plated in the corresponding position on the master 
plate. The plates were incubated at 37°C for 16 hours 
after which the master plate was stored at 4°C. The 
nitrocellulose disc on which the bacterial colonies had 
grown was then layed, colony side up, on a tray containing 
two sheets of 3MM that had been moistened with denaturing 
solution (0.5M NaOH, 1.5M NaCl). After 2 minutes the 
nitrocellulose disc was transferred to two sheets of 3MM 
moistened with neutralising solution (3M NaCl, 0.5M 
Tris.HCl pH7), and left colony side up for 5 minutes or 
until the NaOH had been completly neutralised. The disc 
was then placed, colony side up, on a dry piece of 3MM and 
a second piece of dry 3MM carefully placed on top of the 
disc. Firm pressure was applied, avoiding any sideways 
movement, blotting the colonies on to the nitrocellulose. 
The filter paper was pealed off, and this blotting 
procedure repeated with a fresh piece of 3MM. The 
nitrocellulose disc was then placed, colony side up, on 
two sheets of 3 MM moistened with 2*SSC for several 
minutes. After air drying for one hour the disc was baked 
at 80°C under vacuum for 2 hours and then prehybridised 
and hybridised in 3*SSC, 0.1Z SDS, l*Denhardts, lOOpg/ml
E.coli tRNA.
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3.30 Syntheaia of complementary DNA (cDNA) from mRNA.
3.30.1 Synthesis of double stranded cDNA.
The method described here is based upon the original 
method of Gubler and Hoffman (1983) which uses a 
combination of reverse transcriptase, ribonuclease H, and 
DNA polymerase I to generate double stranded cDNA. This 
was subsequently modified so that all the reactions could 
be carried out in a single tube (Gubler, 1988), and this 
protocol is outlined here. The first strand was 
synthesised in a reaction containing 50mM Tris.HCl 
(pH8 .3), lOmM MgCl2, 10mM DTT, 0.1M NaCl, 0.7mM each of 
dATP, dGTP, dCTP, dTTP, 1 to lOpg of poly A+ RNA, kyt of 
ollgo dTdj.tg), $»il of 0<[3 JP] dGTP, 80 unit. of 
pancreatic ribonuclease inhibitor, and 60 units of AMV 
reverse transcriptase in a final volume of 60^1. The 
reaction was allowed to proceed at 37°C for 90 minutes and 
then stopped by putting the tube on ice. At this point two 
ljil aliquots were removed for analysis of the first strand 
products. To the remaining 58jil was added 1 2 5 f i l of 2*2nd 
strand buffer (40mM Tris.HCl pH7.5, lOmM MgCl2, 20mM 
ammonium sulphate, 200mM KC1, 100^ig/ml bovine serum 
albumin), 50jil of water, 10 units of ribonuclease H, and 
140 units of DNA polymerase I, making the final volume 
250^1. The reaction was incubated at 14°C for 1 hour and 
then at 22°C for a further 1 hour. The reaction was 
stopped by heating at 70°C for 10 minutes and the tube 
cooled on ice. The ends of the double stranded cDNA were
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than polished by adding 20 units of T4 DNA polymerase and 
incubating at 37°C for 10 minutes. The reaction *was 
terminated by the addition of EDTA (pH8 ) to a final 
concentration of 20mM and SDS to a final concentration of 
1 Z (w/v). The solution was extracted twice with an equal 
volume of neutral phenol, and the aqueous phase run down a 
sepharose CL4B column in NaE, that was set up in a 1ml 
pipette. The eluate was collected in 0.5ml fractions and 
monitored with a geiger counter to asses the progress of 
the cDNA down the column. The fractions containing the 
first peak of radioactivity (the excluded peak) were kept 
separate and precipitated with 2 . 2  volumes of ethanol. 
Fractions representing the first third of the excluded 
peak (the larger cDNA molecules) were pooled as were 
fractions from the second third and the remaining third. 
Aliquots of these three sets of pooled fractions were 
analysed on an alkaline agarose gel to assess the size of 
the cDNA molecules synthesised.
3.30.2 Methylation of cDNA and addition of EcoRl linkers.
The first set of pooled fractions (the largest cDNA 
molecules) was protected from restriction at internal 
EcoRl sites by treatment with EcoRl methylase. The cDNA 
was incubated in l*methylase buffer (50mM Tris.HCl 
(pH7.5), IraM EDTA (pH8 )t 5mM DTT) and 8^M s-adenosyl 
methionine^ with 40 units of EcoRl methylase in a final 
volume of 60jil for 15 minutes at 37°C. The reaction was
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terminated by phenol extraction and DNA precipitated with 
ethanol. The methylated cDNA was resuspended in sterile 
water and then mixed with 0.7^ ig of EcoRl linkers, that had 
previously been kinased in the presence of lO^ iCi of 
2f[^P] ATP and a large excess of unlabelled rATP. After 
adding 24 units of T4 DNA ligase the reaction was 
incubated at 4°C overnight. The ligase was then 
inactivated by heating at 65°C for 10 minutes and the 
reaction made lOOmM with NaCl. 25 units of EcoRl were 
added and the tube incubated at 37°C for 1 hour. The 
digestion was terminated by extracting with phenol and the 
aqueous phase applied to a sepharose CL4B column. 
Fractions were collected and counted using a geiger 
counter to generate a column profile. The first peak of 
radioactivity which corresponds to high molecular weight 
linkered cDNA was taken and precipitated with ethanol.
3.31 cDNA Cloning In >ZAP.
3.31.1 Ligation of linkered cDNA into XZAP.
The EcoRl linkered cDNA was dissolved in sterile water 
and aliquots ligated with 0.5^ ig of A ZAP DNA that was pre­
digested with EcoRl and dephosphorylated. The ligation was 
carried out overnight at 4°C in 1*C buffer, ImM rATP in a 
final volume of 5^1 with 6 units of T4 DNA ligase.
159-
Materials And Methods
3.31.2 In vitro packaging.
In vitro packaging of ligated XzAP was carried - out 
exactly as directed by the manufacturer (Stratagene)• 
After the packaging reaction was completed, 0.5 ml of SM 
buffer (5.8g/l NaCl, 2g/l MgS04 .7H20, 50mM Tris.HCl 
(pH7.5), 0.1g/l gelatin) and 20 y l of chloroform was added, 
and the solution stored at 4°C.
3.32 Plating Of Bacteriophage Lambda.
Host cells (BB4, Y1090 or XLl-blue) from an overnight 
culture were inoculated into an appropriate volume of 2*TY 
and grown on a shaker at 37°C until the A5 5 0 reached 0.5. 
The cells were then pelleted by centrifugation at 2000 rpm 
for 5 minutes and resuspended in 1 /ioth the original 
culture volume of lOmM MgS04. Bacteriophage particles 
(from a packaging reaction or a phage stock in SM buffer) 
were then mixed with an appropriate volume of these host 
cells and allowed to adsorb for 15 minutes at 37°C. Up to 
20,000 phage were absorbed with 0.2ml of host cells. For 
the circular, 1 0cm diameter petri dishes 0 .2ml of infected 
host cells were plated on each plate. For larger plates 
this was scaled up accordingly. Molten top agarose was 
aliquoted in to sterile tubes and cooled to 45°C. The 
appropriate volume of infected cells was added to the top 
agarose and this was then poured onto dried NZY plates and 
allowed to set on a level surface. 3ml of top agarose was 
used on 10cm diameter petri dishes, 6.5ml on 15cm diameter
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on 15csi diaaeter petri dishes and 5al on lOca square 
plates. With ^ ZAP it is possible to use the lacZ colour 
reaction to identify plaques in which the bacteriophage 
contain insertions within the polylinker. To make use of 
this facility 50pl of 0.5M IPTG and 50^1 of 250ag/nl X-gal 
was added to each 3ml of top agar prior to plating. The 
plates were then incubated upside down at 37°C for the 
appropriate length of time.
3.33 Amplification Of AzAP Libraries And Long Term 
Storage.
After determining the titre of the packaged phage, 
aliquots of 50,000 pfu were plated on BB4 on 15cm diameter 
petri dishes as described in section >32. After 6 hours 
growth at 37°C (when the plaques had not become too 
large), each plate was overlayed with 10ml of SM buffer 
and incubated for 12 hours at 4°C with gentle rotary 
shaking. The SM was then removed to sterile oakridge tubes 
(polypropylene) and the plates rinsed with a further 2ml 
of SM buffer. This was pooled with the first 10ml of SM 
buffer and chloroform was added to a final concentration 
of 5X (v/v). The tubes were mixed well and left at room 
temperature for 15 minutes. They were then centrifuged at 
5,000 rpm for 10 minutes to pellet the debris and the 
supernatants transferred to a sterile glass bottle. 
Chloroform was added to 0.3X (v/v) and the phage stock 
stored at 4°C.
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3.34 The Benton And Davis Plaque Lift Procedure.
This procedure was used to transfer bacteriophage - DNA 
from plates to nitrocellulose filters and is essentially 
as described by Benton and Davis (1975). The host strains 
BB4 or Y1090 were used in all cases, and these support 
rapid plaque formation. Bacteriophage lambda were plated 
in the morning, always using top agarose, and then 
incubated at 37°C for 5 to 6 hours during the day. Plaques 
became visible about 4 hours after plating and were 
allowed to grow for a further 1 to 2 hours. Vhen doing the 
primary screen of a library, care was taken not to allow 
the plaques to get too large. The plates were then 
transferred to the fridge and left overnight. The next day 
the plates were removed from the fridge, several at a 
time, and pieces of nitrocellulose cut slightly smaller 
than the plates and labelled appropriately, were carefully 
lowered on to the surface of the top agarose. Great care 
was taken not to allow any air bubbles to form. These were 
left in place for 1 minute during which time the position 
of the filters was marked by making three asymmetrical 
holes through the filter and into the agar with a syringe 
needle. The position of the holes was also marked on the 
base of the plates using a marker pen. The filters were 
carefully removed with a pair of forceps and layed, DNA 
side up, onto a tray containing several sheets of 3MM that 
had been moistened with denaturing solution (0.5M NaOH, 
1.5M NaCl). The filters were allowed to denature for 1
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1 minute during which time a second nitrocellulose filter 
was applied to each plate. This replica filter was left in 
place for 2 minutes, and orientated by making holes in the 
identical positions used for the first filter. After 
denaturation the first filter was transferred to a tray 
containing several sheets of 3MM moistened with 
neutralising solution (3M NaCl, 0.5M Tris.HCl pH7, ImM 
EDTA) and left in place for 4 minutes. It was then moved 
to a second tray of neutralising solution for a further 5 
minutes and finally onto a tray of 3MM soaked in 2*SSC 
for 5 to 10 minutes. The filters were then allowed to air 
dry for at least 30 minutes. The same denaturation and 
neutralisation procedure was followed for the replica 
filters.
The filters were then baked at 80°C under vacuum for 2 
hours and either pre-hybridised immediately or stored at 
room temperature for a short period.
3.35 Automatic Excision Of Phagemids From XzAP Clones.
This was carried out exactly as described by the 
manufacturers. A culture of BB4 was grown until the A5 5 0  
was between 0.8 and 1, and 0.2ml mixed with IOO^ jI of A zaP 
phage stock and lOjil of R408 helper phage (7*10*® pfu/ml, 
supplied by Stratagene) in a sterile plastic universal. 
The cultures were incubated in a 37°C shaker at 200 rpm 
for 4 to 6 hours. During this time there was very variable 
growth of the bacteria, but this did not seem to effect
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the yield of phagemld. The cultures were heated at 70°C 
for 2 0 nlnutes and then centrifuged at 2 , 0 0 0  rpm for 5 
minutes. The supernatant, which contains the phagemld 
particles, was transferred to a fresh tube and stored at 
4°C. The phagemld was converted to colony form by mixing 
0.2ml of a fresh BB4 culture (A5 5 0 about 0.5) with 0.1 to 
lOO^ il of the phagemld stock. After Incubating at 37°C for 
15 minutes to allow adsorption of the phage, 10 and lOOpl 
aliquots were spread on dried L-amp plates and incubated 
overnight at 37°C.
3.36 In Vitro Translation.
3.36.1 Translation in rabbit reticulocyte lysate.
RNA was translated In rabbit reticulocyte lysate by 
mixing lOjil of the lysate (Amersham) with 0.75)il of RNA 
and 1.75pl of [3 5 S] methionine, and incubating at 30°C for 
45 minutes. After adding 30jj1 of dye mix and heating at 
100°C for 3 minutes the sample was analysed on an SDS 
polyacrylamide protein gel (see section 3.40)
3.36.2 Translation in wheat germ extract.
This was carried out essentially as described by Roberts 
and Patterson (1973). 3.75jil of wheat germ extract was 
combined with 2.4^1 of energy mix, lyl of RNA and ijil of 
[3 5 S] methionine and incubated at 30°C for 45 minutes. The 
products were then analysed on an SDS polyacrylamide 
protein gel (see section 3.40).
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3.37 Methods For Radiolabelling DNA And RNA.
3.37.1 Nick Translation.
DNA fragments isolated from agarose gels or undigested 
plasmids were labelled by nick translation using the 
following protocol. A 20^1 reaction was assembled 
containing 1*NTB (50mM Tris.HCl (pH7.2), lOmM MgS04, O.lmM 
DTT, 50jig/ral BSA), 100 ng of DNA, ImM each of dATP, dCTP, 
dTTP, 2 to ifil of o<[3 2 P] dGTP, 2.3*10“ 3 units of 
deoxyribonuclease I and 10 units of E.coli DNA polymerase 
I. The reaction was allowed to proceed at 14°C for 1 hour 
after which 0.2ml of NaE was added. The solution was 
extracted with an equal volume of neutral phenol and then 
with ether. This was then applied to a 10 ml sephadex G-50 
column using TE as the buffer. The high molecular weight 
DNA passes through this column much faster than 
unincorporated nucleotides, thus allowing the efficiency 
of incorporation of label into the DNA to be assessed. The 
first peak of radioactivity was collected, leaving the 
unincorporated label on the column, and precipitated with 
ethanol. The labelled DNA was recovered by centrifugation, 
resuspended in water, heated at 100°C for 5 minutes and 
then cooled on ice before adding to the hybridisation 
buffer.
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3.37.2 End-labelling of oligonucleotides with $[^P] ATP 
and polynucleotide kinase.
A 15jil reaction was assembled containing 1*C buffer 
(6 6mM Tris.HCl (pH7.6), 6 .6mM MgCl2, 10«M DTT), 4 ng of 
oligonucleotide (these ar* already dephosphorylated), 2 to 
4jj1 of %  [32P] ATP and 20 units of T4 polynucleotide 
kinase. The reaction was incubated at 37°C for 1 hour 
after which 0.2ml of NaE was added, and the solution 
extracted with an equal volume of neutral phenol. The 
aqueous phase was extracted with ether and applied to a 
sephadex G-50 column in order to remove the majority of 
the unincorporated label. Being relatively small 
molecules, oligonucleotides tend not to form a distinct 
peak on a G-50 column, but run just ahead of the 
unincorporated label. Generally the first 7 radioactive 
0.5 ml fractions were taken and precipitated with ethanol.
3.37.3 Preparation of radiolabelled size markers.
Lambda DNA (CI857) that had been digested with both 
Hindlll and EcoRl, was end-labelled by mixing lyg of 
restricted DNA, ^ll of loM dATP, 2jil of CX[3 2 P] dGTP, 1^1 
of 10*TM buffer (lOOmM Tris.HCl (pH7.5), 50mM MgCl2) and 
10 units of E.coli DNA polymerase Klenow fragment in a 
final volume of lO^ il. The reaction was allowed to proceed 
at 37°C for 30 minutes and terminated by adding 0.2ml of 
NaE followed by extraction with an equal volume of neutral 
phenol. Unincorporated label was removed by running the
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aqueous phase down a sephadex G-50 column, and the 
labelled DNA recovered by ethanol precipitation.
Essentially the same protocol was used to end— label 
Hpall digested pBR322 DNA, which was used as molecular 
weight markers on sequencing gels.
3.37.4 Preparation of mixed cDNA probes from poly A* RNA.
A 2 5^i 1 reaction was assembled which contained 1*TDM
buffer (0.1M Tris.HCl (pH8.3), lOmM MgCl2, 20mM 
^-mercaptoe thanol) , lOOmM KC1, 1.5jjg of oligo dT, ImM each 
of dATP, dCTP, dTTP, 100 ng of poly A+ RNA, 5jil ofO<[3 2 P] 
dGTP, 90 units of pancreatic ribonuclease inhibitor and 40 
units of AMV reverse transcriptase. The reaction was 
allowed to proceed at 42°C for 2 hours and then chased by 
adding dGTP to a final concentration of 2mM, and 
incubating for a further 15 minutes at 42°C. The RNA:DNA 
hybrids were denatured by adding NaOH to a final 
concentration of 0.3M and heating at 65°C for 15 minutes. 
After cooling rapidly on ice, 0.2ml of NaE was added and 
the solution applied to a sephadex G-50 column. The 
excluded peak was recovered by ethanol precipitation.
3.37.5 End—labelling of mRNA with polynucleotide kinase. 
The RNA to be labelled was made up to lOjil with water
and then heated at 100°C for 5 minutes, and allowed to 
cool at room temperature. This breaks the RNA in such a 
way that 5' OH termini are generated (Spradling £t^  al,
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1980), and these can be labelled with polynucleotide 
kinase as described below. To the heated RNA was added 2jil 
of 10*PNK buffer (0.5M Tris.HCl (pH7.6), 0.1M MgCl2, 50mM 
DTT, ImM EDTA (pH8 ), ImM spermidine), 3jil of water, 3jil of 
¿f[32p] ATP and 2pl (20 units) of T4 polynucleotide kinase. 
The reaction was incubated at 37°C for 30 minutes and 
terminated by adding 0.2ml of NaE and extracting with 
neutral phenol. The aqueous phase was applied to a 
sephadex G-50 column, and the excluded peak recovered by 
ethanol precipitation.
3.37.6 Single stranded M13 "prime cut" probes.
2jil of the appropriate M13 template DNA (0.5 to 0.7 
^ig) was combined with 3jil of water, 2jil of 10*TM and ljil 
of the M13 17 mer sequencing primer (2ng/jjl) in a 0.5ml 
eppendorf tube. The tube was floated in a shallow tray of 
water at 80°C and left to cool for about 40 minutes. IjjI 
of 0.5mM dATP/dCTP/dTTP, ifil of o<[3 2 P] dGTP and 2 units of 
DNA polymerase klenow fragment were added and the tube 
incubated at room temperature for 20 minutes. The reaction 
was then chased by adding ljil of 0.5mM dGTP and incubating 
at room temperature for a further 2 0 minutes, l^ il of the 
appropriate restriction enzyme buffer and 1 0 units of the 
appropriate restriction enzyme was then added and the 
reaction incubated at 37°C for 1 hour. The reaction was 
then heated at 100°C for 5 minutes, cooled on ice and 
after adding 2ul of gel loading dye fractionated on a low
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melting point agarose gel. The single stranded probe 
fragment was located by autoradiography for 5 minutes at 
room temperature, excised from the gel and melted in 1 ml 
of hybridisation buffer at 65°C. The melted gel slice was 
then added directly to the hybridisation buffer.
3.37.7 [^2p] labelled Synthetic RNA probes.
High specific activity single stranded RNA probes are 
often the best probes for use on northern blots. However 
they can occasionally hybridise very strongly and non- 
specifically to ribosomal RNA, something which must be 
borne in mind when using a probe for the first time. 
Synthetic RNA probes were prepared by transcribing DNA 
fragments, cloned in the appropriate vector, with either 
SP6 , T7 or T3 RNA polymerase using the following protocol. 
The template DNA was first linearised at an appropriate 
polylinker restriction site, and after phenol extraction 
and ethanol precipitation dissolved in sterile water. A 
transcription reaction with a final volume of 25^ il was 
then assembled at room temperature (to prevent 
precipitation of the spermidine). The reaction contained 
transcription buffer (40mM Tris.HCl (pH7.5), 6mM MgCl2, 
2raM spermidine), 0.5mM each of rATP, rGTP, rCTP, lOmM DTT, 
0.5mg/ml BSA, 2 to 5yg of template DNA, 60 units of 
ribonuclease inhibitor, 1 to 4pl of OC[^2p] rUTP, and 5 
units of the appropriate RNA polymerase. This reaction was 
incubated at 37°C for 1 hour and then terminated by phenol
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extraction. The aqueous phase was applied to a sephadex G- 
50 column, and the excluded peak collected and 
precipitated. Typically 40 to 60Z of the labelled rUTP was 
incorporated. The labelled RNA was recovered by 
centrifugation, dissolved in hybridisation buffer and 
added directly to the hybridisation bag.
3.37.8 Preparation of [^H] labelled synthetic RNA.
In order to quantitate the results of primer extension 
analysis with the albumin primer, synthetic RNA was 
prepared which would hybridise to this primer. In order to 
calculate the mass of synthetic RNA produced, the RNA was 
labelled with [^ H] rUTP and then aliquots precipitated 
with TCA and counted in a scintillation counter. The RNA 
was prepared using essentially the same reaction described 
in section 3.37.7, except that 4jil of [^H] rUTP replaced 
the [^P] rUTP, and after incubating for an hour at 37°C 
the RNA was recovered by a single ethanol precipitation
3.38 Transcription Of Cloned DNA In Vitro For Use In 
In Vitro Translations.
Unlabelled RNA was prepared i_n vitro using essentially 
the same procedure outlined in section 3.37.7 except that 
the reaction contained all 4 unlabelled ribonucleotides. 
The reaction was terminated by phenol extraction and RNA 
recovered by ethanol precipitation.
170-
Material* And Methods
3.39 DNA Sequencing Using The M13 Dideoxy Chain 
Termination Method.
3.39.1 Standard M13 dideoxy sequencing.
This is a method for rapid and accurate sequencing of 
DNA fragments cloned in bacteriophage M13 vectors that was 
first described by Sanger e£ al (1977).
A set of deoxynucleoilde and dideoxynucleotide mixes 
were assembled as shown below using O.SmM stocks of each 
dNTP.
A° C° G° To
O.SmM dCTP 20^11 l>il 2 0p 1 2 0 ^ 1
0.5mM dGTP 2 0pl 2 0pl Ijil 2 0>il
0.SmM dTTP 2 0pl 2 0pl 2 0pl 1^.1
TE buffer 2 0pl 2 0pl 20jil 2 0 ^ 1
Dideoxy NTP working solutions; O.lmM ddATP, O.lmM ddCTP, 
0.3mM ddGTP, O.SmM ddTTP
These concentrations were altered as necessary to fine 
tune the sequencing reaction.
Chase mix; O.SmM of all 4 cold dNTPs.
For each clone to be sequenced an annealing reaction 
was set up by mixing lpl of single stranded template DNA, 
6 .S^ il of sterile water, l.S^ il of freshly prepared klenow 
reaction buffer (9jil of 10*core buffer [lOOrnM Tris.HCl 
(pH8 ), 50mM MgC^]» lpl of 700mM ^ S-mercaptoethanol), and 
Ijil of M13 17mer sequencing primer (2ng/pl). The tube was
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placed in a large shallow tray containing water at 80 to 
85°C and left to cool at room temperature for about 40 
minutes. For each template, four 0.5ml eppendorf tubes were 
labelled A, C, G, and T. In to the bottom of each of the 
"A” tubes was placed ljil of the A° nucleotide mix and ljil 
of the ddATP nucleotide. This was repeated for the "C", 
”G", and "T" tubes using the appropriate nucleotide mixes. 
The annealed template/primer mix was centrifuged briefly to 
bring down any condensation and 0.75^ il of [^S] dATP added. 
The solution was mixed, and then 0.5^ il of sequencing grade 
DNA polymerase Klenow fragment (5 units/jjl) was added. 
After mixing briefly 2.5^ il of this annealed template/- 
primer/label/enzyme mix was transferred to the side of each 
of the tubes containing the nucleotide mixes. The tubes 
were closed and then centrifuged in a minifuge for 1 0  
seconds to start the reaction. The reaction was allowed to 
proceed at 30°C for 15 to 20 minutes after which 2jil of 
chase mix was added and the tubes incubated for a further 
15 to 20 minutes at 30°C. The reaction was terminated by 
pipetting Ujxl of sequencing dye mix on to the side of each 
tube and then centrifuging briefly to mix the contents. 
Each reaction was then split into two aliquots by removing 
5jil to a fresh tube. These samples were either stored at 
-20°C overnight or analysed immediately on a 6% 
polyacrylamide (w/v), urea sequencing gel in 1*TBE buffer, 
utilising sharks tooth combs throughout. One aliquot of 
each sample was heated at 100°C for 5 minutes and then
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loaded using a gilson P20. The gel was then run at 38 watts 
for 2 to 2.3 hours after which the second aliquot of each 
sample was heated and electrophoresed on the same gel until 
the bromophenol blue had almost reached the end of the 
plate. The gel was then fixed in 10Z (v/v) glacial acetic 
acid/IOZ (v/v) ethanol for 20 minutes. After transferring 
to a sheet of 3MM_, the gel was dried under vacuum at 80°C 
and exposed to X-ray film at room temperature.
3.39.2 Extended M13 dideoxy sequencing.
This is an adaptation of the standard M13 dideoxy 
sequencing protocol which enables one to read sequence at 
greater distances from the primer. This method was obtained 
from the BRL M13 cloning/dideoxy sequencing manual. With 
the greater resolving power of 1 meter gel systems this 
method enables up to 800 bases to be read from a single set 
of reactions. However, with the gel system available it was 
only possible to read a maximum of 630 bases from the 
primer.
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The following termination mixes were prepared;
A C G T
d A T P 2 5 j iM 2 5 0 p M 2 5 0 p M 2 5 0 p M
d T T P 2 5 0 j j M 2 5 0 p M 2 5 0 j j M 25j i M
d C T P 2 5 0 j iM 2 5>iM 2 5 0 ^ j M 2 5 0 p M
d G T P 2 5 0 j iM 2 5 0 jjM 2 5 p M 2 5 0 p M
d d A T P 3 0 0 p M - - -
d d T T P - - - 5 0 0 j iM
d d C T P - lO O p M - -
d d G T P - - I S O ^ i M -
The template and the primer were annealed by mixing l^ il 
of template DNA, 2jil of 5*sequencing buffer (200mM Tris.HCl 
(pH7.5)f 50mM MgCl2, 250mM NaCl) and 4ng of primer in a 
final volume of lO^ il. The tube was then placed in a shallow 
tray of water at 80°C and left to cool at room temperature 
for about 40 minutes. For each template, four tubes were 
labelled A, C, G and T( and 2.5^1 of the appropriate 
termination mix was placed in the bottom of each of these 
tubes. To the annealed primer/template mix was added 2^ il of 
extension mix (l.SpM dCTP, 1.5yuM dGTP, l.SpM dTTP), l^ il of 
C35S] dATP, l^ il of 0.1M DTT, ljil of water and 2 units of 
DNA polymerase I Klenow fragment. The contents of the tube 
were mixed and the tube incubated at room temperature for 
5 minutes. 3.5jil aliquots of this labelling/extension
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reaction were pipetted onto the sides of each of the tubes 
containing the termination mixes. The tubes were 
centrifuged briefly to mix the contents and then incubated 
at 37°C for 5 minutes. The reactions were then terminated 
by addition of 4j j1 of sequencing gel loading dye, heated at 
100°C for 5 minutes and analysed on a 6Z 
polyacrylamide/urea sequencing gel using two loadings. 
These gels contained only 0.5*TBE and were run with 0.5*TBE 
in the top buffer tank and 1*TBE in the lower buffer tank. 
The first set of samples were run at 24mA for 1.5 hours 
after which the second set of duplicate samples were loaded 
on the same gel. The gel was then run at 18mA for a further 
4.5 to 5 hours. The gel was then fixed, dried down and 
autoradiographed.
3.40 SDS Polyacrylamide Protein Gels.
A denaturing protein gel was prepared in two stages. 
First, the separating gel which consisted of 18Z 
acrylamide, 0.48Z bis-acrylamide, 0.375M Tris.HCl (pH8 .8 ), 
and 0.1Z SDS, was poured. After this had set it was 
overlaid with with a stacking gel which contained 3Z 
acrylamide, 0.15Z bis-acrylamide, 0.12M Tris.HCl (pH6 .8 ), 
and 0.1Z SDS into which the well former was inserted. The 
gel was run in a buffer containing 6g/l tris base, 29g/l 
glycine, and 0.1Z SDS. Before loading, an equal volume of 
sample loading buffer (62mM Tris.HCl (pH6 .8 ), 10Z glycerol, 
2Z SDS, 0.73M B-mercaptoethanol, 0.001% bromophenol blue)
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was added to each of the samples, which were then heated at 
100°C for 3 minutes. The gel was run at 10mA overnight or 
at 40mA during the day. The gel was then stained in 45X 
methanol, 10X acetic acid, 0.1X coomassie blue for 30 
minutes and destained in 45X methanol, 10X acetic acid. In 
order to visualise labelled proteins the gel was then 
placed on a sheet of 3MM, dried down on a vacuum drier, and 
autoradiographed.
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R E S U L T S  A N D  D I S C U S S I O N  
C H A P T E R  4
Characterisation Of The Xenopus laevis 6 8Kd Serum 
Albumin Genomic Clone Ax68a206.
Introduction
The blood of adult Xenopus laevis contains two distinct 
serum albumin proteins that have molecular weights of 
6 8Kda and 74Kda^ and are encoded by two distinct but 
closely related mRNAs (Westley £t al^ 1981; Schoenberg, 
1981). It has been reported that X. laevis has a single 
6 8Kda albumin gene and one or perhaps two 74Kda genes (May 
et al. 1982a; May et al, 1983). The albumin genes are 
transcribed primarily in the liver of adult frogs, where 
the resulting mRNA constitutes approximately 10X of the 
total mRNA population (Westley et ¿1, 1981). The
differences in the molecular weights of the two albumins 
is largely due to the 74Kda^ but not the 6 8Kda albumin 
being glycosylated (May et^  1983). In serum, the 74Kda
albumin is approximately twice as abundant as the 6 8 Kda 
albumin, and this is reflected in the abundance of their 
respective mRNAs.
Our main aim upon receiving the 6 8 Kda albumin genomic 
clone (May et al, 1982a) was to develop an oocyte assay 
for identifying promoter sequences and trans-acting 
factors required for the liver-specific transcription of 
this gene. At this time the restriction map of this clone
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had been published (May ¿t £l, 1982a), and the approximate 
positions of the exons determined by R loop mapping *(May 
et £l, 1983). Our first goal was to identify the
transcription start site. Initial attempts were made using 
SI mapping with probes based upon the published maps, but 
without success. As we discovered later, these failed to 
work because of inaccuracies in the published maps (May et 
a_l, 1882a; May et al^ , 1983). This chapter describes some 
of the work which eventually le d to the determination of 
the transcription start site.
4.1 A probe taken from the predicted 5* end of the 
coding region of the 68Kd albumin gene fails to 
detect albumin mRNA.
Introduction.
It was decided that it would be interesting to determine 
the profile of albumin gene transcription in Xenopus 
development. Initially this was attempted using northern 
blot hybridisation.
Results
5pg of ovary polyA* RNA and lyig of liver polyA* RNA were 
separated on a formaldehyde agarose gel and transferred to 
nitrocellulose as described in the Materials and Methods. 
An M13 prime cut probe was prepared from the KpnI-Hindlll 
M13 sub-clone of Xx68a206 designated mpl8KH2.5 (figure 
10). Prehybridisation and hybridisation was carried out
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Figure 10.
The published restriction map (May et al, 1982a) of the 
68Kda albumin genomic clone Xx68a206 with the approximate 
positions of the exons superimposed. Also shown are two M13 
sub-clones of Ax68a206.
The albumin genomic clone Ax68a206 is a 19.6Kb genomic 
EcoRI fragment from X.laevis (open box) encompassing the 
complete 68Kda albumin gene, inserted in the lambda vector 
Charon 4A (thin line) (May et al, 1982a). Numbers within 
the boxes indicate the sizes in Kb of the EcoRI fragments. 
Those restriction sites within the lambda arms that are 
relevant to the mapping experiments detailed in chapter 4.2 
are shown, as are the sizes of some relevant restriction 
fragments. A more detailed map of the albumin genomic 
fragment is shown enlarged below the complete map. The 
exon/intron structure of the 68Kda albumin gene as 
determined by analysis of RNA/DNA hybrids (May et «1, 1983) 
is shown superimposed upon the restriction map. Also shown 
are two M13 sub-clones of Xx68a206a that are relevant to 
experiments described in chapters 4.1 and 4.3.
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exactly as described in Materials and Methods. Final wash 
conditions were 0.1*SSC, 0.11 SDS at 50°C. Even on a long 
exposure, no hybridisation to the liver polyA'*’ RNA (or to 
the ovary polyA'*’ RNA) was visible (data not shown). This 
northern blot was repeated with 2.S|ig of freshly prepared 
liver polyA* RNA and again no hybridisation was 
detectable. However, when the whole genomic clone \x68a206 
was nick translated and used to probe a northern blot, it 
hybridised very strongly to a transcript of about 2Kb in 
both polyA* and total liver RNA (data not shown).
Conclusions.
From these results I concluded that the KpnI-Hindlll 
fragment present in mpl8KH2.5 was upstream of the first 
exon, indicating that the published restriction map was 
unreliable.
4.2 Crude mapping of the exons within^x68a206. 
Introduction.
Having discovered that the published map was inaccurate 
I decided to try and determine the degree of inaccuracy. 
We needed to know the approximate location of the first 
exon in order to map the transcription start site. Because 
albumin mRNA is so abundant in liver (about 10X of polyA+ 
RNA), it should be possible to use a mixed probe prepared 
from liver message to detect exons within *Xx68a206.
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Results.
Ax68a206 DNA was digested with several restriction 
enzymes (as indicated in figure 11), and then each digest 
was split into two aliquots. Each aliquot was heated at 
65°C for 10 minutes to ensure that the cohesive ends of 
lambda had not annealed, and then separated on a IX 
agarose gel. After photographing the gel under U.V. light, 
the DNA was transferred to nitrocellulose using the 
Southern blotting protocol described in Materials and 
Methods. A calibration curve was drawn for this gel and 
used to accurately determine the sizes of all the 
fragments. This showed up several inaccuracies in the 
restriction map of Xx68a206 and the map was modified 
accordingly. After baking, the filter was cut in half to 
generate two identical filters. One was hybridised with 
yjg of adult male liver polyA* RNA that had been end- 
labelled with polynucleotide kinase as described in 
Materials and Methods (section 3.37.5). The second filter 
was hybridised to a probe that was prepared by reverse 
transcription of adult male liver polyA* RNA primed from 
oligo d(T) annealed to the poly (a} tail (Materials and 
Methods section 3.37.4). After hybridisation, both filters 
were washed in 2*SCC, 0.1Z SDS at 60°C and exposed to X- 
ray film.
As can be seen in figure ll^both the cDNA probe and the 
kinased mRNA probe hybridised to the same restriction 
fragments. The EcoRI digest of Xx68a206 produced 9
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Figure 11.
Crude mapping of the coding regions within Xx68a206.
Ax68a206 DNA was digested with various restriction 
enzymes as indicated above each track. Equal aliquots of 
each digest were separated on an agarose gel and 
transferred to nitrocellulose using the procedure of 
Southern (1975). The filter was cut in half to generate two 
identical filters, one of which was hybridised with 
radiolabelled single stranded cDNA prepared from male 
X.laevis liver raRNA ("cDNA probe” : see chapter 3.37.4). The 
second filter was hybridised with male X.laevis mRNA that 
had been end-labelled with polynucleotide kinase ("mRNA 
probe”: see chapter 3.37.5). Prehybridisation and
hybridisation was in 3*SSC, 1* Denhardts, 100jjg/ml E.coli 
tRNA, 0.25Z SDS at 65°C. After hybridisation the filters 
were washed in 2*SSC at 60°C and then exposed to X-ray film 
for 4 hours.
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fragments, 2 of which are the arms of the vector, (the 
0.5Kb fragment predicted by the map was not visible on* the 
gel). Four of these EcoRI fragments; the 5.1Kbf 3.6Kb, 
2.7Kb, and 2.2Kb fragments hybridised to both probes. All 
these fragments are predicted by the published map (figure 
10) to contain exons. In agreement with this map, neither 
the 1.8Kb doublet or the 5' most 1.7Kb EcoRI fragments 
hybridised to the probes. It is quite clear that with the 
cDNA probe, but not with the mRNA probe, the ladder of 
EcoRI fragments shows a steady increase in hybridisation 
intensity going down the gel. This reflects the inability 
of most of the reverse transcriptase molecules to reach 
the 5' end of the albumin mRNA during synthesis of the 
probe. Therefore, strongest hybridisation occured to the 
3' most exon-containing fragment. The relative intensities 
of the hybridisation to the EcoRI fragments in figure 11 
does correspond to the order of the fragments in the 
published map (see figure 10). This indicates that the map 
is essentially correct, at least in respect to the EcoRI 
sites, and the rough positions of the exons.
In the Hindlll/EcoRI double digest, the 2.2Kb and 2.7Kb 
EcoRI fragments are the same fragments as in the EcoRI 
digest and hybridised to the probes as before. The 5.1Kb
F.coRI fragment is cut by Hindlll to give a 4.3Kb fragment 
which hybridised weakly to the cDNA probe. The 3.6kb EcoRI 
fragment contains two Hindlll sites, giving rise to a 
fragment of 2.2Kb which ran as a doublet with the 2.2Kb
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EcoRI fragment. It is therefore not possible to say 
whether or not this fragment hybridised to the probest In 
the BamHI digest 5 fragments were produced, of which the 
three smaller fragments all come from the vector. Only the 
two largest fragments (20.3Kb and 18.8Kb)f which were only 
just resolved on the gel, contain any albumin sequence. 
Although it is not particularly clear on the photograph, 
the probes hybridised to both these fragments. This means 
that there must be at least one exon on the 5' side of the 
BamHI site within the 5.1Kb EcoRI fragment.
Bglll digestion of Xx68a206 generated 6 fragments larger 
than 1.3Kb. In addition, a number of very small fragments 
were produced, that all come from the vector and can 
therefore be ignored in the context of this experiment. 
Three of the 6 larger fragments are also derived entirely 
from the vector (see figure 10). This leaves a 1.95Kb 
fragment that comes from within the 5.1Kb EcoRI fragment 
plus two large fragments (23Kb and 16Kb). The 1.95Kb 
fragment hybridised only weakly to both probes, and in 
fact this was only visible on a longer exposure than that 
shown in figure 11. This suggests that this fragment 
contains only a single exon, or even only a part of one 
exon. The 16Kb Bglll fragment contains the majority of the 
insert of Ax68a206 and hybridised strongly to both probes. 
However, the 23Kb Bglll fragment did not hybridise to 
either probe. The cDNA probe is not particularly 
informative in this situation since I only expect this
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fragment to have at most the first two exons. The kinased 
RNA probe appeared to detect S' and 3' coding regions with 
equal sensitivity. Given the fact that the 1.95Kb Bglll 
fragment, which must contain at least one exon, gave only 
a feint signal I can only tentatively conclude that there 
is at most one exon (exon one) on the 5' side of the S' 
most Bglll site. As discussed earlier, a fragment which 
extends as far as the next BamHI site does hybridise to 
the mRNA probe.
Conclusions.
This mapping data supports the northern blot result 
which had suggested that the first exon was further to the 
3' side of the 5.1Kb EcoRI fragment than was indicated by 
the published map. This data in fact suggests that the 
first exon may well lie on the 3' side of the 5' most 
Bglll site.
4.3 Subcloning the 5.1Kb EcoRI fragment of Xx68a206 
(containing exons one to six) into pBR322. 
Introduction.
In order to map more acurately the coding regions at the 
5' end of the albumin genomic clone it was decided to 
subclone the 5.1Kb EcoRI fragment into pBR322.
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clone p682F.
The 68Kda albumin sub-clone p682F was digested with 
various restriction enzymes as shown above each track. The 
digested DNA was separated on an agarose gel and then 
transferred to nitrocellulose using the procedure of 
Southern (1975). The filter was hybridised to male X.laevis 
mRNA that had been end-labelled with polynucleotide kinase 
as described in chapter 3.37.5. Prehybridisation, 
hybridisation and washing conditions were exactly as 
described in the legend to figure 11. The markers were end- 
labelled fragments from a digest of lambda DNA with EcoRI 
and Hindlll. Marker sizes are in kilobase pairs (Kb).
Figure 12.
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Results.
pBR322 was linearised with EcoRI, dephosphorylated and 
ligated with the mixture of DNA fragments from an EcoRI 
digest of \x68a206. The E.coli strain MC1061 was 
transformed with this ligation and plated on L-amp plates. 
The resultant clones were therefore a mixture of non­
recombinants and recombinants potentially containing all 8 
EcoRI fragments of Ax68a206. Clones containing the 5.1Kb 
fragment were selected by colony hybridisation with an M13 
sub-clone of Xx68a206, designated mpl8HE1.0 (see figure 
10). One positive colony was selected, and its identity 
confirmed by restriction enzyme digests. This plasmid was 
designated p682F.
4.4 Crude mapping of the coding regions within p682F. 
Results.
p682F DNA was digested with a number of restriction 
enzymes as indicated in figure 12, and the fragments 
separated on a 1Z agarose gel. After photographing under 
U.V. light the gel was Southern blotted and the filter 
hybridised to male Xenopus liver polyA+ RNA that had been 
end—labelled using polynucleotide kinase. Figure 12 shows 
the resulting autoradiograph, and the data is summarised 
in figure 13. The sizes of the various fragments produced 
by digestion of p682F with the various restriction enzymes 
was used to update the restriction map. This gave rise to 
the map shown in figure 13. This figure indicates the
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The restriction enzyme map of the albumin sub-clone p682F 
and summary of the exon mapping data from figure 12.
p682F consists of the 5.1Kb EcoRI fragment from the 
albumin insert in \x68a206, containing exons one to six, 
cloned into the EcoRI site of pBR322. Restriction enzyme 
sites within pBR322 which are relevant to the mapping 
experiments described in chapter 4.4 are also shown. Below 
the restriction map is a summary of the exon mapping data 
from figure 12. The fragments produced by the various 
restriction enzyme digests of p682F are shown. Those 
fragments which hybridised strongly to male X.laevis liver 
mRNA are represented by thick lines, whilst those which 
hybridised only weakly are represented by the cross-hatched 
boxes. Fragments represented by the thin black lines did 
not hybridise to this probe.
Figure 13.
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restriction fragments of p682F which hybridised to the 
probe, and perhaps more importantly, those which did not.
Conclusions.
From the hybridisation data summarised in figure 13, it 
can be concluded that no significant length of sequence 
complementary to albumin raRNA is present on the 5' side of 
the 5' most Bglll site (marked with a *). The
transcription start site must therefore lie on the 3' side 
of this Bglll site, almost certainly between this Bglll 
site and next BamHI site.
4*5 Identification of the probable 5' end of the albumin 
transcript by sequencing and comparison to the 5* ends 
of other albumin mRNAs.
Introduction.
It was decided to determine the DNA sequence of p682F in 
the region I had identified as containing the
transcription start site. This work was carried out by R. 
W. Old and P. Day, and will not be discussed in any detail 
here.
Results.
Both Maxam Gilbert (Maxam and Gilbert, 1980) and M13 
dideoxy sequencing was used to generate DNA sequence 
spanning the region of the 68Kda albumin gene from 650bp 
upstream of the transcription start site through to the
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The DNA sequence around the transcription start site of 
the Xenopus 68Kda serum albumin gene.
The DNA sequence of the X.laevis 68Kda serum albumin gene 
spanning the region from 199 nucleotides upstream of the 
transcription start site to 136 nucleotides downstream of 
the transcription start site (Sweeney £t al, 1987) is
shown. The positions of the transcription start site used 
in liver, the TATA box, and the predicted amino acid 
sequence of the first exon are also shown. The hatched 
rectangle indicates the binding site for the albumin primer 
which was used to identify the exact transcription start 
site. Also shown are the conserved sequences that could 
theoretically base pair to form a stem loop structure in 
the the 5' untranslated leader of the 68Kda albumin tnRNA.
Figure 14.
Figure  14
DNA Sequence Around The Transcription Start Site Of 
The Xenoptm 68 Kda Serum Albumin Gene.
- 1 9 9  AATTTAAAAG GTTTCTAAAA TTCAGAAAAC CGAATATAGA GCAACAGCAA 
- 1 4 9  TACGTTATTT GACCTTAAAA GTTGATTGAC ATTAGGAAAT TCCACAAAGC
- 9 9  TAAAACAACT GCAAACAGCA ACAATTTGAT AGGTTTCAAT AAGTTTTCCA
B glll
•TATA"
Transcription 
start site
- 4 9  GATCTCTCTG AGCAATAGTA TAAAACAAGA GGTATCACTC ATTTCAGATC
+ 2  AGGCTTCTCA GAGGTCCCCA CCCAATACAT CTCCAGTC ATG AAG TGG
Met ly s  trp
Albumin primer
+ 4 9  ATC^ACC^CTC ATT TGT CTG TTA ATT AGC TCC ACT TTA ATA GGA 
lie  th r  leu  lie  c y s  leu  leu  l ie  s e r  s e r  th r  le u  He g lu
+ 9 9  TCA AGA ATA ATT TTC AAA AGA 
s e r  a r g  Ile Ile p h e  ly s  a r g
GAT ACA G/GTAAGCCTT 
asp thr ' 1st intron
= b in d i n g  s i t e  f o r  t h e  a lb u m in  p r im e r
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first exon/intron boundary (Sweeney et^  al, 1987). It has 
been reported that the untranslated leaders of albumin 
mRNA's contain several conserved motifs (Hache et al, 
1983). By examining the sequence we had determined for the 
Xenopus albumin gene, it was possible to identify these 
conserved motifs. Figure 14 shows the sequence around the 
transcription start site of the 68Kda albumin gene, and 
these conserved motifs have been marked "conserved". It 
has been proposed that these conserved sequences (CCCCAC 
and GTGG in the case of the Xenopus albumin gene) base 
pair to form the stem of a stem loop structure in the mRNA 
(Hache et al, 1983). In the case of the Xenopus mRNA the 
stem would consist of only 4 nucleotides rather than the 5 
predicted for human and the 6 predicted for rat. The first 
five encoded amino acids of exon one of the Xenopus 
albumin gene were identified as being identical to those 
predicted for the albumin proteins of rat (Sargent et al, 
1981), human (Minghetti et al, 1986), and chicken (Hache 
et al. 1983) and the alpha-fetoprotein of mouse (Scott and 
Tilghman, 1983), except for the substitution of isoleucine 
for valine. This helped to confirm that we had indeed 
located the 5' end of the Xenopus albumin coding region. 
The first intron/exon boundary on figure 14 has been 
confirmed by SI mapping (G. Sweeney, pers. comm.), and its 
position relative to the transcription start site is 
identical to that of the human albumin gene. Also 
indicated on figure 14 is the actual transcription start
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site used in vivo in adult liver. This was determined by 
primer extension analysis of liver RNA as described in*the 
next section. Almost exactly 30bp upstream of the 
transcription start site is a good consensus TATA box. The 
transcription start site lies about 50bp downstream of the 
Bglll site, which is consistent with the mapping data 
described in sections 4.2 and 4.4. The map published by 
May e£ al (1983) positioned the first exon about 2Kb too 
far to the 5' end of the albumin genomic fragment.
4.6 Identification of the exact transcription start site 
by primer extension with the "albumin'* primer. 
Introduction.
Based upon sequence homology to the 5' ends of other 
albumin mRNA's we had identified the probable 
transcription start site. In order to determine this 
unambiguously an oligonucleotide called the albumin primer 
was designed. This 17mer oligonucleotide is complementary 
to the sequence of the mRNA just downstream of the 
putative transcription start site, as indicated in figure 
14. This oligonucleotide was used in a primer extension 
analysis of adult male Xenopus liver RNA.
Results.
The albumin primer was end-labelled with polynucleotide 
kinase and hybridised to 2jig of total liver RNA and 4jjg of 
ovary polyA+ RNA. The liver RNA gave rise to two primer
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Figure 15.
Identification of the exact transcription start site of 
the 68Kda albumin gene.
End-labelled albumin primer (GAGGGTGATCCACTTCA) was 
annealed to 4jig of X. laevis ovary polyA* RNA (lane 2) or 
2jig of adult male X. laevis total liver RNA (lane 1). 
Annealed primers were extended with reverse transcriptase 
and the products fractionated on an 8Z sequencing gel and 
located by autoradiography after exposure for 18 hours. 
Markers (M) were end-labelled fragments from a digest of 
pBR322 DNA with Hpall. The arrow indicates the position of 
the band corresponding to correctly initiated transcripts.
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extension products of 56 and 57 nucleotides (figure 15), 
and the largest of these corresponds to the 5' end of 
albumin mRNA. This doublet of bands is often observed with 
primer extension back to the 5' end of eukarytotic mRNA's 
in general. This is thought to be due to the inability of 
some of the reverse transcriptase molecules to traverse 
the final nucleotide, because in many eukaryotic mRNAs it 
is capped. This gives rise to a second band 1 nucleotide 
shorter than the full length product. Even after a longer 
exposure of the gel shown in figure 15, no primer extended 
products were detected with the ovary polyA* RNA, 
indicating that the albumin genes are not transcribed at 
detectable levels in oocytes.
The sequence of the Xenopus 74Kda serum albumin gene 
(Schorpp e_t a_l, 1988a) is identical to that of the 68Kda 
gene within the region to which the albumin primer binds. 
Furthermore, the distance from the albumin primer binding 
site to the transcription start site is identical in the 
two genes. We can therefore be confident that the albumin 
primer will detect both mRNA's and give identically sized 
primer extended products.
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C H A P T E R  5
The profile of albumin gene transcription during • 
Xenopus development.
Introduction.
One approach to identifying sequences within the albumin 
promoter required for liver-specific transcription is to 
inject albumin promoter constructs into fertilised eggs 
and then analyse transcription from the injected promoter 
as development proceeds. Before such an experiment could 
be attempted it was necessary to know when the endogenous 
albumin promoter first becomes activated so that I could 
tell whether the injected promoter was being correctly 
regulated. The developmental profile of albumin 
transcription would also be of interest in itself.
5 . 1  D e v e l o p m e n t  o f  a n  R N A  p r o b e  t o  d e t e c t  a l b u m i n  m R N A .  
Introduction.
Single stranded RNA probes synthesised in vitro and 
labelled to a high specific activity make the most 
sensitive hybridisation probes for use on northern blots. 
Being single stranded, the RNA probe cannot hybridise to 
itself, and RNA:RNA hybrids formed between the probe and 
the RNA on the filter are more stable than RNAtDNA 
hybrids.
Results.
I decided to subclone the 3' most Xbal-EcoRI fragment of
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Figure 16.
Construction of the albumin sub-clones pSP65/EX2.2 and 
pGEMl/XE2.2.
p682F DNA was digested with Xbal (for which there are no 
sites in pBR322) and EcoRI and the resulting 2.2Kb fragment 
isolated from a low melting point agarose gel. This 
fragment was cloned into both pSP65 and pGEMl that had 
been digested with Xbal and EcoRI. This gave rise to the 
plasmids designated pSP65/EX2.2 and pGEMl/XE2.2 
respectively. Iji vitro transcription of pSP65/EX2.2 with 
SP6 RNA polymerase gives rise to RNA complementary to 
albumin mRNA (anti-sense). In vitro transcription of 
pGEMl/XE2.2 with SP6 RNA polymerase generates an RNA 
molecule containing sequences the same as those in albumin 
mRNA (sense).
Figure  16 Construction of the albumin subclones 
pSP65/EX2.2 and pGEM1/XE2.2
Scale
1 cm=500bp 68Kd albumin
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Figure 17.
Northern blot analysis for albumin mRNA using single 
stranded SP6 RNA prepared from pSP65/EX2.2 as a 
hybridisation probe.
One embryos worth of total RNA prepared from X.laevis 
larvae at various stages of development (stages 8 to 47 as 
indicated above each track), 2.5jig of total ovary RNA, and 
3jig of total adult liver RNA were fractionated on a 
formaldehyde agarose gel. The RNA was then transferred to 
nitrocellulose and hybridised to a ^2p labelled single 
stranded RNA probe prepared by transcription of pSP65/EX2.2 
in vitro. Prehybridisation and hybridisation was in 50X 
formamide, 5*SSC, 1* Denhardts, 23mM sodium phosphate 
(pH6.5), lOOpg/ml E.coli tRNA at 60°C, and final wash 
conditions were 0.1*SSC at 60°C. A 20 hour exposure of the 
filter is presented. The arrows indicate the positions of 
the 28S and 18S rRNAs as detected by ethidium bromide 
staining of the formaldehyde agarose gel.
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p682F into the SP6 transcription vector pSP65 (see figure 
16). This vector has a polylinker into which restriction 
fragments can conveniently be inserted. By using pSP65 
(rather than pSP64 in which the polylinker is inverted) I 
could ensure that transcription from the SP6 promoter 
would generate RNA antisense to albumin mRNA. This clone 
was designated pSP65/EX2.2 (see figure 16). In order to 
quantitate the signal obtained with this probe on northern 
blots, the same fragment was subcloned into the 
transcription vector pGEM-1. This generated a clone, 
designated pGEMl/XE2.2, in which transcription from the 
SP6 promoter produces RNA which is complementary to that 
produced from pSP65/EX2.2. This sense RNA was synthesised 
in a reaction containing [^H] rUTP (see Materials and 
Methods section 37.8), and the quantity of RNA produced 
determined by scintillation counting.
5.2 An RNA probe fails to detect albumin mRNA in all
stages of Xenopus embryogenesis up to and including 
stage 47.
Results.
Figure 17 shows a 20 hour exposure of a northern blot 
probed with a single stranded "antisense" RNA probe 
prepared from pSP65/EX2.2. The probe has detected albumin 
mRNA in adult liver total RNA with great sensitivity, but 
failed to detect albumin mRNA in any of the embrvo 
samples. Even after a 10 day exposure (data not shown) no
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signal was detected in these samples. Using known amounts 
of synthetic RNA prepared from pGEMl/XE2.2 it was shown 
that this probe can detect as little as Spg of RNA on a 
northern blot (data not shown).
Conclusions.
The albumin genes are not transcribed at detectable 
levels in embryonic stages up to and including stage 47. 
This was perhaps not surprising given that previous 
workers had reported that serum albumin was undetectable 
in the blood of pre-metamorphic laevis larvae, and that 
levels of the protein increased dramatically during 
metamorphic climax (Herner and Frieden, 1960). I therefore 
decided to look for albumin mRNA in later stages of 
development, during metamorphic climax (stages 50*65).
5.3 The profile of albumin gene transcription throughout 
Xenopus development as analysed by primer extension. 
Introduction.
A very sensitive method for detecting albumin mRNA is 
primer extension with the albumin primer. I have used this 
method to determine the levels of albumin mRNA throughout 
the development of Xenopus laevis.
Results.
The albumin primer was end— labelled and hybridised to 
4|ig aliquots of various RNA samples as indicated in figure
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Figure 18.
Primer extension analysis for albumin mRNA throughout 
Xenopus development.
The albumin primer was end-labelled and annealed to 4jig 
aliquots of ovary polyA* RNA, ovary total RNA, whole embryo 
total RNA prepared from the stages indicated, total RNA 
prepared from pooled dissected abdominal regions (D.A.R.) 
of embryos at the stages indicated, total RNA prepared from 
the livers of single larvae at the stages indicated, and 
total adult liver RNA. The annealed primers were extended 
with reverse transcriptase and the products fractionated on 
8Z sequencing gels, and detected by autoradiography for 18 
hours. The markers were end-labelled fragments from a 
digest of pBR322 DNA with Hpall.
Figure 18
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18. After extension with reverse transcriptase the 
products were analysed on an 8Z sequencing gelt and* the 
results are presented in figure 18. This figure is a 
combination of two gels on which the samples from a single 
analysis had been electrophoresed. Both gels were exposed 
for 18 hours.
The first point to make is that albumin mRNA first 
becomes detectable in RNA prepared from the abdominal 
regions of stage 48 tadpoles (the band is barely visible 
on this photograph, but was clear on the autoradiograph). 
Given that the liver only makes up a small percentage of 
the tissue in these dissected abdominal regions (probably 
about 10Z), the level of albumin transcripts in the liver 
of these embryos was at least 10 fold higher than is seen 
in this figure. This means that the albumin genes are in 
fact being transcribed fairly efficiently at stage 48. I 
cannot rule out the possibility that low levels of albumin 
transcripts are present in the livers of larvae before 
this stage since I have not analysed RNA from the 
abdominal regions of earlier stage larvae. However, on a 
longer exposure of this gel (data not shown), when the 
signal from the stage 48 RNA is quite strong, nothing is 
visible in the adjacent track (stage 44). Also, albumin 
transcripts could not be detected in total embryo RNA 
prepared from any stage up to and including stage 47 
(figure 17). By stage 51 the level of albumin transcripts 
is significantly higher than at stage 48.
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The variation in the level of albumin mRNA detected in 
the RNA prepared from the livers of individual larvae 
(tracks 14 to 19) is almost certainly due to RNA 
degradation in some of the samples. Primer extension 
analysis of other larval liver RNA samples has shown no 
consistent variation in the level of albumin raRNA during 
metamorphosis (data not shown). Clearly, the level of 
albumin transcripts in some of these larval liver samples 
is significantly higher than the level in the same amount 
of adult liver RNA. This indicates that albumin gene 
expression is more active in the livers of metamorphosing 
larvae than in the adult liver. This could of course be 
either a transcriptional effect or a post-transcriptional 
effect, or a combination of the two.
Conclusions.
The Xenopus albumin genes are first transcribed in the 
liver of metamorphosing larvae at about stage 48 of 
development. This corresponds to the start of the 
metamorphic climax and is therefore consistent with the 
results reported by Herner and Frieden (1960). The level 
of albumin transcripts in the livers of larvae undergoing 
metamorphic climax (stages 59 to 62) is significantly 
higher than in adult liver.
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C H A P T E R  6
Cloning of albumin cDNA*a from Xenopus laevis. 
Introduction.
At the time I began this work, four groups had reported 
the isolation of albumin cDNA clones from Xenopus laevis 
(Westley e_t al, 1981; Schoenberg, 1981; Phillip e_t si, 
1982; Wolffe et al, 1985). The restriction maps of these 
albumin cDNAs show considerable diversity, and we were 
therefore suspicious that some of them were not albumin 
clones at all. It is known that X.laevis has one 6 8 Kda 
albumin gene and one or possibly two 74Kda genes (May e_t 
al, 1982a). One might therefore expect to find 2 or
possibly 3 classes of albumin cDNAs. I therefore decided 
to isolate my own albumin cDNAs with the aim of resolving 
the paradox of the inconsistent restriction maps.
6.1 Preparation of double stranded cDNA and cloning in 
M13mpll.
Introduction.
Since albumin mRNA is very abundant in liver RNA it 
should be necessary to screen only a small number of liver 
cDNA clones in order to obtain albumin clones. For this 
reason it was decided to use an M13 vector rather than a 
lambda vector which would be much less convenient.
Double stranded cDNA was prepared from adult male liver 
mRNA essentially as described by Gubler and Hoffman
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(1983). In this method oligo d(T) is annealed to the polyA 
tail and then extended back towards the 5' end of the mRNA 
with reverse transcriptase. The second strand is 
synthesised by DNA polymerase I in the presence of 
ribonuclease H. Ribonuclease H introduces nicks into the 
RNA strand of the RNA:DNA hybrid, and DNA synthesis by DNA 
polymerase I is primed from these nicks.
Results.
Double stranded cDNA was synthesised essentially as 
described in Materials and Methods (section 3.30.1) except 
that the first and second strands were synthesised in 
separate reactions rather than in the same tube.
The double stranded, blunt-ended cDNA (20 to 160ng) was 
then ligated with 50ng of Smal cut, dephosphorylated 
M13mpll RF DNA. The ligations were transformed into JM101 
using the high efficiency procedure of Hanahan (1983). The 
transformed bacteria were plated in top agarose containing 
X-gal and IPTG, and a total of about 300 white plaques 
were obtained. Two of these plates (about 220 white 
plaques) were screened for albumin clones.
6.2 Screening the liver cDNA clones for albumin.
Results.
M13 plaques on the two plates selected were transferred 
to nylon (Hybond-N) discs exactly as described for phage 
lambda in Materials and Methods except that the DNA was
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fixed to the filter by ultra violet illumination. The 
hybridisation probe used was an albumin cDNA clone 
designated pXlAl4 (Schoenberg, 1981) which we had 
independently sequenced and confirmed as an albumin 
sequence. After hybridisation the filters were washed in 
0.1*SSC at S5°C. Two plaques hybridised strongly to the 
probe, and these were designated mpllXlal and mpllXla2.
6.3 Restriction enzyme mapping of the albumin cDNA clone 
mpllXla2 indicates that it belongs to the 74Kda class. 
Results.
Both mpllXlal and mpllXla2 were mapped with the 
restriction enzymes EcoRI. Hindlll, PstI. Kpnl. Xbal. 
Xhol, and BamHI. mpllXlal was found to have an insert of 
just 650bp and contained no sites for these restriction 
enzymes. mpllXla2 contained an insert of just under 2Kb 
and the restriction map is shown in figure 19, along with 
the published maps of the other albumin cDNA clones which 
align with that of mpllXla2. The characteristic bunching 
of an EcoRI site and a Hindlll site at one end of the 
clone and an EcoRI site and a PstI site at the other end 
indicates that mpllXla2 is a 74Kda albumin cDNA clone. The 
map of mpllXla2 fits well with that of the 74Kda albumin 
cDNA clones isolated by Uestley et al (1981), and of the 
class I albumin clones isolated by Schoenberg (1981). 
Interestingly, there would appear to be two types of 74Kda 
albumin cDNAs based upon the restriction maps (see figure
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Figure 19.
The restriction enzyme map of mpllXla2 and alignment with 
the maps of other albumin cDNA clones.
The X.laevis albumin cDNA clone mpllXla2 was mapped with 
the restriction enzymes EcoRI, Hindlll» PstI, Kpnl, Xbal, 
Xhol. and BamHI to generate the map shown. Comparison with 
the published restriction maps of other X.laevis albumin 
cDNA clones indicated that the clones could be aligned as 
shown. The albumin clone pcXal-5 is known to encode the 
74Kda form of serum albumin (Uestley et^  al^ 1981). The 
restriction map of mpllXla2 does not resemble that of the 
6 8 Kda albumin clone isolated by Westley et al^  (1981). The 
orientation of the restriction maps with respect to the 5' 
end of the mRNA is based upon the known orientation of 
pcXal-5.
Restriction enzyme map of mp11Xla2 and alignment 
with the maps of other Xanopim  albumin cDNA clones.
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19). In the first type (mpllXLa2, pXlAl, pXA3b), the EcoRI 
site is on the 5' side of the PstI site, while in* the 
second type (pcXal-5, pXA3a) the order of these sites is
reversed. The positions of the Alul sites is also
consistent with the existence of two classes of 74Kda
albumin cDNA clones. This would support the proposal that 
there are two 74Kda albumin genes in X. laevis (May e_t al, 
1983).
Conclusion.
I have isolated an albumin cDNA clone which is very 
nearly full length. The restriction enzyme map of this 
clone indicates that it is probably a 74Kda albumin cDNA. 
Comparison with published restriction maps of other 
albumin cDNA clones indicates that mpllXla2 can be grouped 
with a number of other 74Kda albumin cDNA's as shown in 
figure 19.
The restriction map of the albumin cDNA clone pXlA14, 
which was used as the probe to isolate mpllXla2 bears no 
resemblance to the published restriction maps of any other 
albumin cDNA clones.
As well as the group III clones whose maps appear to 
match that of mpllXla2 (see figure 19), Jackson and 
Shapiro (1986) also isolated two other classes of albumin 
cDNA clone (groups I and II). These groupings were made 
based upon both cross-hybridisation studies between the 
different clones and on restriction enzyme mapping. The
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restriction maps of these two groups of clones (groups I 
and II) also do not resemble (even partially) any of- the 
other published restriction maps. There is little doubt 
that the various clones isolated by the different groups 
are all albumin cDNA clones. I am therefore forced to 
conclude that there is considerable restriction enzyme 
site polymorphism within the coding regions of X.laevis 
albumin genes from different frogs.
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C H A P T E R  7
Transcription Of Albumin Gene Constructs Microin ject-ed 
Into Xenopus Oocytes,
Introduction.
Xenopus oocytes are a useful system for studying 
transcription of cloned genes. Many of the genes that have 
been microinjected into Xenopus oocytes were found to be 
faithfully transcribed. However, those tissue-specific 
genes that have been tested in oocytes have often been 
found to be poorly or inaccurately transcribed. This is 
perhaps what would be expected given that one would not 
expect the oocyte to possess the trans-acting factors that 
are known to be required for the transcription of many 
tissue-specific genes. We and others have shown that the 
endogenous albumin genes are not transcribed in oocytes 
(see figure 15). Presumably this is because the oocyte is 
deficient in the trans-acting factors present in 
hepatocytes that are required for transcription of these 
highly liver-specific genes. However, this is perhaps a 
very simplistic view. Another possibility which is not 
mutually exclusive of the first, is that the albumin genes 
in the oocyte are repressed in an inactive chromatin 
structure.
We set out to develop the oocyte as an assay system for 
two complementary lines of investigation. Firstly we hoped 
to use biochemical complementation to identify the trans­
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acting factors required for liver-specific transcription 
of the 6 8Kda albumin gene. In this assay liver mRNA is 
injected into the cytoplasm of the oocyte, where it will 
be translated. This should provide all the liver-specific 
factors required for efficient transcription of the 
albumin gene, thereby complementing deficiencies in the 
oocyte. When the albumin promoter is subsequently injected 
into the nucleus it should be transcribed more efficiently 
than without pre-injection of liver mRNA.
Secondly, and in conjunction with this approach, we 
planned to carry out an analysis of the promoter by 
microinjection of altered promoter constructs into oocytes 
that had been pre-injected with liver mRNA. This obviously 
depends upon transcription of the albumin gene being 
dependent on pre-injection of liver mRNA.
7.1 Construction of an albumin promoterrhistone fusion 
&ene-
Introduction.
In order to do these experiments we had to be able to 
distinguish transcripts initiating at the injected 
promoter from those of the endogenous genes (even though 
the endogenous genes are not normally expressed). This was 
achieved by fusing the 6 8Kda albumin gene, within the 
first exon, to the 3' end of a histone H3 gene.
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Figure 20.
Construction of an albumin promoter:histone fusion gene 
and a series of S' deletion derivatives.
A 2Kb EcoRI/HincII DNA fragment from the Xenopus 6 8 Kda 
albumin gene consisting of 1.7Kb of 5' flanking DNA (thin 
line), exon 1 (filled box) and the first 150bp of intron 1 
(thick line) was cloned into M13mpl9 RF DNA (zig-zag line) 
that had been cleaved with EcoRI and Smal to give clone 
HcE2.0 (A). Site directed mutagenesis was used to create a 
BamHI site within exon 1 and the DNA between this site and 
the BamHI site in the M13 polylinker was deleted to give 
GS1 (B). A 370bp DNA fragment containing the sequence 
encoding the 3' end of the Xenopus histone H3 RNA (hatched 
box) and also some 3' flanking DNA from the histone H3 gene 
(Old et £l, 1985) (clear box) was inserted into the BamHI 
site of GS1 to give albone (D). Clones A.“950 (E), A -670 
(F),A“232 (G),A“50 (H) were made by deleting albumin DNA 
upstream of the PstI, Hindlll, Hind i . and Bglll sites of 
albone, respectively. Abbreviations used: E, EcoRI; P, 
PstI: Hd, Hindi 11; He, Hindi; Bg, Bgl.II; Bm, BamHI. The 
arrows indicate sites complementary to the M13 sequencing 
primer (mp) and the albone primer (ap), CGCCTCGGATCCACTTC
Figure 20
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Results.
The clone called albone was constructed by G. Sweeney 
and R. W. Old as outlined in the legend to figure 20. A 17 
rner oligonucleotide complementary to nucleotides spanning 
the junction between the albumin and histone sequences was 
synthesised. This oligonucleotide, designated the albone 
primer, was used to detect transcripts initiating at the 
albumin promoter within the albone construct in a primer 
extension assay. Because the primer spans the junction of 
the albumin and histone sequences it is specific to 
transcripts initiating on this construct.
7.2 Construction of a series of albumin promoter deletions 
for analysis in oocytes and embryos.
Introduction.
As mentioned at the beginning of this chapter, one of 
our main aims was to carry out a functional analysis of 
the albumin promoter. I therefore made a set of 
derivatives of albone in which various amounts of albumin 
5' flanking DNA had been deleted.
Results.
Increasing amounts of albumin 5' flanking DNA was 
deleted from the albone construct by digestion with PstI, 
Hindlll, Hindi and Bglll. The resulting clones were 
designated A -950, ^-670, ^-232, and ^-50 respectively
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Figure 21.
Analysis of transcripts from oocytes injected with albone 
and its derivatives.
End-labelled albone primer was annealed to 20jig samples 
of RNA from oocytes each injected with lOng of RF DNA from 
albone, A -950, A -670, A-232, andA-50 as indicated above 
each lane. Extension products were fractionated through an 
81 sequencing gel and detected by autoradiography. The 
arrow indicates the bands (a doublet) corresponding to 
correctly initiated transcripts. Markers were end-labelled 
fragments from a digest of pBR322 DNA with Hpall.
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(figure 20 e-h). The numbers here refer to the amount 
albumin DNA upstream of the transcription start site. -
7.3 The albumin promoter directs accurate and efficient 
transcription when microinjected into oocytes.
Results.
Xenopus oocytes were given nuclear injections with 20nl 
aliquots of O.Smg/ml solutions of albone RF DNA or its 
deletion derivatives. After incubating for 24 hours RNA 
was prepared from the oocytes and analysed by primer 
extension with end-labelled albone primer. The result of 
an analysis of this type is shown in figure 2 1 . In each 
track 20jig of RNA (equivalent to the content of 4 oocytes) 
prepared from a batch of 20 oocytes injected with the RF 
DNA indicated was analysed. All five RNA samples gave rise 
to a major primer extended product of 57 nucleotides which 
represents correctly initiated transcripts. Each lane also 
has fainter bands at 58 and 45 nucleotides which represent 
transcripts initiating 1 nucleotide upstream and 1 2  
nucleotides downstream of the correct start site 
respectively. Oocytes injected with A -50 gave rise to a 
number of larger primer extension products that represent 
transcripts initiating further upstream of the correct 
start site. However, the majority of transcripts from A-50 
were initiated at the correct start site. On a longer 
exposure, some of the higher molecular weight bands seen 
in track 5 could also be seen in lanes 1 to 4, but they
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were very much weaker than in lane 5. From this it is 
quite clear that all 5 clones were being accura-tely 
transcribed in oocytes even without pre-injection of liver 
mRNA. In order to quantitate the level of transcription 
from these clones the insert of A -50 was subcloned into 
pBluescribe and this was used to prepare synthetic RNA. 
The amount of synthetic RNA produced was calculated by 
incorporating [3 H] rUTP into the RNA and counting aliquots 
in a scintillation counter. Known amounts of this 
synthetic RNA were analysed by primer extension using the 
same albone primer used to perform the analysis shown in 
figure 2 1 , and the products run on a separate sequencing 
gel. The slices of gel giving rise to the resulting bands 
together with the slices of gel giving rise to the 57 
nucleotide band in lanes 1 to 5 of figure 21 were excised 
and counted in scintillation fluid. From these results it 
was calculated that clones A-950, A-670, A-232 and A-50 
each gave rise to about 2.5*10"3 pmoles of correctly 
initiated transcript per oocyte. This is equivalent to 
about 1.5 transcripts per gene copy per day. Albone itself 
gave rise to about two thirds this number of transcripts, 
but this difference was not observed in repeat 
experiments. The efficiency of transcription of albone and 
its derivatives is greater than that of the Xenopus beta 
globin gene, which was estimated to produce between 0.005 
and 0 . 1  correctly initiated transcripts per gene copy per 
20 hours when injected into oocytes (Jiendig and Williams,
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1984). In addition, large amounts of incorrectly initiated 
transcripts were produced from the beta-globin gene.
When GS1 RF DNA (see figure 20) was injected into 
oocytes and transcription analysed by primer extension 
with the M13 universal sequencing primer, it was found 
that only 0.018 correctly initiated transcripts were 
produced per copy of GS1 per day (data not shown). GS1 is 
identical to albone except for the fusion of a DNA 
fragment encoding the 3' end of the histone H3 RNA onto 
the 3' end of the albumin sequence. Thus, it is probable 
that the albone transcript is substantially stabilised by 
the histone sequences, as might be expected since histone 
RNA is very stable in Xenopus oocytes. The possibility 
that a previously unidentified transcriptional enhancer 
was present in the histone gene fragment was eliminated by 
placing this fragment upstream of the albumin S' flanking 
DNA in GS1. This construct gave similar levels of 
transcripts to that produced by GS1 when microinjected 
into oocytes (data not shown).
Conclusions.
Despite the fact that the endogenous 6 8Kda albumin gene 
is inactive in oocytes, the cloned promoter is able to 
direct accurate and relatively efficient transcription 
when injected into oocytes. These results are in contrast 
to those reported for other homologous cell-type-specific 
genes such as the Xenopus cardiac actin genes (Mohun et
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al, 1986) and the Xenopus alpha and beta globin genes 
(Bendig and Williams, 1984), where transcription was found 
to be very inaccurate, with only a few percent of the 
transcripts initiating at the correct start site. However 
it should be noted that a recent report (Ualmsey and 
Patient, 1987) contradicts the previous data on the 
Xenopus ^-globin gene, suggesting that it functions 
efficiently and accurately when Injected into oocytes.
As mentioned previously, we had hoped to use oocytes as 
a system in which to assay factors that stimulate 
expression of the albumin gene. This has not been possible 
because of the high constitutive activity of the albumin 
promoter in oocytes. Presumably, the injected albumin 
promoter does not require additional factors for activity 
in oocytes. It is not clear why the injected, but not the 
endogenous albumin promoter is active, but it may reflect 
the fact that a large number of copies (about 1 0^) of the 
promoter are injected into each oocyte nucleus. This is 
therefore a very artificial situation. It is possible that 
the endogenous gene is under negative control by a 
negative transcription factor. In this case it could be 
that the negative element with which this factor interacts 
lies upstream or downstream of the albumin sequences in 
our constructs. Alternatively, the large number of 
injected genes could be in excess over the number of 
repressor molecules in the oocyte nucleus, leading to 
transcription of the unrepressed genes.
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Deletion of increasing amounts of the albumin upstream 
sequence within albone clearly has very little effect -upon 
either the accuracy or the efficiency of transcription in 
oocytes. Correct tissue-specific expression of genes, 
including albumin genes from other systems (Heard e£ al, 
1985, Gorski et al, 1986) and the Xenopus 6 8 Kda albumin 
gene (Schorpp et al, 1988b) requires upstream sequence, so 
it seems highly likely that the activity of the albumin 
promoter in oocytes requires only a subset of the 
sequences required for full activity in liver. The albumin 
construct A -50 contains only 50bp of upstream sequence and 
the only notable feature within this region is the TATA 
box. So it would seem that the TATA box alone is 
sufficient to direct accurate and efficient transcription 
in oocytes.
Similar results regarding the activity of the 6 8Kda 
albumin gene in oocytes have been reported by Schorpp £t^  
al (1988a).
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C H A P T E R  8 .
Analysis Of The 6 8Kda Albumin Gene Promoter By- 
Microin jection Into Xenopus Embryos. 
Introduction.
The microinjection of cloned genes into Xenopus embryos 
is a potentially powerful system for the study of gene 
regulation. It has a great advantage over i_n vitro studies 
in that the introduced gene is expressed inside a living 
organism and should therefore be subject to the normal 
control mechanisms. A number of cloned genes from both 
Xenopus and other organisms have been analysed by 
injection into Xenopus embryos. Busby and Reeder (1983) 
were able to demonstrate correct temporal activation of 
injected Xenopus rRNA genes. Brown and Schlissel (1985) 
showed competition between oocyte and somatic 5S rRNA 
genes injected into fertilised eggs. They found that there 
was considerably more transcription of the somatic 5S 
genes than the oocyte 5S genes, thus mimicking what is 
seen with the chromosomal genes.
A number of genes that are transcribed by RNA polymerase 
II have also been tested in Xenopus embryos. Bendig 
(1981) reported that when a sea urchin histone gene 
cluster was microinjected into Xenopus embryos, 4 out of
the 5 histone genes were faithfully transcribed at the
blastula stage . Curiously no H4 transcripts with the
correct 5'1 end were detected.
Rusconi and Schaffner (1981) reported that when the
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rabbit ^-globin gene was injected into embryos, 
transcripts with the correct 5' end and splicing of at 
least one intron could be found in both gastrulae and 
swimming tadpoles (stage 35). However, the injected genes 
were transcribed very inefficiently (given the large 
number of copies of the injected gene that were present). 
The tissue-specificity of transcription was not tested, 
but the fact that transcripts could be detected at the 
blastula stage suggests that the injected genes were not 
being correctly regulated.
When the Xenopus adult alpha and beta globin genes were 
injected into embryos (Bendig and Williams, 1983) it was 
found that they were transcribed at low levels, but from 
the correct promoters during early development. This is in 
contrast to the chromosomal genes which are not expressed 
until metamorphosis.
Andres et ¿1 (1984) failed to find correct developmental 
regulation of Xenopus vitellogenin gene constructs that 
had been injected into fertilised Xenopus eggs.
However there have been some encouraging reports of the 
correct regulation of polymerase II genes injected into 
embryos. Krieg and Melton (1985) found that the Xenopus 
gene GS17 showed correct temporal regulation, whilst 
Wilson et a_l (1986) demonstrated, for the first time, the 
correct temporal and spatial regulation of a tissue- 
specific gene injected into Xenopus embryos. They showed 
that transcription of a X.borealis cardiac actin gene was
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localized to the myotonies of tailbud stage embryos. 
Although the injected gene was transcribed at a low level 
at the mid-blastula transition (MBT), transcription 
increased sharply at the late gastrula stage when 
endogenous actin transcripts first appear.
Most if not all of the genes that have been tested in 
embryos appear to be activated to some degree at the MBT. 
Zygotic transcription is first activated at the MBT 
(Newport and Kirschner, 1982), so transcription of 
injected genes at this time may be a consequence of this 
general gene activation. Generally, between lOOpg and 2ng 
of DNA has been injected into each embryo. Quantities 
greater than 2ng have been found to be toxic.
There have been numerous reports of, and investigations 
into the replication and persistence of genes injected 
into Xenopus embryos. Bendig (1981) injected both linear 
and circular plasmids containing histone genes and found 
that both replicated during early development. Maximum 
replication (about 1 0 fold) was attained by the late 
blastula stage after which the exogenous DNA was rapidly 
degraded. Linear DNA persisted longer, with small amounts 
still detectable by stage 40. The physical form of the DNA 
altered following injection; linear DNA was ligated to 
form large concatemers soon after injection. Supercoiled 
DNA was initially partly converted to relaxed circles 
before being converted back to supercoiled circles by the 
blastula stage. The rabbit ^-globin gene was also
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replicated in Xenopus embryos (Rusconi and Schaffner, 
1981). The extent of replication varied between different 
batches of embryos but seemed to depend upon the amount of 
DNA injected. Replication did not depend upon whether the 
DNA contained a pBR322 replicón or an SV40 replicón. Small 
amounts of the injected plasmid were still detectable in 
the tissues of 6 month old frogs, but in an unintegrated 
form as head to tail multimers.
These observations have been extended to other DNA's by 
Bendig and Williams (1983) who found that the X.laevis 
adult alpha and beta globin genes (in the vectors Charon 
4A and pAT153 respectively) were replicated 50 to 100 fold 
by the gastrula stage.
Etkin and Pearman and their co-workers (Etkin ¿t al. 
1984; Etkin and Pearman, 1987; Etkin et £1, 1987) have 
carried out several investigations inko the replication, 
persistence and germ line transmission of exogenous DNAs 
injected into fertilised Xenopus eggs. They tested a total 
of ten DNAs, most of which were recombinant pBR322 
plasmids, and found that they replicated to different 
extents ranging from 2 fold to 300 fold. The extent of 
replication did not correlate with the size of the 
plasmid, and they proposed that replication could depend 
upon specific sequences (replication origins) within the 
plasmids. Etkin and Pearman (1984) reported that 
recombinant plasmids (containing a Drosophila alcohol 
dehydrogenase gene and a prokaryotic CAT gene) that had
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been injected into fertilised eggs, persisted in the
tissues of 60Z of the resulting adult frogs. However they
estimated that integration of the exogenous DNA into the
chromosomal DNA had occurred in only 5 to 10Z of those
frogs in which the DNA persisted. In the majority of
individuals the DNA persisted as high molecular weight
concatemers. Analysis of DNA from different tissues
fCMci'n «**1 fkr*fMohj 11**)
indicated a mosaic distribution of the exogenous DNA, so 
integration probably occurred at some time during the 
first cleavage stages, but not prior to the first 
division. Conclusive evidence of the integration of the 
exogenous DNA was provided by the demonstration of the 
transmission of the injected DNA to the offspring. 
Analysis of the generation indicated that the sperm 
from the original transformed animal contained the 
injected DNA integrated at different sites within the 
chromosomes. This is further evidence of the extreme 
mosaicism of the initial transformants. Therefore, in 
order to generate true transgenic Xenopus (in which every 
cell has the transgene integrated at the same site), it 
may be essential to utilize the Fj or even F2 generations.
In conclusion, Krieg and Melton (1985) and Wilson e_t al
(1986) have demonstrated correct expression of injected 
genes, but only at a relatively early stage of development 
(tailbud or earlier). At these early stages the majority 
of the injected DNA is extrachromosomal and it is likely 
that the transcription they detect originates from these
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extrachromosomal copies. As development proceeds the 
majority (if not all) of this extrachromosomal DNA is 
degraded, with only a small percentage of the resulting 
animals retaining some DNA integrated in the chromosomes. 
These transformed frogs are highly mosaic.
Despite the problems outlined above it was decided that 
I should try to investigate the regulation of the Xenopus 
6 8Kda albumin gene using this approach. This decision was 
made before the finding that the albumin genes are not 
expressed prior to metamorphosis. A set of albumin 
constructs (albone and its deletion derivatives) were 
already available so I decided to inject these into 
embryos. They were perhaps not the ideal constructs to use 
since we are unsure of the stability of transcripts with 
the histone 3' end in embryos. The transcript from albone 
is very stable in oocytes but may well be less stable in 
embryos.
8.1 Persistence of albumin constructs in Xenopus embryos. 
Results.
There is general agreement in the literature that linear 
DNA persists longer in Xenopus embryos. Therefore albone, 
¿L-950, A-670, At232 andZi-50 were linearised at the unique 
EcoRI site that lies in the M13 polylinker at the 3* end 
of the histone gene fragment. In initial experiments about 
lng of DNA was injected into each embryo, but this
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The persistence of albumin promoter constructs 
microinjected into fertilised Xenopus eggs.
X.laevis eggs were fertilised in vitro and injected at 
the 2 cell stage with RF DNA from either A -9 5 0 , A -6 7 0 , 
A “232, or A-50 that had been linearised by digestion with 
EcoRI. The amounts of DNA injected into each embryo are 
indicated in the figure. The injected embryos were allowed 
to develop and total nucleic acids prepared from pools of 
10 to 15 embryos at the gastrula stage (G.A.: stage 10 to 
12), and the hatching tadpole stage (T.B.:stage 42-43). One 
embryos worth of total nucleic acids were fractionated on 
agarose gels along with known quantities of EcoRI 
linearised RF DNA from the four albone 5' deletion 
constructs. The nucleic acids were transferred to 
nitrocellulose using the method of Southern (1975) and 
hybridised with a radiolabelled DNA probe prepared from 
non-recombinant M13mpl8. The filters were washed in 2*SSC 
at 60°C and then exposed to X-ray film for 40 hours. 
Markers were end-labelled fragments from a digest of lambda 
DNA with EcoRI and Hindlll.
Figure 22.
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appeared to be toxic, with few of the embryos gastrulating 
successfully. The linearised DNAs were therefore diluted 
and between 70 and 500pg injected inko each embryo. Total 
nucleic acids were prepared from pools of 10 to 15 embryos 
at the gastrula stage and at the hatching tadpole stage 
(stage 43). Some injected embryos were also sacrificed 
when they had reached stage 49/50.
One embryos worth of DNA was digested with EcoRl and 
electrophoresed on a 1Z agarose gel along with one embryos 
worth of undigested DNA. The gels were then Southern 
blotted and the filters hybridised to a prime cut probe 
prepared from non-recombinant M13. After hybridisation the 
filters were washed in 2*SSC at 60°C and the results are 
presented in figure 22. It is clear from these Southern 
blots that none of the DNAs injected had replicated by the 
gastrula stage. In fact, the opposite is true; by the 
gastrula stage less DNA remained than was injected. The 
amount of DNA remaining does not appear to depend upon the 
amount of DNA injected since embryos injected with 60pg of 
A-670 contained similar amounts of the DNA at the gastrula 
stage as those injected with 300pg of h-670.
In all cases the injected DNA was no longer in a linear 
form at the gastrula stage. In the tracks containing 
undigested DNA very little injected DNA was detectable. 
Upon digestion with EcoRl (the enzyme used to linearise 
all the plasmids prior to injection), a hybridising DNA 
fragment which co-migrates with the linear form of the
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injected DNA was generated. This indicates that by the 
gastrula the injected DNA had been ligated to form high 
molecular weight concatemers, which migrated with the high 
molecular weight Xenopus DNA, and therefore failed to 
transfer efficiently to the filter. When these concatemers 
were digested with EcoRI a single linear species was 
generated, indicating that the concatenated DNA had not 
been grossly rearranged. A small percentage of the DNA 
appeared to persist as linear molecules in gastrulae. By 
the time the embryos had developed to stage 42 very 
little, if any, of the injected DNA remained.
Conclusions.
None of the plasmids injected appeared to replicate, in 
contrast to what has been found for other DNAs. However, 
the injected, linear DNA was ligated to form large 
concatemers as has previously been observed by other 
workers. There are no reports in the literature of the 
injection of M13 constructs into Xenopus embryos, and it 
could be that these albumin constructs do not contain 
sequences necessary for replication. Very little if any 
exogenous DNA remained by stage 42, although the analysis 
shown in figure 22 would not be sensitive enough to detect 
a low copy number (less than 10 copies per cell). Given 
that initial transformants have been reported to be highly 
mosaic, this system is unsuitable for a rapid analysis of 
the regulation of the albumin gene. One would need to
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inject a large number of fertilised eggs, breed from the 
resulting frogs, and screen the offspring for the injected 
gene.
8.2 Analysis of transcription from the injected albumin 
constructs in early embryos and tadpoles.
Results.
The nucleic acid samples analysed in figure 22 and RNA 
prepared from a number of stage 49/50 tadpoles that had 
been injected with albone or one of its derivatives at the 
two cell stage, was analysed for transcripts from the 
injected constructs by primer extension with the albone 
primer.
No transcripts initiating at the correct start site were 
detectable in any of the samples analysed (data not 
shown). In some of the RNA samples prepared from gastrula 
and stage 42/43 embryos small amounts of a transcript 
initiating about 14 nucleotides downstream of the correct 
start site was detected. So it would appear that some 
inaccurate transcription from the injected albumin 
promoter occurred at a very low level in early stage 
embryos, long before the endogenous albumin genes become 
active.
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C H A P T E R  9
Neither The Rat Albumin Promoter Or The Rat g-Fibrlnogen 
Promoter Can Be Trans-Activated In Xenopus Oocytes By 
Pre-Injection With Liver Message.
Introduction.
Following our discovery that the Xenopus 6 8 Kda albumin 
promoter has high constitutive activity in Xenopus oocytes 
(Old et al, 1988) we decided to test some other liver- 
specific genes in this system. Two rat p-fibrinogen 
constructs in which the promoter is fused to the reporter 
gene CAT (Courtois £t £l, 1987), were tested. These two 
clones are designated B-S400 and B-120, where the numbers 
refer to the amount of ^-fibrinogen 5' flanking DNA 
upstream of the transcription start site. B-5400 had been 
reported to show correct liver-specific transcription 
whilst B-120 gave only a low level of expression when 
transfected into a liver cell line (Courtois et^  al, 1987).
We also tested a rat albumin promoter construct. This 
plasmid, designated pUMS&El contains the first lSlbp of 
the rat albumin promoter fused to the reporter gene CAT 
(Heard et al^ , 1987). This plasmid also contains the so- 
called upstream mouse sequence (UMS) that is a potent 
transcription terminator in eukaryotic cells (McGeady et 
al, 1986), inserted immediately upstream of the rat
albumin promoter. This was shown (Heard £t a_l, 1987) to 
reduce readthrough transcription from the vector. pUMSAEl 
was found to contain all the albumin promoter sequences
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Activity of the rat ^-fibrinogen and rat albumin 
promoters microinjected into Xenopus oocytes.
Pools of Xenopus oocytes were given cytoplasmic 
injections of about 20ng of either adult male X.laevis 
liver polyA+ RNA or rat liver polyA* RNA. These were 
incubated for 2 hours in 1*BX at 22°C, along with some un­
injected oocytes, after which various pools of oocytes were 
given nuclear injections of 4 to lOng of the appropriate 
supercoiled plasmid DNA. After incubating for a further 18 
hours in 1*BX at 22°C, "CAT extracts" were prepared from 
pools of 5 to 10 oocytes. Where sufficient numbers of 
oocytes had been injected, they were split into two pools 
which were homogenised and analysed separately in order to 
control for variation. One oocytes worth of extract was 
assayed for CAT activity as described in chapter 3.21. 
Acetylated chloramphenicol was detected by exposing the 
thin layer chromatography plate to X-ray film for 7 days. 
Abbreviations used: CAM and CM, chloramphenicol; Ac-CAM, 
acetylated chloramphenicol; CAT, chloramphenicol
acetyltransferase; Xen, Xenopus; 5400, B5400; 120, B120.
Figure 23.
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required for correct liver-specific expression as assessed 
by transient transfection into various cell lines (Heard 
et al, 1987).
All three of these plasmids could easily be tested in 
the oocyte system by assaying CAT activity.
Results.
Xenopus oocytes were injected as described in the legend 
to figure 23, and "CAT extracts" were prepared as 
described in Materials and Methods. One oocytes worth 
(50pl) of extract was then assayed for CAT activity 
exactly as described in Materials and Methods, and the 
results are presented in figure 23.
The rat albumin promoter (first 151bp upstream of the 
transcription start site) was completely inactive when 
injected alone into Xenopus oocytes (figure 23a). Pre­
injection of liver mRNA failed to activate the promoter.
The ^-fibrinogen construct B-120, but not B-5400, showed 
a low constitutive level of expression in oocytes (figure 
23b) This may be the result of readthrough transcription 
from the vector in B-120. In B-5400 this readthrough may 
be prevented by the large segment (5.4Kb) of B-fibrinogen 
upstream DNA that lies between the CAT gene and the
vector. Alternatively, sequences upstream of -120 may be 
required to prevent promiscuous activity of the
^-fibrinogen promoter in oocytes. Neither B-120 or B-5400 
were activated by pre-injection of liver mRNA.
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Conclusions.
Both the rat albumin promoter and the rat ^-fibrinogen 
promoters had very low or undetectable activity when 
injected into the nucleus of Xenopus oocytes. This is in 
complete contrast to the high constitutive activity of the 
Xenopus 6 8Kd albumin gene in oocytes. Maybe the difference 
in the behaviour of the rat and Xenopus albumin genes in 
oocytes is a reflection of the heterogeneous nature of the 
rat promoters.
The inability to activate the rat albumin and p -  
fibrinogen promoters in oocytes by pre-injection of liver 
mRNA would seem to suggest that this assay system is not 
generally applicable.
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C H A P T E R  10 
Xenopus laevis Has a c-erb-A Gene. 
Introduction.
The cellular homologues of the avian erythroblastosis 
(AEV) v-erb-A gene are known to encode high affinity 
receptors for thyroid hormone (Weinberger et al^ 1986, Sap 
et al, 1986). Cellular erb-A (c-erb-A) cDNA clones have 
been isolated from human, ratf mouse and chicken (see 
chapter 1) by homology to the v-erb-A gene or other c-erb- 
A genes. As a probe, we employed the 50Qpb Pst I fragment 
of the AEV v-erb-A gene. This fragment contains sequences 
homologous to the putative hormone binding domain (as 
defined by homology to the glucocorticoid receptor) and 
therefore should not cross-hybridise to other members of 
the steroid hormone receptor superfamily (within which the 
DNA binding domain is conserved).
Results.
lO^ jg of X. laevis genomic DNA was digested with EcoRI, 
Southern blotted, and then hybridised to the v-erb-A PstI 
fragment, and figure 24 shows the resulting
autoradiograph. The probe hybridised to a single EcoRI 
fragment of 5.1Kb. This indicates that X.laevis does have 
a c-erb-A gene. The fact that only a single fragment
hybridised to the probe indicates that X.laevis has one or 
at most 2 c-erb-A genes.
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Xenopus laevis has a c-erb-A gene.
lOjjg of X. laevis genomic DNA prepared from the blood of a 
single individual, was digested exhaustively with EcoRI and 
then fractionated on a 0.7X agarose gel. The DNA was then 
transferred to nitrocellulose by the method of Southern 
(1975), and hybridised to lOOng of the 500bp PstI fragment 
from the v-erb-A gene of avian erythroblastosis virus, that 
had been radiolabelled by nick translation. 
Prehybridisation and hybridisation was in 50Z formamide, 
6*SSC, 5* Denhardts, lOOjig/ml E.coli tRNA, 4mM sodium 
phosphate (pH6.5), 0.1X SDS at 37°C. After hybridisation 
the filter was washed in 1*SSC at 42°C and exposed to X-ray 
film for 12 days. Markers were end-labelled fragments from 
a digest of lambda DNA with EcoRI and Hindlll.
Figure 24.
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C H A P T E R  11
Isolation Of c-erb-A cDHA Clones From A X.laevis - 
Mature Oocyte cDNA Library.
Introduction.
A X.laevis mature oocyte cDNA library (in the 
provided, ky J~ 5huHieworH\ and. A. and
bacteriophage vector lambda ZAP) vasA screened with the 
v-erb-A probe. This library had been prepared from polyA4- 
RNA that had been extracted from X. laevis oocytes that 
were matured i_n vitro with progesterone. The layer of 
follicle cells which surrounds each oocyte had not been 
removed. The cDNA had been synthesised, and the library 
constructed, almost exactly as described in section 3.30. 
After packaging, the bacteriophage had been plated and 
amplified in BB4. The library contains 4*10^ independent 
clones (insert size 1 to 2.5Kb, 0.25Z blue plaques), and 
we received an aliquot of the amplified library with a 
titre of 0 . 6  to 1*1 0 1 0 pfu/ml.
Results.
A total of 2*10^ bacteriophage were screened with the 
nick translated PstI fragment of v-erb-A exactly as 
described in Materials and Methods (see the legend to 
figure 25 for hybridisation and washing conditions). After 
only a very short exposure (16 hours) a total of 13 
positives were identified. All 13 positives were picked 
and re-screened with the v-erb-A probe. 11 out of the 13
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An example of the fourth round screen of one positive 
cDNA clone from the X. laevis oocyte cDNA library with the 
v-erb-A probe.
Bacteriophage eluted from a single plaque that hybridised 
strongly to the 500bp PstI fragment from the v-erb-A gene 
on the 3rd round screen, were plated on BB4 at low density. 
Phage were transferred in replica to nitrocellulose filters 
as described in chapter 3.34. The filters were then 
prehybridised in 501 formaraide, 6*SSC, 5* Denhardts, 
lOOjig/ml E.coll tRNA, 4mM sodium phosphate (pH6.5), 0.1X 
SDS at 37°C. Hybridisation was in the same buffer 
containing approximately lOng/ml of the 500bp PstI fragment 
from the v-erb-A gene that had been radiolabelled by nick 
translation. After hybridisation, the filters were washed 
in 1*SSC at 42°C and exposed to X-ray film for 16 hours. In 
the resulting autoradiograph the two filters are above one 
another in the same orientation with respect to the plate 
from which the lifts were made.
Figure 25.

Results and Discussion
positives turned out to be true positives. This re­
screening procedure was repeated twice more after which 
virtually every plaque hybridised to the probe. An example 
of this final 4th round screen is shown in figure 25.
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C H A P T E R  12
Automatic Excision Of The Eleven Prospective c-erb-A 
Clones And Initial Restriction Enzyme Analysis.
Results.
The 11 prospective c-erb-A clones were converted to 
plasmid form using the automatic excision protocol 
described in Materials and Methods. For each X zA P  clone, 4 
single colonies were picked and used to prepare miniprep 
DNA which was then restricted with EcoRI and analysed on 
agarose gels. There is some evidence that gross
rearrangements of the insert DNA can sometimes occur 
during the excision process (Dr. J. Shuttleworth, pers. 
comm.), and this is why 4 clones were picked from each 
excision. However, in all cases the 4 clones picked gave 
identically sized fragments upon digestion with EcoRI, 
indicating that rearrangement was not a problem with these 
particular clones. Ten of the eleven positives all gave 
rise to two EcoRI insert fragments of 1.7Kb and 1.4Kb. 
These ten clones were assumed to be identical isolates of 
a single independent clone that had been over represented 
when the library was amplified. This clone was designated 
overbl. The remaining positive generated a single EcoRI 
fragment of 2.3Kb and this clone was designated overbl2.
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C H A P T E R  13
Detailed Restriction Enzyme Analysis Of 
Overbl And 0verbl2.
Introduction.
I had decided to sequence these clones by sub-cloning 
restriction enzyme fragments into M13 vectors. Before I 
began this I needed comprehensive restriction maps of both 
clones.
13.1 Restriction enzyme mapping of overbl by partial 
digestion of end-labelled DNA.
Results.
Initial restriction enzyme digests of overbl indicated 
that the insert contained one EcoRI site, 3 Hindlll sites, 
2 PstI sites, 4 Hindi sites and no sites for BamHI, 
Bglll. SacI. Smal, Xbal, Xhol, and Notl. I decided to map 
the sites for EcoRI, Hindlll, Hi n d i and PstI within 
overbl by doing partial digests of the insert DNA labelled 
at one end. I therefore needed to excise the whole insert 
using two polylinker enzymes such that one end could be 
preferentially labelled. Four candidate enzymes for this 
were Xhol. Xbal, BamHI and Notl. In the initial digests 
sites for these enzymes which lay close to the polylinker 
site would not have been detected. To be certain that 
there really were no sites for these enzymes within the 
insert, overbl was digested with these enzymes 'and the
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Restriction enzyme mapping of overbl by partial 
digestion.
Overbl DNA was digested with Xhol and then with BamHI and 
the products separated on a LMP agarose gel. The 3.4Kb 
fragment, that contains the complete cDNA insert, was 
isolated and end-labelled with the klenow fragment of DNA 
polymerase I in the presence of dGTP and no cold
nucleotides. Unincorporated label was removed on a sephadex 
G50 column, and the end-labelled DNA recovered by ethanol 
precipitation. Aliquots of approximately 1200cpm of this 
end-labelled insert DNA were mixed with 0.8^ jg of lambda 
cI857 DNA and digested with the appropriate number of units 
(u) of various restriction enzymes, as indicated above each 
lane. After 15 minutes at 37°C the reactions were 
terminated by adding EDTA (pH8 ) to a final concentration of 
20mM, and then fractionated on a 1.7X agarose gel. Labelled 
DNA fragments were detected by drying the gel and exposing 
it to X-ray film for 18 hours. Markers were end-labelled 
fragments from a digest of lambda DNA with EcoRI and 
Hindlll. or pBR322 with Hpall (lane 14).
Figure 26.
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ends labelled by end-filling with the Klenow fragment of 
DNA polymerase I in the presence of o<[32p] dGTP and* the 
appropriate cold nucleotides. After precipitating with 
ethanol to remove the majority of the unincorporated 
label, the products were separated on a 1Z agarose gel 
which was subsequently dried down and autoradiographed. In 
each case a labelled vector (-»-insert) band was visible, 
but no other bands were present indicating that these 
enzymes really do not cut in the insert.
For partial digest mapping, overbl DNA was digested with 
Xhol and then with BamHI, and the insert fragment was 
isolated and end-labelled with the klenow fragment of DNA 
polymerase I. Under the conditions used only the BamHI end 
was labelled. The number of units of each restriction 
enzyme required to get partial digestion was determined 
using 0.8^ jg of un-labelled lambda CI8S7 DNA. Partial 
digests of the end-labelled insert of overbl were then 
carried out as detailed in the legend to figure 26. Figure 
26 shows the results of two such partial digest mapping 
experiments. This data, together with further double and 
triple restriction digests, was used to construct the 
restriction map of overbl shown in figure 27. It should be 
noted that the partial digest mapping of overbl indicated 
the presence of six Hind i  sites. However, subsequent 
restriction mapping showed that there was only a single 
Hin d i site in the region between the 5' end of the insert 
and the 5' most Hindlll site.
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Restriction enzyme map of overbl showing the M13 sub­
clones and extent of sequencing.
The data from the partial restriction enzyme digests of 
overbl shown in figure 26, together with double and triple 
digests of un-labelled overbl DNA was used to construct the 
restriction map shown in this figure. It should be noted 
that the partial digests indicated the presence of six 
Hind i  sites. However, subsequent restriction enzyme 
mapping with un-labelled DNA (data not shown) showed that 
there could only be a single Hind i  site in the region 
between the 5' end of the insert and the 5' most Hindlll 
site. Also shown below the restriction map are the 
locations and identities of the 7 M13mpl8 sub-clones (ovl.l 
to ovl.8 ) derived from overbl. Each clone was constructed 
by isolating the appropriate restriction enzyme fragment 
from a LMP agarose gel and then ligating it into the 
appropriate M13mpl8 vector. The arrows above each sub-clone 
indicate the direction of sequencing from the universal M13 
primer. The numbers above each arrow refer to the total 
length of sequence (in nucleotides) obtained from that 
particular sub-clone. Where it is not clear exactly where a 
sub-clone begins or terminates the restriction site has 
been indicated. Abbreviations: He, Hind i ; Hd, Hindlll; Pt, 
PstI: Kp, Kpnl.
Figure 27.
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13.2 Restriction enzyme mapping of overb!2 indicates that 
it is closely related to overbl.
Results.
0 verbl2 was mapped by single and double digests, i.e. 
not by partial digestion. This gave rise to the map shown 
in figure 28, in which the maps of overbl2 and overbl have 
been aligned according to common restriction enzyme sites. 
Quite clearly the two clones are related. The restriction 
maps are identical (within acceptable margins of error) 
within a region spanning the right-most PstI site to the 
left-most Hindi site of overbl2. To the left hand side of 
this Hindi site in overbl2, overbl extends for an extra 
1.8Kb not present in overbl2. There are very few sites for 
the common restriction enzymes in this region of overbl.
1 3 . 3  L o c a l i s a t i o n  o f  t h e  l i g a n d  b i n d i n g  d o m a i n  w i t h i n  
o v e r b l  a n d  o v e r b ! 2 .
Results.
0 verbl2 and overbl were digested with various 
restriction enzymes, as indicated in figure 29, and the 
products separated on agarose gels. The DNA fragments were 
transferred to nitrocellulose using the procedure of 
Southern (1975). After baking, the filters were probed 
with the nick translated PstI fragment of v-erb-A, which 
by analogy to the glucocorticoid receptor, corresponds to 
the N-terrainal 131 amino acids of the ligand-binding 
domain and the C-terminal 34 amino acids of the spacer
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Alignment of the restriction maps of overbl and overbl2 
and a summary of the v-erb-A hybridisation data.
The restriction enzyme map of overbl2 was elucidated by 
single, double, and triple digests of unlabelled DNA (data 
not shown). Comparison with the restriction map of overbl 
indicated that the the two clones had a number of sites in 
common, and could be aligned as shown in this figure. Below 
each restriction map is a summary of the v-erb-A 
hybridisation data from figure 29. For each restriction 
enzyme digest the DNA fragments produced have been 
represented by double headed arrows. Those fragments which 
hybridised strongly to the PstI fragment from the v-erb-A 
gene are represented by the thick lines with large arrow 
heads. Fragments which hybridised only weakly to this probe 
are represented by the thin lines with small arrow heads, 
whilst fragments which did not hybridise to this probe are 
represented by the dashed lines with small arrow heads.
Figure 28.
Figure 28 
Alignm
ent of the restriction m
aps of overbl and overb12
Southern blot analysis of overbl and overbl2 with the 
SOObp PstI fragment from the v-erb-A gene.
Overbl or overbl2 DNA was digested to completion with 
various restriction enzymes as indicated above each lane. 
The products were fractionated on agarose gels and 
transferred to nitrocellulose using the procedure of 
Southern (1975). After baking, the filters were hybridised 
to the PstI fragment from the v-erb-A gene that had been 
radiolabelled by nick translation. Hybridisation and 
washing conditions were as described in the legend to 
figure 25, and five hour exposures of the filters are 
presented. Markers were end-labelled fragments from a 
digest of lambda DNA with EcoRI and Hindlll. The digest of 
overbl2 DNA with Hind i  and Kpnl gave rise to a partial 
product of about 0.7Kb that also hybridised weakly to the 
v-erb-A probe.
Figure 29.
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region (which separates the DNA and ligand-binding 
domains). Final wash conditions were 2*SSC at 42°C,-and 
the results are presented in figure 29. Clearly both 
clones hybridised strongly to the probe. The data has been 
summarised in figure 28, which shows those fragments which 
hybridised to the probe and those which did not. This 
helped to confirm that the two clones are closely related 
and can be aligned as shown in figure 28. From this data 
it can be concluded that the ligand binding domain is 
located to the right of the unique Kpnl site in overbl and 
overbl2 as the maps are drawn in figures 27 and 28.
-226-
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C H A P T E R  14
Partial Sequencing Of Overbl Indicates That This Clone 
Does Not Contain The Complete Coding Region, But 
0verbl2 probably Does.
Results.
Various restriction enzyme fragments from overbl were 
isolated from LMP agarose gels and sub-cloned in the 
appropriate M13mpl8 vectors. A total of 7 sub-clones, 
designated ovl.l to ovl.8 , were constructed and these are 
shown in figure 27. All seven clones were sequenced by 
standard N13 dideoxy sequencing, and the amount of 
sequence data obtained is indicated in figure 27. This 
sequence was translated in all three reading frames and in 
both orientations (using the "Microgenie" sequence analyis 
program), and compared to the predicted protein sequence 
of the chicken thyroid hormone receptor (Sap et al,, 1986). 
From this it soon became clear that the predicted protein 
sequence of overbl showed considerable homology to the 
chicken thyroid hormone receptor. By aligning the chicken 
sequence with the partial sequence of overbl I was able to 
identify the probable translation start site within overbl 
(data not shown). The translation start site appeared to 
be about 80 nucleotides downstream (to the right) of the 
Hindi site that lies at one end of the sub-clone ovl.3 
(see figure 27). By comparison to the chicken thyroid 
hormone receptor I was able to determine the orientation 
of the clone with respect to the 5' and 3' end of the tnRNA
-227-
Results and Discussion
and this is also indicated in figure 27. Fro« the sequence 
of clone ovl.l it was predicted (by comparison to - the 
chicken thyroid hormone receptor) that overbl did not 
contain all the coding region of the Xenopus ovary c-erb-A 
mRNA. The clone terminates some 40 to 50 amino acids short 
of the predicted 3' end of the coding region. If it is 
assumed that the Xenopus ovary thyroid hormone receptor is 
not significantly longer than the chicken receptor at its 
carboxy terminus then the other clone, overbl2 , should 
contain the complete coding region.
-228-
Figure 30.
The restriction enzyme map of overbl2 showing the M13 
sub-clones and the sequencing strategy.
The restriction enzyme map shown in this figure was 
derived directly from the complete nucleotide sequence of 
the overbl2 cDNA. The open box indicates the position of 
the long open reading frame. Also shown by the arrows are 
the directions of RNA synthesis from the T7 and T3 RNA 
polymerase promoters that lie on either side of the 
pBluescript polylinker. Shown beneath the restriction map 
are the 19 M13 sub-clones that were derived from overbl2 by 
cloning gel isolated restriction fragments into the 
appropriate M13 RF vector. In cases where it is unclear 
where a particular sub-clone begins or ends, the
restriction site has been shown at the end of the clone. 
Arrows above and below each sub-clone indicate the 
direction and extent of sequencing from the M13 universal 
primer. Where there are two arrows, the particular
restriction fragment was either cloned into both M13mpl8 
and M13mpl9, or into M13mpl8 in both orientations, thereby 
allowing sequencing from both ends of the restriction 
fragment. Where the name of the sub-clone contains "19" it 
indicates that the vector is M13mpl9, otherwise it is 
M13mpl8. Some extended M13 dideoxy sequencing was carried 
out on the sub-clones ovl219i, ovl2a, and ovl219a. The 
extent of this extended sequencing is indicated by the 
dotted arrows.
Kpnl 
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C H A P T E R  15
Complete Sequencing Of 0verbl2 Shows That This cDNA 
Clone Contains A Complete Long Open Reading Frame 
Encoding A Thyroid Hormone Receptor.
Results.
Various restriction enzyme fragments of overbl2 were 
isolated from LMP agarose gels and subcloned into the 
appropriate M13 vector (mpl8 or mpl9). A total of 19 sub- 
clones (11 different restriction fragments, some in both 
orientations) were generated and these are shown in figure 
30. The identities of all sub-clones was checked by 
restriction digests of miniprep DNA. These sub-clones were 
sequenced using M13 dideoxy sequencing as indicated in 
figure 30. In order to obtain the complete sequence of the 
3' untranslated region, and to confirm that there was only 
a single Hindi site in the 5' non-coding region (overbl 
has two) some extended M13 dideoxy sequencing was 
undertaken. This is indicated by the dashed arrows in 
figure 30. All restriction sites except for the central 
Hind i  site and the SacI site, were sequenced across to 
check that there were no extra sites that may have been 
missed in the restriction mapping. For approximately 50Z 
of overbl2, only one strand was sequenced because of the 
limited time available.
Where sequence data from different sub-clones 
overlapped, the sequences were compared using the 
"Microgenie" DNA sequence analysis package and any
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Figure 31.
The complete nucleotide sequence of overbl2 and the 
predicted amino acid sequence of the encoded protein 
(XenTR«).
Sequence data from the various M13 sub-clones shown in 
figure 30 was combined to generate the complete nucleotide 
sequence of overbl2. Examination of this sequence showed 
that it contained a long open reading frame encoding a 
protein of 418 amino acids. In addition to the ATG codon at 
nucleotide position 460 which is taken to be the 
translation start site, there are four other ATG codons 
upstream. The predicted protein sequence has been compared 
to that of the chicken thyroid hormone receptor (Sap et al, 
1986) and the amino acids which differ have been 
underlined. The Xenopus protein has ten amino acids in the 
amino terminal domain that are absent from the chicken 
thyroid hormone receptor, and these have been boxed. Also 
indicated on the sequence are the locations of the DNA- 
binding and ligand-binding domains which were determined by 
homology to other steroid and thyroid hormone receptors. 
The ligand-binding domain extends from the arrow to the c- 
terminus of the protein.
'he chickon Tt
Figure 31
Ammo ocidi <vh«h diHer from
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pCCAGATGAAAAAAG^TQGCCOGATQQGAAGCOAAAAAGAAAG 540
«DdMotAapGloAanLouooroir
LouAapcyaLouoorGluProAopGluLyaArgTrpProAopoiyLyaArgLyaArgLy«
Al aTbrGlyTyrHlaTyrArgCyel leTltrCyaCluGlyCyaLyaGlyPbaPbaArgArg
ThrlleClnLy»A«nLeuni«ProserTyrSorCyaLyaTyrAapGIycyaCy«Ileilo
SACAAGATCACCCCAAATCAOTOCCAiOCTCTOCCOCTTCAAQAAATOCArTOCCaTTOOC 040 
AspLys 11 eThr ArgAsoG 1 ncy eC 1 nLeuCy aArgPbe Ly • Ly eCy ■ Ile Al «Va lei y
ProSorSorciuGluTrpGluLoulloArgI1«ValThrGluAlaHl«ArqSorThrA«o
Ly*IleI1eThrProA1a11eThrArgValVelAapPbeA1aLya Lye LeuP roMe t phe
SarGluLeuTtirCyeGl uAapClnl lei leLeuLeuLyaGlyCyaCyaHetGluI laKet
TCTCTCCOTOCTOCTGTACOCTACQATCCAGACAOCGAGACCCTAACOCTGAGCOGAGAG 1320 
SarLouArgAlaAlaValArqTyrABpProAapaorGluThrLouThrLouOerClyGlu
2atAlayalLyoArpGl«»GlaL0uLyoAaoGlyGlyLeuGlyVaiyal*orAapAlaIla
CAOGCIOI 11 IGCTAATCTCATCAGACCGAAll'UGI ITAATCTQCACGGACAAGATAGAC 1500 GlnAlavalLeuLeuKetSerOerAapArgThrGlyLeuIlecyeThrAapLyallaClu
LvegveG^nGlurhSvrLouLouAlaPhoGlttHuryrlleAaimiaArgLyaHlaAan
ATTCCCCACTTCTGGCCCAAACTCCTAATGAAGGTGACOGACCTOCGCATGATAGOGGCA 1420 
IlaProMlaPheTrpfroLyoLeuLeuMetLyaWalThrAopLouArgMetllaGlyAla
TOCCATOCCAGCUA-l l'TCTOCACATGAAOCTCGAGTGCCCCACCGAGll H  1 l«-CACCG 1600 CyeHlaAlaOerArgPbeLeulUBHetLyavalGluCyeProThrGluLeuPheProPro
CTl'l'llCTTGAaGlVl1» rUAGGACCAGGAAGTTTGAGOGACAGTqCATGTCGCTAGAGAG 1740 
LeuPbeLeuG1uva1Phec1uAapGloG1uva1End
ACAATATAOGAAAATCCTGCTACAGCTAAAQGAACCTTTTATTGTGGTACACTCGGAAAT 1060
TTGGCCCCAAACCTGATACATTTATAGGTTGGAAGCTCAGTGGCACCACCTTAGGGCACA i960
CATTATGATACACCCAGGAATOCATGTTTATTCTAGCATATCTCTCCCCAACACCACCAA 2100 
AAGGCTCACTGCAAGATTACTTOOOCOGCTTTTAATTGACATCTTCAATATCGGGAGGGG 2160 
AACACATAATGACTGGCTTAAACTCT11'TGTACCCCATATGCAAATGATAGATAGATAGA 2 220TAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGATAGA 2200
PCACTTqCGAOQQOTOTAl
kTTATC 700
CCAAOCAOCGAOGAOTOOGAgrTGATTt kGTACCAAT 1020
rCACC 1140
AAGATAATCACC a n o w n C T W e e M O A iiflciooB eow w e 1200
TCTGAOCTGACTTOTGAAGACCAGATCATCCTOTTGAAAOOATOr bCATCATG 1260
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differences noted. The original sequencing gels were then 
re-examined and alterations made as appropriate, or- the 
sub-clone(s) re-sequenced if necessary. The DNA sequences 
of the different sub-clones were then merged using the 
"Microgenie" to generate the complete DNA sequence of 
overbl2 which is given in figure 31. This cDNA clone 
contains a long open reading frame which encodes a protein 
of 418 amino acids with high sequence identity to thyroid 
hormone receptors isolated from rat, human and chicken. 
The predicted protein sequence of this open reading frame 
is also shown below the DNA sequence in figure 31. A more 
detailed discussion of the primary sequence of this 
protein in respect to thyroid hormone receptors from other 
systems can be found in chapter 17.
230-
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C H A P T E R  16
Overbl Contains Two Un-related cDNA Inserts. One Of 
Which Is Probably A Shorter Version Of 0verbl2. 
Introduction.
In the rat, the primary transcripts from both thyroid 
hormone receptor genes are known to undergo differential 
splicing to generate a total of at least 6 mature mRNAs 
(see chapter 1.4.10, figure 8, and references therein). 
These transcripts encode six related thyroid hormone 
receptors which differ in either their amino or carboxyl 
termini. All these isoforms contain a DNA binding domain 
but some are unable to bind hormone. I have isolated two 
related thyroid hormone receptor cDNAs so this raised the 
possibility that they could be the products of 
differential splicing.
Discussion.
The partial sequence of overbl was compared to the 
complete sequence of overbl2 using the "Microgenie" DNA 
sequence analysis program. Downstream (to the right) of 
the Hind i  site which marks the start of sub-clone ovl.3 
(see figure 27), the available sequence of overbl is 
identical to the corresponding region of overbl2 except 
for a few isolated differences which are almost certainly 
due to sequencing errors. The sequence of ovl.4 from a 
position 2 nucleotides downstream of the EcoRl site to the 
end of the sequence matched exactly the corresponding
231
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sequence of overbl2. However, the remaining 97 nucleotides 
of ovl.4 upstream of and including this EcoRI site- did 
not resemble the corresponding region of overbl2. Thus the 
sequences of overbl2 and overbl diverge precisely at the 
internal EcoRI site in overbl. This site lies some 200bp 
upstream of the translation start site in overbl2 and 
overbl. The sequence of overbl upstream of this EcoRI site 
did not match any of the sequences in the Genbank data 
base. These findings are consistent with the proposal that 
overbl contains a double insert. During the construction 
of the library two EcoRI linkered cDNA molecules must have 
annealed together and ligated into the same A ZAP vector 
molecule. One of these cDNAs was a thyroid hormone 
receptor cDNA whilst the other was completely un-related.
-232-
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C H A P T E R  17
A Comparison Between The Sequence Of The Thyroid Hormone 
Receptor Encoded By 0verbl2 And Other Cloned 
Thyroid Hormone Receptors.
The long open reading frame (ORF) within overbl2 encodes 
a protein of 418 amino acids. Within this open reading 
frame the DNA sequence shows 80Z amino acid similarity to 
the protein coding region of the chicken thyroid hormone 
receptor (TR) cDNA isolated by Sap et^  a_l (1986). Note that 
in this comparison the region encoding the block of 
"extra" ten amino acids that are absent from the chicken 
TR (see below) were not included. At the protein level the 
homology is 92Z (also exluding the block of ten amino 
acids not present in the chicken TR). Clearly overbl2 does 
encode a thyroid hormone receptor and from now on it may 
be referred to as the Xenopus thyroid hormone receptor. A 
comparison between the predicted protein sequences of the 
Xenopus and chicken thyroid hormone receptors is shown in 
figure 31. It is interesting to note that that the Xenopus 
protein has an extra 10 amino acids not present in the 
chicken receptor (these amino acids have been boxed in 
figure 31). Also shown in figure 31 are the putative 
locations of the DNA binding domain and the hormone 
binding domain. These have been located by homology to the 
glucocorticoid receptor and other thyroid hormone 
receptors. The DNA binding domain is most well conserved
-233-
The Xenopus oocyte thyroid hormone receptor most closely 
resembles the rat thyroid hormone receptor type alpha 1.
Comparisons between the predicted amino acid sequences of 
the Xenopus oocyte thyroid hormone receptor (XenTR«*) and 
the rat thyroid hormone receptors (see figure 8) indicated 
that XenTR®^ most closely resembled the rat TR<X1 protein 
(Thompson et al, 1987). A schematic representation of these 
two proteins is shown. The open boxes represent the amino 
terminal (A/B) domains, the dot filled boxes represent the 
DNA binding domains, the black boxes represent the "spacer" 
regions, and the hatched boxes (both sizes of hatching) 
represent the hormone binding domains. The black boxes in 
the amino terminal domains indicate the locations of amino 
acids that are present in one protein but absent from the 
other. Also shown are the percentage amino acid homologies 
for each domain of the receptors.
Figure 32.
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The predicted amino acid sequence of XenTRe< and 
comparison to rat TRc(l.
The predicted amino acid sequence of XenTRM was compared 
to that of the rat thyroid hormone receptor type alpha 1 
(Thompson £t al, 1987). Amino acids which differ from the 
rat TR alpha 1 protein are shown in red. Also shown boxed 
in yellow is a block of 10 amino acids that are absent from 
the rat TR alpha 1 protein. The DNA-binding domain has been 
boxed in blue and the ligand-binding domain in red. The 
single letter amino acid code has been used; A, Ala; R,
Figure 33.
Arg; Asn; D, Asp; c, Cy.i Q, Gin; E, Glu; G, Gly; H
His; I. He; L. Leu; K, Ly.; N, Met; F, Phe; P, Pro; S
Ser; T, Thr; W, Trp; Y, Tyr; V, Val.
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between the two receptors, whilst the lowest level of 
homology lies in the amino terminal domain, which has been 
implicated in trans-activation of transcription.
The sequence of the Xenopus thyroid hormone receptor is 
also highly homologous to that of the human thyroid 
hormone receptor (data not shown).
As discussed in the introduction, the rat has at least 
six thyroid hormone receptor isoforms that are produced 
from two genes by alternate splicing (see figure 8). Only 
three of these isoforms actually bind hormone. When the 
predicted protein sequence of the Xenopus thyroid hormone 
receptor is compared to these rat isoforms it is clear 
that it most closely resembles the alpha 1 type, which is 
the only alpha type capable of binding hormone. All the 
other alpha types are considerably longer than the Xenopus 
receptor at the carboxy terminus. The beta types on the 
other hand are considerably longer than the Xenopus 
receptor at the amino terminus. Figure 32 shows schematic 
representations of the Xenopus receptor and the rat 
thyroid hormone receptor type alpha 1 (rTR<* 1), and a 
direct amino acid sequence comparison is shown in figure 
33. Clearly the two proteins are very closely related and 
I have therefore designated the Xenopus ovary thyroid 
hormone receptor an alpha type (XenTR«). The DNA binding 
domains of rat TRo( 1 and XenTRoC are 942 identical at the 
amino acid level. The amino terminal domains show only 642 
identity, including a block of 10 "extra" amino acids in
Figure 34.
Sequence comparison between the DNA-binding domains of 
the Xenopus thyroid hormone receptor and other members of 
the thyroid hormone/retinoic acid receptor family.
As discussed in chapter one, the thyroid hormone and 
retinoic acid receptors are closely related, and indeed can 
recognise the same response elements in DNA. It is 
therefore not surprising that their DNA-binding domains 
show significant sequence similarities. The predicted amino 
acid sequences of XenTR alpha, the chicken TR (Sap £t al, 
1986), the human TR alpha 2 (Nakai et al, 1988), the rat TR 
alpha 1 (Thompson et al, 1987) and the human retinoic acid 
receptor alpha (see Benbrook and Pfahl, 1988) have been 
aligned in this figure. Common amino acid residues have
been boxed. The single letter amino acid code is used; A;
Ala; », Arg ; N, Asn; D, Asp; C, Cys; Q, Gin; E, Glu; G
Gly; H, His ; I, Ile; L, Leu; K, Lys; M, Met; F. Phe; P
Pro; s, Ser; T, Thr; W, Trp; Y,► Tyr; V, Val.
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Results and Discussion
the Xenopus protein that are absent from the rat TR®<1 
protein. These are the same 10 amino acids that -are 
''missing” from the chicken thyroid hormone receptor (see 
figure 31). In addition, the rat protein has 2 amino acids 
that are absent from the amino terminal domain of the 
Xenopus protein. Together this accounts for the fact that 
the Xenopus protein is 8 amino acids longer than rTROtl. 
The hormone binding domain of XenTR°( can be split into 
two sections on the basis of homology to rTROf1. The first 
164 amino acids are 89Z identical in the two proteins, 
whilst the C-terminal 57 amino acids are 100X identical 
(figure 33). The spacer region that separates the DNA and 
hormone binding domains also shows a high degree of amino 
acid identity (87Z).
On the basis of overall sequence homology the steroid 
hormone receptor superfamily has been divided into sub* 
groups (see Green and Chambon, 1988 and figure 3). The 
estrogen receptor, vitamin D3 receptor, retinoic acid 
receptors and thyroid hormone receptors form one of these 
sub-families. Figure 34 shows a comparison between the 
amino acid sequences of the DNA binding domains of some 
members of this sub-family. The DNA binding domain has 
been very highly conserved among all the members of the 
thyroid hormone receptor family with two large blocks of 
amino acids being almost absolutely conserved. In fact the 
DNA binding region cf the Xenopus thyroid hormone receptor 
is the least conserved among the thyroid hormone receptors
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The hypothetical structure of the Xenopus thyroid hormone 
receptor's DNA-binding region.
As discussed in chapter 1.4.4, the DNA-binding domains of 
steroid and thyroid hormone receptors are believed to form 
two finger-like structures, each coordinated by a zinc ion. 
The hypothetical structure of the DNA-binding domain of 
XenTRof has been drawn by analogy with the zinc fingers of 
other steroid hormone receptors. Amino acids which differ 
from the consensus for thyroid hormone receptors (see 
figure 34) are drawn in italics and boxed. Also shown are 
the locations of the "discriminatory" amino acids whose 
identities (by analogy with the ER and GR) are probably 
important for determining target gene specificity (see 
chapter 1.4.13).
Figure 35.
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shown here. The retinoic acid receptor is less well 
conserved but still shows significant homology.
It has been proposed that the DNA binding domain forms a 
zinc finger like structure (Evans, 1988; Evans and 
Hollenberg, 1988; Freedman et al, 1988). Two zinc fingers 
would be formed by the tetrahedral coordination of two 
zinc molecules. The hypothetical zinc finger structure of 
the DNA binding domain of XenTRc* is shown schematically in 
figure 35. Both fingers are formed by the coordination of 
a zinc atom by four cysteine residues. It has been 
proposed that the fingers lie between the major groove of 
the DNA double helix (Miller et ml, 1985). Specific amino 
acids then make contact with specific bases in the core of 
the helix thus providing the sequence specificity of the 
interaction. As expected, the three "discriminatory" amino 
acids identified as being important for determining target 
gene specificity (Mader e_t al, 1989; Danielsen et al, 
1989; Umesono and Evans, 1989) are the same in the Xenopus 
thyroid hormone receptor and thyroid hormone receptors 
isolated from other species.
-236-
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C H A P T E R  18
The Xenopus Thyroid Hormone Receptor cDNA 
Translates Very Inefficiently In Vitro.
Results.
To confirm the presence of a long open reading frame 
within the XenTRo< cDNA it was decided to attempt to 
translate the cDNA in vitro. To do this the complete cDNA 
was transcribed in vitro from either the T7 or T3 RNA
polymerase promoters that flank the polylinker in 
pBluescript SK' (see the legend to figure 36 for details). 
Aliquots of the RNA were then translated in wheat germ 
extract in the presence of [^S] methionine. The products 
were electrophoresed on a denaturing SDS polyacrylamide 
gel which was subsequently dried down and
autoradiographed. Figure 36 shows a 10 day exposure of one 
such gel. Clearly the sense transcript but not the
antisense transcript has given rise to a number of
proteins, the largest of which is about 49Kd in size. The 
sequence of XenTR®< predicted that this cDNA encoded a 
protein of 418 amino acids. Given that the average 
molecular weight of an amino acid residue is 120, then 
this protein would be expected to have a molecular weight 
of 50Kd. This corresponds well to the size of the largest 
protein produced by translation of sense overbl2 RNA in 
vitro. The smaller proteins, below the largest band, must
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Translation of synthetic RNA prepared from overbl2 in 
wheat germ extract.
To synthesise sense RNA, overbl2 DNA was first linearised 
with BamHI and then transcribed in vitro with T7 RNA 
polymerase (see figure 30). Antisense RNA was synthesised 
by transcribing Xhol linearised overbl2 DNA in vitro with 
T3 RNA polymerase. After the transcription reaction the RNA 
was recovered by ethanol precipitation and resuspended in 
water. Approximately 0.5^ ig of synthetic RNA and 0.5^ jg of 
natural ^J-globin mRNA, and a mixture of the two were then 
translated in wheat germ extract (chapter 3.36.2). As an 
additional control, one translation reaction was carried 
out without added RNA. After translation, an equal volume 
of sample buffer was added to each reaction, and the 
samples heated at 100°C for 3 minutes. The samples were 
then fractionated on a 18X polyacrylamide/SDS gel which was 
subsequently dried down, and labelled proteins were 
detected by autoradiography for ten days. The markers were 
a commercial mixture of ^5$ labelled proteins of known 
molecular weight.
Figure 36.

Figure 37
There is a correlation between the sizes of the 
truncated proteins produced by translation of 
XenTR alpha Inv/tro and the positions of internal 
methionine codons.
Position* of
internal
methionines.
Distance from 
internal methionine 
to the end of the 
XenTR alpha protein.
Predicted size 
(Kda) of the 
resultant 
protein (•).
Size of truncated 
proteins produced 
in vitro (Kda). Taken 
from figure 36.
(D (4 18) (50) (49)
32 386 46 .3 } -----46
37 381 45.7 >
128 290 34.8 ?
130 288 34.5 >
158 260 31.2 32
209 209 25.1 }
212 206 24.7 5
246 172 20.6 20
267 151 18.1 18
288 130 15.6 15
333 85 10.2
377 41 4.9
384 34 4.1
396 22 2.6 I
• Assum ing that the average molecular weight of an 
amino acid Is 120
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be truncated versions of the full length XenTRo( protein. 
The origin of these forms remains uncertain. They may have 
resulted from the action of proteases present in the wheat 
germ extract. Another more intriguing possibility is that 
they resulted from initiation by ribosomes at internal 
methionines within the long ORF (this is discussed in more 
detail later). Synthetic RNA prepared from the chicken 
thyroid hormone receptor cDNA gives rise to seven proteins 
when translated ^n vitro (Bigler and Eisenman, 1988). 
Antibody and kinetic studies suggested that these multiple 
proteins were produced by initiations at sites within the 
RNA, generating a set of nested proteins (Bigler and 
Eisenman, 1988). These workers also reported that a sub­
set of the truncated proteins seen in vitro also exist in 
vivo, in chicken red blood cells. Their data is consistent 
with, but not proof of irwtiation at internal methionine 
codons iji vivo.
Figure 37 demonstrates that the positions of internal 
methionines within XenTRo< are also consistent with the 
idea that the truncated proteins seen in figure 36 are the 
result of internal initiations.
The wheat germ extract programmed with natural beta- 
globin mRNA has given rise to an intense band of 
approximately 12Kda in size, which represents beta-globin 
protein. By comparison to this, overbl2 sense RNA has 
clearly been translated very inefficiently in the wheat 
germ extract. This basic experiment was repeated a number
-238
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of times using different extracts and new batches of 
synthetic RNA in an attempt to get better translationbut 
without success. The RNA was also translated very poorly, 
if at all in rabbit reticulocyte lysate (for example see 
figure 39). Similar results regarding the inefficient 
translation of synthetic RNA prepared from thyroid hormone 
receptor cDNAs vitro have been reported for the chicken 
receptor (Sap et al, 1986), the rat TR<* 1 (Murray et al, 
1988) and the human ear-7 thyroid hormone receptor 
(Benbrook and Pfahl, 1987). In all these cases (and in 
fact in all the thyroid hormone receptor cDNA clones for 
which sequence is available) there are several ATG codons 
upstream of the long open reading frame. In some cases 
these ATG codons mark the start of short ORFs (terminated 
by in frame stop codons). In order to obtain efficient 
translation of RNA prepared from these cDNA clones in 
vitro, these workers removed part or all of the 5' 
untranslated region, thus removing some or all of these 
ATG codons. For a number of other thyroid hormone receptor 
cDNA clones (Rat TRcx 1 and Rat TR©<2; Izumo and Mahdavi, 
1988; Rat TRJJ 1; Koenig et al^ , 1988), the 5' untranslated 
region was removed before translation but it was not 
stated that this was done to increase translation. In 
contrast to these findings, Thompson e£ £l (1987) reported 
that removal of two of the three upstream ORFs from the 
rat TRO^l cDNA did not increase the efficiency of 
translation. This is in direct contrast to the results of
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Figure 38
The DNA sequence of the XenTR©< cDNA clone upstream of the 
long open reading frame showing the ATG codons and the 
conserved upstream open reading frame.
The nucleotide sequence of XenTRO< (overbl2) from 
nucleotide 330 to 468 is shown, and all the ATG and TGA 
codons have been italicized and underlined. The long open 
reading frame which encodes the 418 amino acid XenTRoi 
protein begins at the ATG codon at position 460. The short 
upstream open reading frame that directly precedes the long 
open reading frame is conserved between a number of thyroid 
hormone receptor cDNA clones from different species as 
illustrated. It should be noted that the rat TRJJ (Murray ¿t 
alt 1988), the human TR (Weinberger et al, 1986), and the 
rat TR^ J 1 (Koenig £t a_l, 1988) do not contain this 
conserved upstream open reading frame. The relevant 
sequence data for the other four thyroid hormone receptor 
cDNA clones that have been isolated is not available.
Figure 38
The DNA sequence of the XenTR a cDNA clone upstream 
of the long open reading frame showing the ATG codons 
and the conserved upstream open reading frame (ORF).
330 GTGGGCArgGTCGACCTGrCilGAOGCGTCCGCCGCCTCOfrCrCAACGC'BSO
381 ACGCCCCATG ATCCT CGGGGAGCT GGGGGCGGAGCCCGCCTT GGT CT CTT 430
4 3 1  CGGATTGGTTCTGGAT'CGAATTACGT TGAATG  GAC CAG 
i A *p Gin
c o n s e rv e d  
( s e e  below)
Long opon 
reading frame.
■  marks the nucleotide which was altered from A to C 
by site directed mutagenesis to create an EcoRI site, 
therby allowing removal of all the upstream ATG codons.
Conservation of the short upstream 
open reading frame.
Chicken TR ATG GAA TTG C G Q G A  ATG
(Sap ¿t a], 1986) Met Glu Leu Arg MET
Long
ORF
Rat TR a lp h a -1 
(N a k a i¿ t£ j, 1988)
Huma TR alpha 2 
(Thompson e^t a), 1987)
ATG GAA TTG 
Met Glu Leu
ATG GAA TTG 
Met Glu Leu
A A Q G A  ATG 
Lys MET
aaIg U ga  ATG
Lys MET
ATG GAA TTA C 0  TGA ATG 
M«t Glu L«u  Arg MET
Xenopus TR alpha
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Murray et al^  (1988) who independently isolated an 
apparently identical rat TR<* 1 cDNA, and found that it-was 
necessary to remove these same two upstream ORFs in order 
to get efficient translation in vitro.
The Xenopus thyroid hormone receptor cDNA clone also has 
a number of upstream ATG codons (see figure 38). There are 
in fact 4 in total and all of them are in frame with the 
long ORF. One of these upstream ATG codons is followed 
immediately by a stop codon, whilst the other three mark 
the beginning of short ORFs. Two of these ORFs are very 
short, containing just 4 codons. The other one would 
encode a protein of 23 amino acids, terminating 
immediately before the start of the long ORF. Thus, the 5' 
untranslated region of the Xenopus thyroid hormone 
receptor cDNA resembles those of thyroid hormone receptor 
cDNAs from other systems in this respect. However, the 
actual DNA sequence of these 5' untranslated regions show 
no significant homology, except for a stretch of 15 
nucleotides immediately prior to the start of the long ORF 
(see later discussion).
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C H A P T E R  19.
The Xenopus Thyroid Hormone Receptor cDNA is Efficiently 
Translated In Vitro When All The 5* Untranslated 
Sequence Has Been Removed.
Results.
In an attempt to increase the translational efficiency 
of synthetic RNA prepared from the XenTRo< cDNA, all of the 
upstream ATG codons were removed. This work was carried 
out in collaboration with G. Sweeney. The EcoRI insert of 
overbl2 was sub-cloned into M13mpl8 and then site directed 
mutagenesis was used to create an EcoRI site 9 nucleotides 
upstream of the start of the long ORF (see figure 38). 
This plasmid was then digested with EcoRI to release a 
fragment containing the complete long ORF, all the 3'
untranslated region but only 9 base pairs of the 5'
untranslated region, thereby removing all the upstream ATG
codons. This fragment was sub-cloned into pBluescript KS 
and the resulting plasmid designated pBlueXenTR^HE. This 
plasmid was used to synthesise both sense and antisense 
RNA which was translated in rabbit reticulocyte lysate and 
the resulting labelled proteins analysed on a denaturing 
polyacrylamide gel. A 4 day exposure of the gel is
presented in figure 39. The RNA containing the complete 5' 
leader did not give rise to detectable amounts of protein, 
whereas the RNA from which the leader had been removed 
gave rise to a single strong band which represents the
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Figure 39.
Removal of the 5' untranslated leader significantly 
increases translation of XenTR* iti vitro.
Synthetic RNA containing the full length 5' untranslated 
leader was prepared by transcribing BamHl linearised 
overbl2 DNA in vitro with T7 RNA polymerase. To remove the 
S' untranslated leader, including all four upstream ATG 
codons, the EcoRI insert of overbl2 was cloned into M13mpl8 
and site directed mutagenesis was used to create an EcoRI 
site centred at 9 nucleotides upstream of the start of the 
long open reading frame (see figure 38). Digestion of the 
resulting RF DNA with EcoRI liberated a fragment containing 
the complete long open reading frame, all the 3' 
untranslated sequence, but only 6 nucleotides of the
original 5' leader. This fragment was sub-cloned into the 
EcoRI site of pBluescript KS to generate pBlueXenTRciHE. To 
generate sense RNA from this plasmid it was linearised with 
BamHl and transcribed in vitro with T3 RNA polymerase. RNA 
was recovered by ethanol precipitation and approximately 
lpg of both the full length and the shortened RNA were
translated in nuclease treated rabbit reticulocyte lysate. 
A control translation was carried out with no added RNA. 
Each of the samples were fractionated on an 18Z
polyacrylamide/SDS gel which was then dried down, and
labelled proteins detected by autoradiography for 4 days. 
The arrow indicates the position of full length XenTR°( 
protein.
Figure 39
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full length XenTRO< protein (indicated by the arrow in 
figure 39). This experiment shows that removal of all*but 
9 nucleotides of the 5' untranslated region increases 
translation of the long ORF by several orders of 
magnitude. The ladder of smaller proteins that were 
produced when the RNA containing the complete 5' leader 
was translated in wheat germ extract (figure 36), were not 
observed in this experiment. This may simply reflect the 
fact that this is a shorter exposure than the 
autoradiograph shown in figure 36. However, the removal of 
the 5' untranslated region has clearly increased 
translation from what is now the first ATG codon but has 
not le d to an equivalent increase in the synthesis of the 
truncated proteins.
Interestingly, removal of the most 5' of the 4 ATG 
codons by restriction at the Hind i  site did not increase 
translation in vitro (data not shown).
A similar stimulation of translational efficiency 
accompanying the deletion of the 5' untranslated region 
has been observed for translation of these synthetic RNAs 
when injected into oocytes (R. W. Old and G. Sweeney, 
pers. comm.). Assuming that the XenTR<* cDNA is a copy of 
the mature mRNA molecule (and not a copy of a partially 
spliced RNA; see later discussion) this mRNA would appear 
to be a very poor template for translation, iji vivo as 
well as iji vitro.
The scanning model has been proposed to explain
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translation initiation in eukaryotes. This model states 
that a 40s ribosomal subunit (plus associated factors) 
initially binds at the 5' end of the mRNA and then 
migrates along the mRNA until it finds the first AUG codon 
in a favourable context for initiating translation. The 
"first AUG" rule holds true for 90 to 95Z of the many 
hundreds of mRNA sequences that have been analysed (see 
Kozak, 1989). Not all AUG codons at the 5' ends of mRNAs 
are efficient translation initiation sites. The identity 
of nucleotides surrounding the AUG codon has a strong 
influence upon the ability of the 40s subunit to initiate 
translation at this site (see the review by Kozak, 1989). 
A recent survey of 699 vertebrate mRNAs (Kozak, 1987) 
produced a consensus sequence for translation initiation; 
GCCGCCa /gCCAUGG. The importance of the G at +4 (numbering 
begins with the A of the AUG codon as position +1; 
nucleotides 5' to that site are assigned negative numbers) 
and the purine (A or G) at position -3 has been confirmed 
by naturally occurring mutations and by site directed 
mutagenesis. The purine (usually A) at position -3 is the 
most well conserved in eukaryotic mRNAs. Alterations of 
this residue have a more profound effect upon translation 
efficiency than mutations in any other position of the 
consensus sequence. As long as there is a purine at 
position -3 deviations from the rest of the consensus 
sequence will only marginally impair initiation. However, 
in the absence of a purine at position -3, a G at +4 is
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essential for efficient translation.
There are a number of viral and cellular mRNAs in which 
translation initiation is not limited to the first AUG 
codon. Kozak (1989) has concluded that initiation at 
downstream AUG codons (as appears to occur with synthetic 
RNA prepared from some thyroid hormone receptor cDNA 
clones i_n vitro, and possibly in vivo (Bigler and 
Eisenman, 1988) can occur only under three specific 
conditions. The first condition is when the first AUG
codon is less than 10 nucleotides from the 5' end of the 
mRNA, which does not apply to any of the thyroid hormone 
receptor cDNA clones. The second condition is when the
upstream AUG codon(s) lie in an unfavourable context in
which case "leaky scanning" will enable some ribosomes to 
reach the downstream AUG codon and initiate translation. 
Obviously, with more than one upstream AUG codon the
number of ribosomes reaching the "authentic" AUG codon is 
reduced. In the case of XenTRctf, the first AUG codon is in 
a favourable context for initiation, having a G at -3 and 
a G at +4 (see figure 38). The second upstream AUG codon 
is in a very unfavourable context having a T at -3 and a T 
at +4. Similarly, the third upstream AUG codon is in a 
very unfavourable context and would not be expected to be 
an efficient translation initiation site. The fourth 
upstream AUG codon, however is in a favourable context for 
initiation. The actual AUG codon that starts the long ORF 
is also in a favourable context, having the required G at
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+4, although it does not have a purine at -3. The third 
situation which allows initiation at downstream AUG codons 
is when the upstream AUG codons are followed by in frame 
stop codons. Even when the AUG codons are in a favourable 
context, precluding leaky scanning, ribosomes are able to 
translate these invariably short ORFs and then apparently 
resume scanning and re-initiate farther downstream. 
Because re-initiation is usually inefficient the presence 
of short upstream ORFs will usually reduce translation. 
This is probably how ribosomes negotiate the first, 
favourable upstream AUG codon in XenTRe*. They would then 
have to pass two further AUG codons in unfavourable 
contexts, partly by leaky scanning and partly by 
translating the two short ORFs (1 and 23 amino acids) and 
then re-initiating at the downstream ("authentic”) AUG. 
The fourth (favourable) upstream AUG codon lies within the 
23 amino acid short ORF.
Kozak (1989) notes that there are a number of cases in 
which upstream AUG codons identified in cDNA clones 
actually reside in an intron. The cDNA corresponds to a 
partially processed transcript in which this 5' intron had 
not been removed. This would not be present in the mature 
mRNA and would therefore not effect translation. There are 
in fact examples of Drosophila transcripts in which the 
excision of a 5' intron is developmentally regulated. This 
intron contains AUG codons which prevent efficient 
translation. Following the splicing out of this intron
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translation is activated (Bingham ejt al, 1988).
The DNA sequence of the 5' untranslated region- is 
available for seven of the eleven thyroid hormone receptor 
cDNA clones that have been isolated so far. A short ORF of 
4 amino acids immediately upstream of the long ORF is 
conserved in four out of these seven cDNA clones, 
including the Xenopus cDNA clone (figure 38). The first 
three amino acids of this ORF are absolutely conserved, 
with only one nucleotide difference in the Xenopus 
sequence occurring at the third (redundant) position of 
the codon for leucine. The fourth amino acid is less well 
conserved among the 4 cDNA clones. In the Xenopus and 
chicken receptors it is arginine with one nucleotide 
difference at the third position of the codon. The human 
receptor and the rat TRO< 1 clones have a lysine codon at 
this position. In all four cDNA clones this short upstream 
open reading frame terminates with a TGA stop codon 
immediately prior to the ATG codon which marks the start 
of the long open reading frame which is presumed to encode 
the functional receptor protein. The strong amino acid 
conservation of this short open reading frame suggests 
that it is important. One possibility is that these four 
amino acids form part of the receptor protein itself. This 
could be accomplished by the removal of the TGA stop codon 
that terminates this short ORF in an RNA processing event. 
Comparison of 5' and 3' splice sites has shown that 
introns generally begin with the sequence GT and end with
Results and Discussion
the sequence AG. Indeed, all four cDNA clones have the 
sequence GT (shown boxed in figure 38) just 5' of the- TGA 
stop codon. The 3' splice site would be somewhere within 
the long ORF, presumably quite close to the 5' end. 
Translation would thus begin at the most 3' of the four 
upstream ATG codons within the XenTRo< cDNA clone, and this 
codon is in a favourable context for initiation.
Kozak (1989) concludes that upstream AUG codons in 
eukaryotic mRNAs are not as common as the literature might 
suggest, and that where they do genuinely occur they are a 
clue to expect some sort of regulation such as promoter 
switching or regulated splicing. This certainly holds true 
for the rat and human thyroid hormone receptors.
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C H A P T E R  20
Xenopus laevis Has A Small Number Of Genes Related To- 
The DNA Binding Domain Of XenTRQf.
Introduction.
I had already shown that JU laevis has one or possibly 
two genes homologous to the v-erb-A gene of avian 
erythroblastosis virus (chapter 10). Having isolated a X. 
laevis thyroid hormone receptor cDNA I wanted to use this 
clone to probe a Southern blot of JU laevis genomic DNA 
partly to confirm the result with the v-erb-A probe. As 
mentioned in the introduction, the DNA binding domains of 
the various thyroid hormone receptors show homology to the 
DNA binding domains of other members of the steroid 
hormone receptor superfamily. The degree of homology is 
highest with the retinoic acid receptors. It would 
therefore be interesting to use a fragment from the DNA 
binding domain of XenTR* as a probe at low stringency to 
see if the JU laevis genome contains such related genes.
Results.
lOpg aliquots of X^ laevis genomic DNA (prepared from a 
single individual) that had been digested with various 
restriction enzymes as indicated in figure 40, were 
fractionated on an agarose gel and Southern blotted. After 
blotting, the filter was cut in half to generate two 
identical filters, one of which was hybridised with a 
probe specific for the ligand binding domain of XenTRot
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Figure 40.
Southern blots of X.laevis genomic DNA hybridised with 
probes from both the DNA-binding and ligand-binding domains 
of XenTR*.
20pg aliquots of X.laevis genomic DNA prepared from the 
blood of a single individual was digested exhaustively with 
the 5 restriction enzymes indicated. After digestion, the 
DNA was recovered by ethanol precipitation and split into 
two lO^ Jg aliquots, each of which was fractionated on a IX 
agarose gel and then transferred to nitrocellulose 
according to Southern (1975). The filter was cut into two 
identical halves, baked, and prehybridised in 6*SSC, 50Z 
formamide, 5* Denhardts, lOOpg/ml E.coli tRNA, 50^g/ml 
denatured, sonicated herring testis DNA, 0.1Z SDS at 42°C. 
Hybridisation was in the same buffer containing one of two 
radiolabelled single stranded DNA probes prepared using the 
prime cut protocol. One filter was hybridised to a probe 
prepared from the M13 sub-clone of overbl2 called ovl219d 
(see figure 30) and is refered to as the DNA-binding domain 
(DBD) probe. The second filter was hybridised to a probe 
prepared from the M13 sub-clone of overbl2 called ovl219J 
(see figure 30), and is refered to as the ligand-binding 
domain (LBD) probe. The filter hybridised with the DBD 
probe was washed in 2*SSC at 55°C (non-stringent wash). The 
filter hybridised with the LBD probe was washed in 0.1*SSC 
at 65°C (stringent wash), and both filters were exposed to 
X-ray film for 3 weeks. Markers were end-labelled fragments 
from a digest of lambda DNA with EcoRI and Hindlll.
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(LBD probe). The other, identical, filter was hybridised 
with a probe that contained almost all of the DNA binding 
domain, all of the "spacer" region and part of the ligand 
binding domain. The ligand binding domain-specific (LBD) 
probe was prepared from the M13 sub-clone of overbl2 
designated ovl219J (see figure 30) using the prime cut 
protocol. The DNA binding domain (DBD) probe was prepared 
using the same method from the M13 sub-clone of overbl2 
designated ovl219d. The filter that had been hybridised 
with the LBD probe was washed at high stringency, whilst 
the filter that had been hybridised with the DBD was 
washed at moderate stringency, in order to detect related 
sequences. The resulting autoradiographs are presented in 
figure 40.
In the EcoRI digest the LBD probe hybridised to a single 
fragment of about 5Kb, which is the same size as the EcoRI 
fragment detected by the v-erb-A probe (see figure 24). 
The DBD probe hybridised to four EcoRI fragments (the band 
at approximately 5Kb is a doublet) one of which is the 5Kb 
fragment detected by the LBD probe.
The LBD probe hybridised to two Hindlll fragments of 
4.3Kb and 1.8Kb. The DBD probe hybridised weakly to the 
4.3Kb fragment, but did not hybridise to the 1.8Kb 
fragment. In addition, the DBD probe detected a Hindlll 
fragment of 4.9kb and one of about 10-15Kb.
In the BamHI digests a single fragment of about 14-18Kb 
hybridised to the LBD probe. This same fragment also
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hybridised with the DBD probe, but an additional fragment 
of 8-10Kb was also detected by this probe.
In the PstI digests the LBD probe detected 3 fragments 
and these 3 fragments were also detected by the DBD probe 
(the 1.7Kb fragment hybridised only weakly to the DBD 
probe, and is barely visible on the photograph). The DBD 
probe hybridised to an additional 4 PstI fragments. Of 
these 4 fragments specific for the DBD probe, one showed 
strong hybridisation and the other 3 only weak 
hybridisation, consistent with hybridisation to fragments 
from distinct but related genes.
The LBD probe hybridised to a single, large Kpnl fragment 
of about 10-15Kb. The DBD probe hybridised weakly to this 
same fragment but very strongly to a second Kpnl fragment 
of 4.3Kb. From examination of a shorter exposure this 
strong band was probably not a doublet.
The LBD probe can be assumed to detect fragments only 
from the XenTRcK gene under these stringent conditions. If 
the DBD probe hybridised only to fragments from the XenTR<K 
gene one might expect to have seen hybridisation to one or 
two fragments not detected by the LBD probe. The fact that 
in the PstI digest 4 fragments not detected by the LBD 
probe were detected by the DBD probe suggests (but does 
not prove) that X,laevis has another gene or genes related 
to the DNA binding domain of XenTRoL This is supported by 
the EcoRI digest where 3 fragments were detected 
specifically by the DBD probe.
Results and Discussion
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This data is rather difficult to interpret without a 
restriction map of the XenTRoC gene (as distinct from- the 
cDNA which lacks introns). It would have been more 
informative to probe two identical genomic Southern blots 
with the DBD probe and then wash one at high stringency 
(detects only fragments from the XenTR®* gene) and the 
other at low stringency. Any hybridising fragments 
appearing on the filter washed at low stringency but 
absent from the filter washed at high stringency would 
clearly indicate the presence of distinct but related 
genes. However, it is clear from this experiment that the 
X. laevis genome contains only a small number of genes 
(maybe just one) with sequences related to the DNA binding 
domain of XenTRoC It is likely that one of these genes is 
the retinoic acid receptor since the DNA binding domains 
of retinoic acid receptors from other organisms most 
closely resemble the DNA binding domains of thyroid 
hormone receptors.
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C H A P T E R  2 1
Northern Blot Analysis Of Thyroid Hormone Receptor- 
Expression In Xenopus laevis.
Introduction.
I had constructed a X.laevis male liver cDNA library 
containing approximately one million recombinants which 
appeared to be of good quality on the basis of several 
tests (data not shown). I was unable to isolate any 
positive clones from this library using the v-erb-A PstI 
fragment as a hybridisation probe, suggesting that thyroid 
hormone receptor transcripts may be extremely rare in 
adult liver. However, I had been able to isolate a thyroid 
hormone receptor cDNA clone from a mature oocyte cDNA 
library. I therefore wanted to see if the XenTRo< 
transcript was present only in oocytes or whether it could 
also be detected in adult liver. Adult male liver polyA* 
RNA was analysed by northern blotting, using the M13 sub­
clone of overbl2 designated ovl219f as a hybridisation 
probe. No transcripts were detected, even when 15pg of 
liver polyA+ RNA was analysed (data not shown). Probing of 
an aliquot of the same RNA for albumin mRNA showed that 
the RNA was not degraded. It would therefore appear that 
XenTR<* is not expressed at detectable levels in adult male 
liver.
The mRNA which gave rise to the XenTRo< cDNA clone could 
be located in the oocyte itself or in the follicle cells,
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Figure 41.
Northern blot analysis of thyroid hormone receptor 
transcripts in early Xenopus development.
15jig aliquots of polyA* RNA prepared from ovary, egg and 
X.laevis embryos at various stages of development, as 
indicated above each lane, were fractionated on a 
formaldehyde agarose gel. The RNA was transferred to 
nitrocellulose and hybridised to a single stranded DNA 
probe prepared from ovl219f (see figure 30) using the prime 
cut protocol. Prehybridisation and hybridisation was in 50X 
formamide, 5*SSC, lOmM sodium phosphate (pH6.5), lOOjjg/ml 
denatured herring testis DNA, 50 i^g/ml E.coli tRNA at 42°C. 
After hybridisation, the filter was washed in 0.1*SSC at 
65°C and exposed to X-ray film for 12 days. The arrows 
indicate the positions of the 28S and 18S rRNA bands as 
detected by ethidium bromide staining of the gel.
Figure 41
W hole embryo
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or both. An easy but ambiguous way of addressing this 
question is to look for the RNA in oocytes - and 
unfertilised eggs. Xenopus eggs have lost the layer of 
follicle cells, so if the RNA is absent from eggs (but 
present in oocytes) one could tentatively conclude that 
the RNA was in the follicle cells and not in the oocyte.
Results.
Total nucleic acids were isolated from pools of 100 to 
200 JU laevis embryos at six stages of development, with 
the latest stage being stage 42-44. For the more advanced 
stages (stages 35-38 and 42-44) the majority of the DNA 
was removed by differential precipitation from 3M lithium 
chloride. PolyA+ RNA was then selected by one passage down 
an oligo d(T) cellulose column. 15jig aliquots of ovary 
polyA* RNA, egg polyA+ RNA, and each of the six embryo 
polyA+ RNA samples were electrophoresed on a formaldehyde 
agarose gel and transferred to nitrocellulose. The filters 
were then hybridised with a a single stranded DNA probe 
prepared from ovl219f (see figure 30), and the resulting 
autoradiograph is presented in figure 41. The probe 
hybridised to a rare RNA species of high molecular weight 
in ovary polyA* RNA. I am convinced that this is 
hybridisation to a specific RNA rather than high molecular 
weight DNA because this band is absent from the egg RNA 
sample and the embryo samples. These samples contained 
similar amounts of high molecular weight DNA (from
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examining the gel under U.V. light). In addition, three 
diffuse bands of lower molecular weight are visible in the 
ovary polyA* RNA track. The high molecular weight species 
is not present in egg polyA* RNA. The other three lower 
molecular weight species are much less abundant in egg 
polyA* RNA than in the ovary polyA* RNA, but a trace of 
them is visible. This would suggest that the majority of 
XenTRo< transcripts are present in the follicle cells 
surrounding the oocyte, not in the oocyte itself.
In the stage 6-7 sample a prominent band of about 4Kb is 
visible. This is a surprising finding because general 
zygotic transcription does not begin until the mid- 
bias tula transition (stage 7/8). The embryos from which 
this RNA was prepared were carefully selected to be at a 
stage prior to mid-blastula transition (MBT). However, the 
absence of transcription prior to MBT is not an absolute 
rule. It has been reported (Nakakura £t al^ , 1987) that 
some new transcription does occur prior to MBT. The other 
surprising aspect of this result is that no transcripts of 
this size are detected in the next sample (stage 9-10). 
One might expect to see a remnant of this transcript in 
latter stages even if it is being rapidly degraded as 
development proceeds. There would seem to be little logic 
in the embryo producing a very short burst of 
transcription at this early stage of development. For 
these reasons I was highly suspicious that this band could 
be due to contamination with a small amount of XenTR°<
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plasmid DNA. However, a subsequent northern blot showed 
that this band was resistant to DNasel (data not shown). 
In addition to this major band, another two bands (one of 
which is rather diffuse) are present in the stage 6-7 
sample. These same transcripts are present in RNA prepared 
from stage 9-10 embryos. The stage 10-12 sample has given 
no signal at all, and probably this RNA is degraded. A 
hint of the same two transcripts can be seen in both the 
stage 14-19 RNA and the stage 35-38 RNA (not visible on 
the photograph but visible on the autoradiograph). These 
same two bands can be seen in the RNA prepared from stage 
42-44 larvae. The stage 42-44 RNA also contains a 
transcript of about 5Kb (migrating just above the 28S 
rRNA band) which is not seen in any of the other samples. 
There are also three fainter, lower molecular weight bands 
in the stage 42-44 track, two of which are the same size 
as two of the lower molecular weight bands in the ovary 
polyA+ RNA.
In total 7 differently sized transcripts which hybridised 
to the XenTRo< probe are visible on the autoradiograph. Two 
of these transcripts are present in all of the stages of 
development analysed (ignoring stage 10-12). It should be 
noted that the abundance of these transcripts (except for 
the prominent band in stage 6-7) is low, and this 
experiment is on the limit of detection.
The existence of several different but related c-erb-A 
transcripts whose abundance varies in a developmental
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manner is intriguing. An obvious explanation for the 
origin of the different transcripts is that they arise by 
differential splicing which is developmentally regulated. 
This would not be unprecedented given that the rat thyroid 
hormone receptor alpha primary transcript has been shown 
to undergo differential splicing to generate at least 4 
slightly different mature mRNAs which show distinct tissue 
distributions.
Thyroid hormone exerts its major effect during 
metamorphosis in Xenopus. The thyroid hormone binding 
capacity of whole larvae increases markedly at stage 35 to 
40 (Tata, 1970). This corresponds to the acquisition by 
the larvae of the ability to respond to thyroid hormone 
(Tata, 1970 and Tata, 1968). Clearly, c-erb-A transcripts 
are present in embryos at stages before this time. As will 
be shown in lat er chapters, the XenTR<* cDNA encodes a 
biologically active thyroid hormone receptor able to bind 
hormone and activate transcription in a hormone dependent 
manner. However I have been unable positively to identify 
the actual transcript that gave rise to the XenTR«< cDNA 
because more than one c-erb-A RNA species is detectable in 
ovary mRNA. It is possible that the transcripts detected 
in the early developmental stages (before stage 30) encode 
receptor-like proteins that do not bind hormone.
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C H A P T E R  2 2
Expression Of The Cloned Xenopus Thyroid Hormone Receptor 
In COS Cells And Demonstration Of Hormone Binding.
Introduction.
The DNA sequence of the XenTRol cDNA clone indicated that 
it encoded a protein with a high degree of homology to 
other thyroid hormone receptors. To show that XenTR<* is a 
functional thyroid hormone receptor it is essential to 
demonstrate that it binds thyroid hormone with high 
affinity. This is especially important given that a number 
of thyroid hormone receptor cDNAs isolated from the rat 
encode proteins that are defective in hormone binding. I 
therefore decided to express XenTROi in COS cells and carry 
out hormone binding studies on extracts from these cells. 
This same expression system could then be used to assess 
whether the receptor could trans-activate transcription 
from the Xenopus albumin gene promoter or a synthetic test 
gene containing a TRE. These experiments required that the 
XenTRo<cDNA be placed in an appropriate expression vector.
22.1 Construction Of pSVLXenTRW; A Plasmid For Expressing 
XenTRtX In COS Cells.
Results.
The SV40 late expression vector pSVL was designed for 
high level transient expression in eukaryotic cells, 
particularly COS cells. It has the SV40 origin of
-257-
Construction of pSVLXenTRo* and the structure of the 
histone H3 construct pSVL-8.
0verbl2 DNA was digested with Xhol and BawHI and the 
2.3Kb insert fragment isolated from a LMP gel. This 
fragment was inserted into the SV40 expression plasmid 
pSVL, that had been digested with Xhol and BamHI, to 
generate pSVLXenTRt*. Note that transcription from the SV40 
promoter gives rise to a transcript that contains all four 
of the upstream ATG codons. pSVL8 consists of a X.laevis 
genomic fragment from a histone gene cluster containing an 
intact histone H3 gene, inserted into the BamHI site of the 
SV40 vector pSVL2. In this plasmid, transcription of the 
histone H3 gene is driven by its own promoter rather than 
the SV40 promoter.
Figure 42.
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Results and Discussion
replication which allows it to replicate efficiently in 
COS cells, and a short polylinker in front of the powerful 
SV40 late promoter. The polylinker is flanked by the SV40 
late polyadenylation signals so that transcripts of the 
inserted gene are polyadenylated. Genes inserted into the 
polylinker are translated from their own ATG codon.
The entire cDNA insert from overbl2 was inserted into the 
polylinker of pSVL as described in the legend to figure 
42, such that transcription of sense XenTR°< RNA would be 
driven by the SV40 late promoter. This plasmid was 
designated pSVLXenTRO< (figure 42). Figure 42 also 
contains a diagram of the plasmid pSVL-8 which was used as 
a control plasmid in the hormone binding experiments. This 
plasmid consists of a fragment from a Xenopus histone gene 
cluster, containing an intact histone H3 gene, inserted 
into the SV40 expression vector pSVL2. The histone H3 gene 
is expressed from its own promoter in this plasmid.
22.2 Demonstration Of Hormone Binding In COS Cells 
Transiently Transfected With pSVLXenTRoi.
Results.
Four flasks of COS cells were each transfected with lOjig 
of pSVLXenTR«* exactly as described in Materials and 
Methods. Another 4 flasks were transfected with lO^ ig of 
pSVL-8. After 48 hours incubation in media containing 
serum the cells were harvested and whole cell extracts 
prepared, keeping each flask as a separate sample. After
-258
Figure 43.
Triiodothyronine binding by XenTRO< expressed in COS cells.
Flasks of COS cells were each transfected with lO^ ig of either 
pSVLXenTRsi(XenTR) or pSVL8 (COS cell background) and whole cell 
extracts were prepared as described in chapter 3.16.
a) Various amounts of extract were incubated with 0.2nM [*^l] 
T3 in T3 binding buffer, and the amount of [*^l] T3 bound was 
determined by filtration through nitrocellulose filters and gamma 
counting (see chapter 3.17). The assay was carried out in 
duplicate with extracts prepared from different flasks of COS 
cells, and the results are presented as a graph.
b) For the Scatchard analysis, 20y\ of both extracts was 
incubated with a range of [*^l] T3 concentrations (0 to 0.8nM) 
in T3 binding buffer, and the number of counts bound was 
determined by filtration through nitrocellulose and gamma 
counting. After subtracting the background (no extract control), 
the ratio of bound to free hormone was calculated by dividing the 
counts bound by the un>bound counts (input counts minus counts 
bound). The concentration of [*^l] T3 bound was calculated, 
taking 2.3*10^ cpm to be equivalent to O.lnM [*^]I T3. COS cells 
contain significant levels of endogenous T3 binding activity (see 
figure 43a), and Scatchard analysis showed that this binding was 
of a low affinity type (data not shown). Therefore, in order to 
obtain the true values for binding of [*^l] T3 by XenTR* it was 
necessary to subtract this background, and the data are presented 
as a graph in figure 50b. From the negative inverse slope of this 
graph the Kd was calculated as 0.12nm.
c) For competition experiments, T3 binding assays were 
assembled containing 40pl of extract from COS cells transfected 
with pSVLXenTRDt, 0.5nM [*^l] T3 and various concentrations of 
the appropriate cold competitor in a final volume of 250^ il of T3 
binding buffer. After 6 hours at 4°C the counts bound were 
determined as before. 100Z binding was taken to be the number of 
counts bound in the absence of competitor. Using this figure the 
percentage of [*^l] bound in the presence of the various 
concentrations of competitor was calculated.
Figure 43
COS call
b Scatchard
c Competition
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determining the O.D.2 go of each extract, triiodothyronine 
(T3) binding assays were assembled containing 4 different 
quantities of each extract, and no extract. Equal O.D«2go 
amounts of the pSVL-8 and the pSVLXenTR* extracts were 
used. An aliquot of diluted [*^l] T3 was applied directly 
to a nitrocellulose disc and counted in the gamma counter 
in order to determine the input radioactivity. The data 
from two duplicate experiments is presented as a graph in 
figure 43a. Clearly, COS cells do possess an endogenous T3 
binding activity. Scatchard analysis and competition 
experiments showed that this was of a low affinity, non­
saturable type (data not shown). These characteristics are 
the complete opposite of the nuclear thyroid hormone 
receptor which directly effects gene expression. COS cells 
transfected with pSVLXenTR« have significantly more T3 
binding activity than those transfected with pSVL-8, 
indicating that XenTR°f does bind thyroid hormone.
22.3 Scatchard Analysis Of Triiodothyronine Binding 
To XenTRct.
Results.
A Scatchard analysis involves incubating a constant 
amount of the receptor preparation with increasing 
concentrations of [*^l] T3, and then measuring the
amount of [*^l] T3 bound. The data were processed as 
described in the legend to figure 43b, and the results are 
presented as a graph in figure 43b. From the negative
-259-
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inverse slope, the dissociation constant (K^), can be 
calculated. From the corrected plot for XenTRo< shown in 
figure 43b (endogenous binding subracted), the 
dissociation constant was calculated to be 0.12nM. This 
value is similar to the dissociation constants reported 
for other cloned thyroid hormone receptors. For example, 
rTRo< 1; 0.4nM (Murray et^  al, 1988), rTRJi 1; 0.49nM (Murray 
et al, 1988), rTRf 2; 0.46nM (Hodin et al, 1989), chicken 
TR; 0.3nM (Sap et al, 1986), ear-7; 0.38nM (Benbrook and 
Pfahl, 1987), human TR; 2.3nM (Nakai et al, 1988).
These experiments confirm that XenTR* is a high affinity 
thyroid hormone receptor.
22.4 Analogues Of Triiodothyronine Compete With [*^l] T3 
For Binding To XenTR®(.
Introduction.
Specific thyroid hormone analogues have characteristic 
competition patterns for T3 binding to native and cloned 
thyroid hormone receptors. Looking at the ability of such 
analogues to compete for [*^l] T3 binding to XenTRo< is a 
way of further characterising the receptor. Generally it 
has been found that 3' triiodoacetic acid (TRIAC) is the 
most efficient competitor while 3,3',5' triiodothyronine 
(reverse T3) competes less well than T3 itself.
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Results.
Whole cell extracts were prepared from COS cells -that 
had been transfected with either pSVL-8 or pSVLXenTR®< as 
previously described, except that the extracts prepared 
from individual flasks were pooled. Binding assays were 
carried out as detailed in the legend to figure 43c, and 
the results are presented as a graph in figure 43c.
With T3, 50X competition should in theory occur at a 
concentration of cold T3 equal to the concentration of 
[ 1251 ] i>3 £n the assay, which was 0.5nM. The competition 
curve is similar to those that have been published for 
other thyroid hormone receptors, (for example Sap et al, 
1986; Weinberger et a_l, 1986; Thompson et al, 1987; Murray 
et al, 1988)
Reverse T3 is a much less effective competitor than T3. 
Here, 50X competition occurs at about ImM reverse T3 
indicating that the Xenopus receptor binds reverse T3 with 
about a 1000 fold lower affinity than T3. This is typical 
of what has been reported for other thyroid hormone 
receptors (see references given above).
TRIAC competes for binding of [*^l] T3 to the Xenopus 
receptor more efficiently than T3 itself. 50Z competition 
occurs at just under O.lnM TRIAC indicating about a five 
fold greater affinity than for T3. This is similar to what 
has been reported for other cloned thyroid hormone 
receptors (see references given above).
The relative affinities of these analogues for the
261
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cloned Xenopus thyroid hormone receptor are consistent 
with their biological potencies.
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C H A P T E R  2 3
Trans-Activation Of Transcription From An Artificial Test 
Promoter By Thyroid Hormone, Mediated By The 
Cloned Xenopus Thyroid Hormone Receptor. 
Introduction.
Having shown that XenTRot binds thyroid hormone I wanted 
to test its ability to function as a ligand dependent 
transcription factor. In particular I wanted to find out 
if transcription from the Xenopus 68Kda albumin promoter 
could be up-regulated by thyroid hormone in the presence 
of XenTR*.
Moore and his co-workers (Brent £t al, 1989a) have 
defined a region between -190 and -167 of the rat growth 
hormone promoter as the minimal thyroid hormone response 
element (TRE). Some mutations within this sequence were 
found to actually increase the response to thyroid hormone 
and this has lead to the synthesis of artificial TREs. 
When such artificial TREs were placed upstream of the 
minimal thymidine kinase promoter they were able to confer 
inducibility by thyroid hormone in a transient 
transfection assay (Brent et_ al, 1989a). These artificial 
TREs confer greater transcriptional activation by thyroid 
hormone upon a linked promoter than any natural TRE. In 
COS cells, which are functionally deficient in thyroid 
hormone receptor, this inducibility was shown to depend 
upon co-transfection with a plasmid expressing a 
functional thyroid hormone receptor (Koenig et al, 1988).
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Figure 44.
SV40 constructs for expressing XenTRo< in COS cells and 
testing for trans-activation of the albumin promoter.
pBlueXenTRQ(HE, which lacks all the upstream ATG codons 
(see legend to figure 39), was digested with BamHI and Xhol 
and the 1.8Kb insert fragment isolated from a LMP agarose 
gel. This DNA fragment was inserted into the plasmid pSVL 
that had been digested with BamHI and Xhol to generate 
pSVLXenTKXHE (a). To construct pSVLAlbA-232, AlbA-232 DNA 
(see figure 20) was digested with Hind i , and the 700bp 
insert fragment that contains 232bp of albumin 5* flanking 
DNA (thin line) and part of the first exon (black box) 
fused to the 3* end of the histone H3 coding region 
(hatched box), and some 3' flanking DNA from the H3 gene 
(open box), was isolated from a LMP agarose gel. This 
fragment was inserted into the Hind i  site of M13mpll and 
subsequently excised with EcoRI to generate essentially the 
same fragment but with EcoRI sticky ends, as shown in the 
figure. This was inserted into the EcoRI site of pSVL to 
generate pSVLAlbA-232 (b). The orientation of the albumin 
fragment in this clone was not determined. To construct 
pSVLAlb/XenTR«, pB lueXenTRofHE DNA was digested with Xhol 
and Smal, which releases the insert intact. This insert 
fragment was gel isolated and cloned into pSVLAlbA-232 that 
had been digested with Xhol and Smal to generate 
pSVLAlb/XenTR«* (c).
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Results and Discussion
I therefore decided to test the response of one such 
artificial thyroid hormone-responsive promoter to thyroid 
hormone in COS cells co-transfected with the Xenopus 
receptor.
The plasmid designated pTK28mult (Brent et a!L, 1989b) 
contains an artificial thyroid hormone responsive 
promoter. It consists of the minimal TK promoter fused to 
the reporter gene CAT with an artificial TRE placed 
immediately upstream of the TK promoter. This artificial 
TRE is based upon the rat growth hormone gene promoter 
TRE. It is a 16 nucleotide sequence containing a perfect 
palindrome (see figure 5) and is able to confer more than 
a 20 fold induction by thyroid hormone on the TK promoter 
(Brent ¿t al, 1989b). When two copies of this sequence (in 
a direct repeat organisation) were placed in front of the 
TK promoter in the plasmid designated pTK28mult (see 
figure 5), the induction by thyroid hormone was reported 
to be 125 fold (Brent £t ¿1, 1989b).
Results.
Removal of all the upstream AUG codons from the XenTRo< 
cDNA gave rise to a plasmid called pBlueXenTR«(HE. This 
plasmid was digested with Xhol and BamHI and the 2Kb 
insert fragment which contains the whole XenTR<* cDNA, but 
without the upstream AUG codons, was inserted into 
XhoI/BamHI digested pSVL to generate the plasmid 
designated pSVLXenTRo»HE (see figure 44). This plasmid is
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Figure 45.
The Xenopus thyroid hormone receptor mediates up- 
regulation of CAT expression from the plasmid pTK28mult in 
response to thyroid hormone.
a) Two flasks of COS cells were each co-transfected with 
2jig of pTK28mult and lO^ ig of pSVLXenTlWHE. Another two 
flasks were each transfected with 2ug of pTK28mult alone. 
After transfection, the cells were cultured in media 
containing serum for 24 hours, after which they were washed 
twice with serum-free media. For the second of these washes 
the cells were incubated in serum-free media for 30 
minutes. One of each pair of flasks was then incubated in 
serum-free medium and the other in serum-free medium 
supplemented with T3 at a final concentration of 10"®M. 
After 24 hours "CAT extracts" were prepared from each flask 
of COS cells, and 5 and 20^ il of each extract assayed for 
CAT activity. The TLC plate was exposed to X-ray film for 2 
weeks after which the area of the of the plate that 
contained the acetylated form of chloramphenicol (the most 
mobile radioactive spot) was carefully scraped off and 
counted in scintillation fluid. The number of counts 
present were then converted to units of CAT and are shown 
above each track.
b) Flasks of COS cells were transfected and cultured 
exactly as described for figure 45a except that each co­
transfection was done in triplicate (a total of 6 flasks), 
and the single transfection was done in duplicate (a total 
of 4 flasks). "CAT" extracts were prepared and 20jil of each 
assayed for CAT activity. A 2 week exposure of the TLC 
plate is presented. The area of the TLC plate containing 
the acetylated form of chloramphenicol was scraped off into 
scintillation fluid and counted. The results were converted 
to units of CAT and are given above each track.
Abbreviations used are: CAT, chloramphenicol acetyl 
transferase; T3, triiodothyronine; u, units; vol., volume.
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identical to pSVLXenTRd except for the removal of the 5' 
untranslated region.
Two flasks of COS cells were each co-transfected with 2ug 
of pTK28mult and 10^g of pSVLXenTWHE. This high ratio of 
the receptor plasmid to the test plasmid was used to try 
to ensure that most of the cells which were transfected 
with the test plasmid (pTK28mult) would also receive the 
receptor expression plasmid. Another two flasks of COS 
cells were each transfected with 2jig of pTK28rault alone. 
The cells were then cultured as detailed in the legend to 
figure 45, after which whole cell extracts were prepared 
and assayed for CAT activity. Each sample was assayed in 
duplicate, with 20^1 and 5pl of extract, and the resulting 
autoradiograph is presented in figure 45a. The area of the 
TLC plate that gave rise to the upper acetylated form of 
chloramphenicol was carefully scraped off and counted in 
scintillation fluid. The results of this counting were 
converted to units of CAT enzyme and these values are also 
shown in figure 45a.
In the absence of the co-transfected receptor, pTK28mult 
produced no CAT activity above the background seen in the 
no extract control, either in the absence or presence of 
T3. It is therefore possible to argue that an induction of 
pTK28mult by T3 did occur in the absence of the co­
transfected receptor, but the assay was not sensitive 
enough to detect it.
In the presence of the co-transfected receptor, CAT
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activity was increased 6 fold by treatment with thyroid 
hormone. In the absence of added thyroid hormone - CAT 
activity was slightly above background. This may reflect 
our inability to remove all the '’endogenous" thyroid 
hormone from the cells. This experiment clearly 
demonstrates that the thyroid hormone responsive promoter 
in pTK28mult is activated by thyroid hormone only in the 
presence of the co-transfected Xenopus receptor. Given 
that other thyroid hormone receptors have been shown to 
directly effect gene expression by binding to DNA and 
activating transcription, it seems likely that the 
receptor I have cloned functions in a similar manner.
One of the problems with these types of transfection 
experiment is that one is comparing different flasks of 
cells. It can therefore be argued that differences in CAT 
activity are the result of different transfection 
efficiencies or other un-defined variations between the 
flasks of cells. I therefore repeated the experiment 
described above in triplicate, and the results are 
presented in figure 45b. This time the CAT activity in the 
absence of the co-transfected receptor was higher, 
significantly above the background of the no extract 
control. The level of T3 induction was less impressive 
than in the first experiment. It is difficult to explain 
this higher background activity given that the 
experimental conditions were the same as before. Treatment 
with T3 however, had no significant effect upon CAT
266-
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activity in the absence of the receptor.
In the presence of the receptor there is a consistent 
induction of CAT activity by thyroid hormone. On average 
the induction is only 2 fold compared to the 6 fold 
induction seen in the previous experiment. Not only was 
the background CAT activity higher in this experiment but 
the CAT activity induced by T3 was also lower. Despite 
this the experiment does confirm that XenTR«< can activate 
expression from a promoter containing a TRE in a ligand 
dependent manner.
Brent e_t a_l (1989b) reported that pTK28mult was induced 
12S fold when co- transfected into GH4C1 cells (a rat 
pituitary tumour cell line) with a plasmid expressing a 
mouse thyroid hormone receptor. One explanation for the 
low level of induction that I have observed is that I have 
not optimised the experimental conditions. The level of 
induction could probably be increased by altering the 
culture conditions or perhaps using a different cell line. 
It is also possible that the Xenopus thyroid hormone 
receptor has different sequence requirements, with respect 
to its response element, from the mouse thyroid hormone 
receptor used by Brent £t^  al^  (1989b).
Results and Discussion
C H A P T E R  2 4
XcnTRC< Mediates Transcriptional Activation Of The Xenopus 
6 8Kda Albumin Gene Promoter By Thyroid Hormone In 
A Transient Transfection Assay»
Introduction,
As discussed in the Introduction (section 1.6) there is 
some circumstantial evidence to suggest that expression of 
the Xenopus albumin genes may be regulated by thyroid 
hormone. Thyroid hormone response elements (TREs) appear 
to consist of a rather poorly conserved "half site" (see 
section 1.4.6) with the consensus sequence AGGT(^/a)A 
(Brent et al, 1989b). At least two copies of this half 
site in close proximity are required for a functional TRE, 
and these can be in either direct or inverted repeat 
orientations (see figure 6 ).
A careful examination of the sequence of the 5' flanking 
region of the Xenopus 6 8Kda albumin gene (Sweeney et al, 
1987 and figure 14) revealed one perfect copy of the half 
site at position -140 (5' TGACCT 3'). In addition, there 
are two imperfect copies of the half site in close 
proximity to the one at -140, as shown in figure 46. These 
two imperfect copies match the half site consensus at four 
out of six positions. This putative TRE is not dissimilar 
to the TREs that have been identified in the rat growth 
hormone gene, the rat alpha myosin heavy chain gene and 
the rat alpha-subunit gene (see figure 6 ). These TREs have 
one half site that matches the consensus in at least five
-268-
Figure 46.
The Xenopus 6 8Kda albumin gene promoter contains a 
putative thyroid hormone response element.
The sequence of the Xenopus 6 8Kda albumin gene promoter 
spanning nucleotides -149 to -120 relative to the 
transcription start site is shown (Sweeney et al, 1987). 
Note that in the published sequence there are 2 guanines at 
what is now nucleotide -146, but re-examination of the 
sequencing gel showed that there is in fact only a single 
guanine at this position. The six bases which match the TRE 
consensus sequence defined by Brent £t a1 (1989b) have been 
boxed. On both sides of this are imperfect copies of the 
consensus half site (marked 2 and 3). Below the sequence 
these three half sites have been aligned with the consensus 
TRE half site. Also shown is the corresponding sequence 
from the promoter of the X.laevis 74Kda serum albumin gene 
(Schorpp et al, 1987). Nucleotides which differ from the 
sequence of the 6 8Kda albumin gene are marked with a #.
F ig u re  46
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out of six positions, with the second half site matching 
the consensus at only four out of six positionsThe 
sequence of the putative TRE I have identified in the 
6 8Kda albumin gene promoter is conserved in the 
corresponding region of the 74Kda albumin gene promoter 
(Schorpp e_t a_l, 1988a) (figure 46). However, the whole of 
the 5' flanking sequence extending to about 250bp upstream 
of the CAP site is well conserved between the the 6 8 Kda 
and 74Kda genes. Given the poor conservation of thyroid 
hormone response elements it is essential to confirm the 
existence of this putative TRE in the albumin promoter in 
a functional assay. Having isolated a functional Xenopus 
thyroid hormone receptor I was in a position to carry out 
such an assay. I decided to do this by transient 
expression in COS cells. The albone construct would be 
suitable for this experiment because transcription from 
this construct can be conveniently analysed by primer 
extension. Co-transfection cannot ensure that both the 
receptor expression plasmid and the test plasmid (albone) 
are taken up by the majority of the transfected cells. I 
therefore decided to put the albone construct and the 
thyroid hormone receptor on the same plasmid. As an 
internal control I proposed to do northern blots on RNA 
prepared from the transfected cells using a probe for the 
XenTROi RNA. The level of RNA produced by transcription 
from the SV40 promoter should not be affected by thyroid 
hormone.
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24.1 Construction of suitable plasmids for testing
transcriptional activation of the 6 8 Kda albumin 
promoter in COS cells.
Results.
I decided to use the albone construct that contains 232bp 
of albumin upstream sequence. This contains the putative 
TRE we had identified at -140 in the albumin promoter. It 
also contains all the upstream sequence required for high 
level transcription in liver cells (Schorpp et al, 1988b).
For the control experiments I would need to transfect COS 
cells with the albone construct alone. I therefore decided 
to insert alboneA-232 into the unique EcoRI site of pSVL, 
which places the albumin promoter well away from the SV40 
promoter. The details of this construction are given in 
the legend to figure 44f and the resulting plasmid was 
designated pSVLAlbA-232 (figure 44b).
To make a combined receptor/albone construct the cDNA 
insert from pBlueXenTRsfHE was sub-cloned into the 
polylinker of pSVLAlbA-232 (see legend to figure 44 for 
details). The resulting plasmid contains the XenTR* cDNA 
inserted in the correct orientation downstream of the SV40 
late promoter, and was designated pSVLAlb/XenTROf (figure 
44c).
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Northern blot analysis of XenTROf transcripts in 
transfected COS cells.
Six flasks of COS cells were each transfected with lOpg 
of pSVLAlb/XenTR°(, and another 4 flasks were transfected 
with lOpg of pSVLAlbA-232. A further 2 flasks were 
transfected with 2jjg of pTK28mult, whilst 2 more were co­
transfected with 2jig of pTK28rault and lOpg of pSVLXenTWHE. 
After transfection the cells were cultured in media 
containing serum for 24 hours, and then washed twice in 
serum-free medium. For the second of these washes the cells 
were incubated in serum-free medium for 30 minutes. The 
medium was then replaced with either serum-free medium or 
serum-free medium supplemented with T3 at a final
concentration of 10"®M, as indicated. After a further 24 
hour incubation RNA was prepared from the cells as 
described in chapter 3.5.4. lOpg aliquots of each RNA 
sample was then fractionated on a formaldehyde agarose gel, 
transferred to nitrocellulose and hybridised with a 
radiolabelled, single stranded DNA probe prepared from 
ovl219f (see figure 30) using the prime cut protocol. 
Prehybridisation and hybridisation conditions were the same 
as those described in the legend to figure 41. After 
hybridisation the filter was washed in 0.1*SSC at 60°C and 
then exposed to X-ray film for 2 weeks. The arrow indicates 
the probable position of intact XenTROt RNA.
Figure 47.
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24.2 Testing for transcriptional activation of the albumin 
promoter in COS cells.
Results.
Six flasks of COS cells were each transfected with lO^ ig 
of pSVLAlb/XenTRtf, and another 4 flasks were each 
transfected with lOjig of pSVLAlhA-232. A further two 
flasks were transfected with 2jig of pTK28mult, and another 
2 were co-transfected with 2jig of pTK28mult and lOpg of 
pSVLXenTRVHE. After transfection the cells were incubated 
as described in the legend to figure 47, after which RNA 
was prepared from the cells as described in Materials and 
Methods.
lOpg of each RNA sample was electrophoresed on a 
formaldehyde gel, northern blotted, and then hybridised 
with a single stranded DNA probe prepared from the M13 
sub-clone of overbl2 designated ovl219f (see figure 30). 
After hybridisation the filter was washed in 0.1*SSC at 
60°C, and exposed to X-ray film, and the resulting 
autoradiograph is shown in figure 47.
Assuming that the thyroid hormone receptor transcript 
produced from pSVLAlb/XenTROi is terminated at the SV40 
polyadenylation signal, this RNA should be about 2Kb in 
size. The probable position of this RNA is indicated by 
the arrow in figure 47. Clearly, all the hybridisation was 
specific to those RNA samples that were prepared from COS 
cells transfected with pSVLAlb/XenTW or pSVLXenTRo( . RNA 
samples prepared from COS cells transfected with
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pSVLAlhA-232 or pTK28mult showed no hybridisation to the 
probe. I am unsure of why there was such a smear of 
hybridising material on this northern, but possibly it was 
due to some degradation of the thyroid hormone receptor 
transcript (clearly the smear is specific to cells which 
received the receptor). I assume that the major band 
indicated by the arrow represents the full length receptor 
transcript.
In all three pairs of flasks transfected with 
pSVLAlb/XenTRrt, and the pair of flasks co-transfected with 
pSVLXenTRo<HE and pTK28mult, the level of this transcript 
was significantly greater when the cells were treated with 
T3. This was surprising since the SV40 late promoter is 
not known to be thyroid hormone responsive. It is 
possible that thyroid hormone has some general effect on 
the cells such as stimulating growth or cell survival that 
lead to greater levels of transcript from the transfected 
plasmid. Alternatively, this phenomenon could be the 
result of thyroid hormone-dependent stabilisation of the 
XenTRoC transcript. Hodin e_t a_l (1989) have recently shown 
that the level of rat thyroid hormone receptor type p  2 
mRNA in a pituitary tumour cell line is markedly reduced 
by treatment with thyroid hormone. It is not known whether 
this is a transcriptional or post-transcriptional effect. 
It would perhaps not be surprising to find that thyroid 
hormone post-transcriptionally regulates the expression of 
its own receptor, and this phenomenon merits further
Primer extension analysis for albone transcripts in 
transfected COS cells.
lOpg aliquots of the same COS cell RNA samples analysed 
on the northern shown in figure 47 (see the legend to 
figure 47 for the details of the transfections), were 
annealed with end-labelled albone primer. The primer was 
extended with reverse transcriptase and the products 
fractionated through an 8Z sequencing gel. Extension 
products were detected by autoradiography for 3 days. The 
area containing the major primer extended product is shown 
enlarged at the top of the figure. Markers were end- 
labelled fragments from a digest of pBR322 with Hpall.
Figure 48.
Figure 48
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investigation. I had intended to use the level of thyroid 
hormone receptor RNA in transfected COS cells as an 
internal control for the albumin activation experiment 
(see below). The finding that thyroid hormone consistently 
increased the level of this RNA made this internal control 
inappropriate. I therefore decided to simply analyse equal 
amounts of RNA from each flask for transcripts from the 
transfected albumin promoter, relying upon repetition to 
control for variation between flasks.
The same RNA samples as analysed on the northern blot 
shown in figure 47 were analysed by primer extension with 
the albone primer, and the result is presented in figure 
48.
All the RNA samples prepared from COS cells transfected 
with a plasmid containing the AlbA-232 construct gave rise 
to a major primer extended product (indicated by the 
arrow) of between 55 and 60 nucleotides. A primer extended 
product of 57 nucleotides represents transcripts 
initiating at the correct start site. Therefore, in COS 
cells the major initiation site is at or close to the 
start site used in Xenopus liver. Further experiments 
would be needed to show that transcription was initiating 
at precisely the correct start site. This major primer 
extended product was not generated by primer extension 
analysis of RNA from COS cells transfected with pTK28mult 
proving that it is not an endogenous transcript.
In all three pairs of flasks transfected with
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pSVLAlb/XenTRot, treatment with thyroid hormone resulted 
in an increase in the level of transcripts from * the 
albumin promoter. The level of induction by thyroid 
hormone was approximately 3 to 4 fold. Of the two pairs of 
flasks transfected with pSVLAlbA-232 (which lacks the 
thyroid hormone receptor), one pair (2.3 and 2.4) showed 
no up-regulation by thyroid hormone. However, in the other 
pair of flasks (2 . 1  and 2 .2 ), the cells not treated with 
thyroid hormone showed a lower level of albumin 
transcripts, but the level of induction by thyroid hormone 
in this pair of flasks was less than that seen in the 
presence of the receptor.
An important point to note here is that the level of 
albumin transcripts synthesised in the presence of the 
receptor but the absence of hormone was lower than was 
produced in the absence of the receptor. Treatment with 
hormone increased the level of transcripts to that 
produced in the absence of the receptor. So transcription 
was not simply increased from a basal level by thyroid 
hormone treatment. Rather, in the absence of hormone, the 
receptor appears to have actively repressed transcription. 
Similar results regarding the effect of the rat thyroid 
hormone receptor type J> 1 upon transcription of a 
synthetic thyroid hormone responsive promoter have 
recently been published (Damm et^  a_l, 1989; Graupner et al, 
1989). They concluded that in the absence of its ligand, 
the thyroid hormone receptor suppressed the activity of
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the promoter. Addition of thyroid hormone resulted in the 
stimulation of expression. If this is the case then 
contrary to the simple model for the action of steroid 
hormones, the thyroid hormone receptor must be able to 
bind to the response element in the absence of ligand 
(this was discussed in some detail in the Introduction, 
section 1.4.14). One could imagine that in the absence of 
thyroid hormone, the receptor is bound to the TRE of 
thyroid hormone responsive genes but makes un-productive 
contacts with other components of the transcriptional 
machinery, thereby preventing transcription. Binding of 
thyroid hormone could induce a conformational change in 
the receptor which allows it to make productive contacts 
with other proteins thereby activating transcription.
From the experiment reported here I tentatively conclude 
that the Xenopus 6 8 Kda albumin promoter is regulated by 
thyroid hormone at the transcriptional level. Currently, 
work is under way in the laboratory to confirm these 
results. Site directed mutagenesis will be used to alter 
the DNA sequence of the putative TRE within the albumin 
promoter to see if this element is responsible for the 
apparent induction by thyroid hormone.
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General Conclusions And Discussion.
I have isolated a full length cDNA clone encoding a 
thyroid hormone receptor from a mature oocyte cDNA 
library. This receptor binds thyroid hormone with high 
affinity when expressed in COS cells. Expression from the 
thymidine kinase promoter containing an artificial thyroid 
hormone response element can be induced by thyroid hormone 
in the presence (but not in the absence) of this receptor. 
Thyroid hormone receptors isolated from other organisms 
are known to act directly upon gene expression at the 
level of transcription by binding to regulatory sequences 
within thyroid hormone responsive genes. My results with 
the Xenopus thyroid hormone receptor are consistent with 
this mode of action.
There appear to be several rare transcripts in Xenopus 
ovary which hybridised to the thyroid hormone receptor 
cDNA clone. 1 have been unable to positively identify the 
mRNA which gave rise to the cDNA clone, but it is likely 
that these transcripts detected in ovary RNA are located 
in the follicle cells rather than the oocyte itself.
Several rare transcripts which hybridised to the cDNA 
clone are also present in early embryonic stages. These 
differently sized, but clearly related, transcripts are 
suggestive of differential splicing.
Synthetic RNA prepared from the entire cDNA translates
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very poorly in vitro and this is almost certainly due to 
the presence of several AUG codons upstream of the long 
open reading frame. These upstream AUG codons and the 
resulting poor translation are characteristics of 
virtually all the thyroid hormone receptors that have been 
cloned so far. Such upstream AUG codons are often 
indicative of differential splicing and indeed it has been 
shown that in the rat, a primary transcript is alternately 
spliced to generate at least four mature c-erb-A rnRNAs. 
Presumably the mRNA which gave rise to the Xenopus thyroid 
hormone receptor that I have isolated is translated poorly 
in vivo as well as iji vitro.
Thyroid hormone is known to play a vital role in inducing 
the many biochemical and physiological changes that occur 
during amphibian metamorphosis. It is almost certain that 
some of these changes are the result of the activation and 
repression of specific genes at a transcriptional level. 
It will be of great interest to look for thyroid hormone 
receptor transcript(s) during metamorphosis. One might 
expect to see a dramatic increase in the levels of 
transcripts encoding the receptor at the onset of 
metamorphosis. The adult 63Kd keratin genes are an example 
of genes whose expression is known to be induced by 
thyroid hormone during Xenopus metamorphosis (Mathisen and 
Miller, 1989). It is not known whether this induction is 
caused by the binding of a thyroid hormone/receptor 
complex to cis-acting regulatory sequences within the
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promoter, but this seems a likely possibility. However, 
unlike the rat growth hormone gene, the induction by 
thyroid hormone is not reversible (Mathisen and Miller, 
1989), suggesting that the thyroid hormone receptor 
complex is only required for the initial induction of 
expression and not for the maintenance of gene expression.
I have demonstrated that transcription of the Xenopus 
albumin genes is activated at the onset of metamorphosis, 
so these are also candidates for genes that are regulated 
by thyroid hormone. From my experiments I tentatively 
conclude that thyroid hormone does increase expression of 
the 6 8Kda albumin gene, at the level of the messenger RNA, 
and that this increase requires the presence of the 
(Xenopus) thyroid hormone receptor. The liver-specific 
expression of albumin genes from Xenopus and other 
organisms is known to be controlled at the level of 
transcription by liver-specific trans-acting factors which 
interact with regulatory sequences upstream of these 
genes. _I_n vivo, in the developing liver, transcription of 
the Xenopus albumin genes might require the presence of 
both tissue-specific trans-acting factors and the thyroid 
hormone receptor complex. I was unable to detect thyroid 
hormone receptor transcripts in adult Xenopus liver, 
suggesting that, as has been reported for the Xenopus 
keratin genes, thyroid hormone might only be required to 
activate albumin gene transcription and not to maintain it 
later in development.
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